fbpx

Search NGU Website

Academics

Academics

School of Pharmacy

About the School:
Through collaborating with UCL School of pharmacy, ranking 4th on the world, Newgiza University utilizes existing UCL teaching and assessment resources, delivering the NGU program that produces distinctive NGU Pharmacists.

Vision:
Create a community of interdisciplinary researchers, professors and students who foster excellence and encourage innovation. This community will spearhead academic and scientific advancement in the region and across the world by building a solid foundation for the 21st century learning.

Mission:
The School of Pharmacy – Newgiza University aims to prepare graduates with competitive competencies who are able to meet the requirements of the pharmaceutical labor market locally and internationally, patient-centered, contribute to raise the health care level, relying on qualified human cadres, a distinguished international educational program, a supportive environment for innovation and scientific research, and active participation in community service while preserving social values.

Dr. Manal Maher,
Dean of the School of Pharmacy

As the first dean and founder of the Newgiza University School of Pharmacy, Prof. Manal Mohamed Maher Hussein has been committed to graduating future leaders and advancing the pharmacy practice. Prior to becoming the dean in 2016, Prof. Manal is a professor of microbiology and immunology and held several positions at the Faculty of Pharmacy, Cairo University including, Acting Dean (7/2014-12/2014); Vice-Dean for Education and Students Affairs (2011-2016); Coordinator of the Clinical Pharmacy Program (2009-2011). Dr. Maher participated in the implementation of the Clinical Pharmacy Program until the first graduated class in 2011.
She is a former member of the Promotion Committee of Professors and Associate Professors for Microbiology and Immunology.
Her research areas of interest are microbial resistance, fermentation technology, and the development of new vaccines and biotechnological products. Dr. Manal was the PI investigator in two research projects covering the process development for the industrial production of Rifamycin B and the feasibility study for a cost-effective process for the production of Rifamycin B. Awarded a Patent No. (200312062) titled “Process for Production of Rifamycin B using improved bacterial strain”

1. Continuous development of the educational process, students support, and enhance competitiveness.

2. Enhancement of the institutional capacity and development of the institutional evaluation systems.

3. Development of scientific research and creating postgraduate programs.

4. Enhancement of the community role of the school and supporting graduates.

1. Qualify the school to apply for accreditation from the National Authority for Quality Assurance and Accreditation of Education “NAQAAE”.

2. Review and develop the educational programme.

3. Continuous development of the capabilities of staff members and TAs.

4. Continuous development of the student support system to build a distinguished personality capable of competing locally and internationally.

5. Enhance the competitive position of the school.

6. Continue to support and develop the infrastructure.

7. Develop the organizational structure and the capabilities of the administrative staff.

8. Develop the quality management system and self-assessment.

9. Support the research environment within the school.

10. Support excellence and innovation in scientific research and encourage international publication, joint, and applied research.

11. Start offering postgraduate programs.

12. Develop and support community service activities.

13. Serve the internal environment and deal effectively with crises and disasters.

14. Support and communicate with alumni.

1. Honesty

2. Respect and teamwork support

3. Scientific integrity

4. Discipline, capacity building, and continuous development

5. Compassion

6. Fairness, justice, and transparency

7. Diversity

8. Excellent professional performance

9. Creativity and innovation

  • A modern, fit-for-purpose course adapted directly from that delivered by UCL, one of the world’s top pharmacy schools (ranked 4th Worldwide).
  • Course designed with University College London (UCL) to provide the professional experience, knowledge, and leadership skills that UCL students enjoy, delivered in a context relevant to the region.
  • Inter-professional education to allow pharmacy students to learn alongside medical and dental students, leading to greater cooperation with the healthcare team and enhanced patient care.
  • Research-focused module that delivers an intimate exposure to research techniques with different outcomes as posters and published manuscripts.
  • Incorporating clinical pharmacy from the very first year, accounting for over 25% of the entire curriculum, with state-of-the-art training facilities on-campus with a modern teaching dispensary.
  • Emphasis on producing leaders with the skills to embrace the future direction of the profession.
  • Emphasizing on experiential learning in placements including JCI-accredited hospitals, community pharmacies, and industrial pharmaceutical companies, as well as in the classroom to produce future leaders of the profession.
  • A newly built university in a beautiful setting, purpose-designed to enhance the student experience in healthcare subjects.
  • Flipped classroom approach in the senior year via self-study on cutting edge topics.
  • A vibrant on-campus student life with numerous clubs, events, and activities offering a unique environment to explore the students’ hidden talents.
  • Provides valuable opportunities to start with their careers by organizing fairs and internships giving students a significant advantage in their professional journeys.
  • Maintaining a low student-to-teacher ratio, enabling dedicated attention to student progress and success, in addition to providing academic support throughout their degree programs.

The NGU School of Pharmacy has an education collaboration with University College London (UCL), enhancing its academic capabilities, as well as offering world-renowned undergraduate program, providing both the school and students with ample opportunities for development on an academic and personal level.

This collaboration ensured that the highest international standards in teaching and research are met at NGU, with highly qualified faculty members providing instruction and supervision. As part of this collaboration, senior faculty, and staff from UCL worked with their NGU colleagues in strategic planning and organization of the new programs, setting up appropriate infrastructure and education governance structures, developing curricula and learning resources, faculty and senior staff recruitment, faculty development, course evaluation and education quality assurance. Where appropriate, NGU utilizes existing UCL teaching and assessment resources to deliver its programs.

Having currently ranked 9th on the QS World University Rankings 2025, and consistently placed in the top 20 of various global university rankings, UCL is widely recognized for its research capabilities and contributions to sciences and innovations. It was rated 2nd in the UK for research power in the Research Excellence Framework 2021. Moreover, UCL boasts 30 Nobel Prize winners, and was recently selected as University of the Year 2024 (The Times and Sunday Times Good University Guide 2024).

The UCL School of Pharmacy is one of the most highly rated pharmacy schools in the UK. It is currently rated 4th in the world by the QS Ranking (Pharmacy and Pharmacology 2023), as well as 3rd in the Shanghai Ranking (Pharmacy and Pharmaceutical Science 2022).

Newgiza University (NGU) was established as a private university by a presidential Decree “93” in April 2010. NGU schools were acknowledged by the Ministry of Higher Education (MHE) and the Supreme Council of Universities (SCU).

The School of Pharmacy was acknowledged by decree “4565” in September 2016. 

The School of Pharmacy is accredited by National Authority for Quality Assurance & Accreditation of Education (NAQAAE) on the 24th of April 2024.

 

NGU School of Pharmacy offers the Bachelor of Pharmacy BPharm (PharmD) program of six academic years in duration (10 semesters and a year of compulsory training). The program includes an Introductory Semester that is shared with other health education programs at NGU (Medicine and Dentistry).  Successful completion of the six-year program will result in the award of the BPharm (PharmD).

The BPharm (PharmD) program at NGU School of Pharmacy contains 198 credit units (20 credit units per semester for 9 semesters, plus 18 credit units for the introductory semester).  These credit units do not represent only contact hours, but the total learning effort required to achieve the learning outcomes including direct contact hours in classrooms, small groups and practical classes, workplace-based learning in clinical placements, project work and self-directed learning.  A credit unit is considered to be equivalent to 25-30 hours of study time.

The program is compliant with the competency based National Academic Reference Standards (NARS) for Pharmacy education, 2nd edition, 2017, approved by the National Authority of Quality Assurance and Accreditation of Education (NAQAAE).

The program adopts diverse teaching and learning strategies, including directed and independent studies. Accordingly, both traditional and non-traditional methods of teaching and learning are applied to achieve the competencies of the educational program and its objectives and to harmonize the graduate’s specifications with the requirements of the labor market and community service. It also adopts various students’ assessment methods:

  1. Formative assessments: based on continuous non-graded evaluation of students during each semester through Post-lecture quizzesFormative examinations
  2. Summative assessments: graded evaluations of students at the end of each semester through Coursework – Calculations – Formulary – Practical – OSPE & OSCE – Summative written examinations
  3. Other assessments: Some modules include graded different assessments like Portfolio & E. Portfolio – Assignments – Research papers – Posters – Presentations and Discussions

MODULES:

Year 1 – Semester 1

IM 1.1.01 [Introductory module]:

The module provides students with a firm foundation in the knowledge, skills and orientations they will need in order to become safe, effective and patient-centered practitioners and to prepare them to appreciate and understand the later learning in their health professions programme.  It is run jointly between Pharmacy, Medicine, and Dentistry in order to foster a spirit of inter-professional collaboration.

Year 1 – Semester 2

PHAR101 [The role of the pharmacist in healthcare]:

The module introduces students to their future role as pharmacists and to the current and evolving pharmacy profession and to prepare students for roles as healthcare professionals, they need to understand the responsibilities they have towards their patients and other members of the health care team.  A “Top 25” drugs list is introduced.
PHAR102 [Body systems and therapeutics 1]:

The module provides a solid foundation of the biological sciences that underpin the clinical therapeutic uses of a drug.  Cell biology and biochemistry, cell and organ system function, whole body physiology and pharmacology are introduced and discussed.  The more applied sciences, such as receptor theory, mechanisms of drug action and pharmacokinetics, build upon this foundation and provide a basis for the systems-based therapeutics modules in subsequent years.

 

Year 2 – Semester 1

PHAR 201 [Chemistry of medicines]:

The module provides a solid foundation of the chemical sciences that underpin the use of a drug in its broadest sense.  In addition, organic, physical, and analytical chemistry concepts are introduced and discussed in detail.  Students will be introduced to the practical aspects of chemical synthesis and analysis of raw materials and formulated products.

PHAR 202 [Making safe and effective medicines]:

The module provides a basis for the formulation and manufacture of safe and effective medicines, both sterile and non-sterile, with particular emphasis on liquid and semi-solid systems.  It incorporates appreciation of the routes available for the administration of a drug to a patient, the physico-chemical aspects of formulations and dosage forms, and the considerations pertinent to manufacture in practice.  Students will be introduced to the practical aspects of producing liquid and semi-solid pharmaceutical formulations and will demonstrate competency in the safe and professional preparation of such dosage forms.  Also, students will be introduced to Radiopharmacy.

Year 2 – Semester 2

PHAR 203 [Clinical and professional considerations]:

The module develops the students in preparation for their future role as pharmacists and the current and evolving pharmacy profession.  The “Top 25” drugs list is extended to a “Top 50”.

PHAR 204 [Body Systems and Therapeutics 2]:

The module introduces students to the concept of clinical therapeutics, demonstrating how drug utilisation is firmly grounded in the pharmaceutical and pharmacological sciences.  It concentrates on the cardiovascular, renal and endocrine systems and will provide a solid underpinning knowledge of the structure and function of these body systems.  Students will understand and be able to explain the aetiology and pathophysiology of typical disease states of these systems and the scientific rationale behind relevant therapeutic interventions.

Year 3 – Semester 1

PHAR 301 [Body Systems and Therapeutics 3]:

The module continues the theme of clinical therapeutics, demonstrating how drug utilisation is firmly grounded in the pharmaceutical and pharmacological sciences.  It concentrates on the central nervous system, the gastro-intestinal system, the liver, the skin and the eye and will provide a solid underpinning knowledge of the structure and function of these body systems.  Students will understand and be able to explain the aetiology and pathophysiology of typical disease states of these systems and the scientific rationale behind relevant therapeutic interventions.

PHAR 302 [Medicines from the bench to the clinic]:

The module describes the processes involved in the discovery, development and testing of a new molecule, i.e. its journey from the laboratory bench to clinical use.  Medicinal chemistry principles are introduced and illuminated by detailed discussions on the use of modern methods in the synthetic and structural elucidation processes.  The legal aspects of drug development, such as clinical trials, safety assessment studies, the worldwide regulatory framework and post-marketing surveillance and pharmacovigilance, are considered.  Conventional drug delivery methods are also described in detail along with their underpinning physical science.  Pharmacokinetic principles are revisited and their importance in the drug discovery and development processes stressed.  Dose regimen calculations are taught.

Year 3 – Semester 2:

PHAR 303 [Body Systems and Therapeutics 4]:

The module continues the theme of clinical therapeutics, demonstrating how drug utilisation is firmly grounded in the pharmaceutical and pharmacological sciences.  It concentrates on the immune system, disease relating to inflammation, infectious diseases, respiratory diseases, and cancer, providing a solid foundation of the relevant biological principles.  Students will understand and be able to explain the aetiology and pathophysiology of typical disease states of these systems and the scientific rationale behind relevant therapeutic interventions.
PHAR 304 [Communicating science and practice]:

The module concentrates on the management and supportive care for patients with diseases of the central nervous system, gastro-intestinal systems, the liver, skin, eyes, immune system, diseases related to inflammation, infectious disease, respiratory diseases and cancer from the clinical perspective. Cancer management, toxicities of chemotherapy, supportive treatment and dietary care for cancer patients is also addressed. The “Top 50” drugs list is extended to a “Top 75”.

Year 4 – Semester 1:

PHAR 401 [Future design and delivery of medicines]:

The module explores some of the more advanced technologies used in the discovery and formulation of new drug molecules and production of the formulated product.  The special challenges in formulating peptide and protein drugs and biological molecules are considered in depth.  Vesicular structures and nano-scale structures are discussed as potential drug carriers.  Gene therapy is introduced and debated from a scientific and ethical perspective.  The fundamental principles of biotechnology are introduced.  Current and potential medical devices are described, with a consideration of associated quality issues.

PHAR 402 [Life skills and professional skills]:

The module explores the research methodology for modern healthcare professionals.  Research ethics and the requirement for data protection and confidentiality will be discussed. The module also develops students’ personal skills in areas such as written and oral communication.

Year 4 – Semester 2:

PHAR 403 [Electives]:

The module splits into two complementary strands.  Strand A allows students to further develop expertise in a specific area of current pharmacy practice.  Strand B introduces students to an area of study at the cutting edge of science and practice.

PHAR 404 [Experiential placement]:

The module explores experiential placements as a mandatory requirement for graduation in Egypt and hence this will serve to ensure that suitable high-quality experiences are available for all students.

Year 5 – Semester 1:

PHAR 501 [Independent research project]:

The module implements a laboratory-based, practice-based or data/literature/theory-based research project.  Each student should present a poster and a research paper independently and assessed individually.

Year 5 – Semester 2:

PHAR 502 [Advancing practice through science]:

The module employes a flexible, highly student-centered approach which brings together new advances in science and practice while revisiting topics previously covered.  It represents the provision of new and cutting-edge topics.

PHAR 503 [Preparation for professional practice]:

The module provides a range of learning opportunities to prepare students as medicines experts within the health care system. for this crucial responsibility. It explores hospital pharmacy; pharmacist roles and models of practice, the standards of practice, technology used in pharmacy, and the distributive functions of the pharmacy. Complex patients and complex situations are explored, with attention to evidence-based practice, ethical issues, and professionalism.  The “Top 75” drugs list is extended to a “Top 100”.

Hospital or health system pharmacy and advanced pharmacy practice experience (APPE).

Activity Training Award
Title Awards for Compulsory Training at Imbaba General Hospital
Date 05 February 2026
Location Imbaba General Hospital
Participants Students: 2 – Y 6
Details
  • At the end of the third training round at Imbaba General Hospital, our Year 6 students were honored with several awards at the closing ceremony held at Imbaba General Hospital on Thursday, February 05, 2026.
  • Rinad Mohamed has achieved an award for Best Presentation
  • Mariam Mahmoud has achieved an award for Best Flyer and Flyer Book Assembly

Activity Training Award
Title Awards for Compulsory Training at Imbaba General Hospital
Date 25 December 2025
Location Imbaba General Hospital
Participants Students: 6 – Y 6
Details
  • At the end of the second training round at Imbaba General Hospital, our Year 6 students from the School of Pharmacy have left an unforgettable mark of excellence through their exceptional performance, remarkable creativity, professionalism, hard work, and dedication throughout their training round at the Hospital. The students were honored with several awards at the closing ceremony held at Imbaba General Hospital on Thursday, December 25, 2025, in the presence of the President of the Giza Pharmacists Syndicate.
  • Fatma Eid Hafez has achieved 3 awards for:

– Best Poster

– Best Flyer

– Best Case Presentation

  • Laila Hisham has achieved 2 awards for:

– Best Poster

– Best Flyer

  • Marwan Mohamed and Al-Zahraa Alaa have achieved awards for Best flyers
  • Hadeer Adel has achieved an award for Best posters
  • Habiba Samir was awarded for her participation in the hospital newsletter although she was not involved in this training round at the hospital.

Activity Training Award
Title Awards for Compulsory Training at Imbaba General Hospital
Date 13 November 2025
Location Imbaba General Hospital
Participants Students: 8 – Y 6
Details
  • At the end of the first training round at Imbaba General Hospital, our Year 6 students from the School of Pharmacy have left an unforgettable mark of excellence through their exceptional performance, remarkable creativity, professionalism, hard work, and dedication throughout their training round at the Hospital. The students were honored with several awards at the closing ceremony held at Imbaba General Hospital on Thursday, November 13, 2025.
  • Habiba Samir has achieved several awards include:

– Best Flyer and Poster for her amazing Pharmacovigilance video

– Volunteering in the preparation of the Oncology booklet

– Best Pediatrics Presentation

– Best Scientific Journal Club at Imbaba General Hospital

  • Jana Elhelw has achieved 2 awards for:

– Volunteering in the preparation of the booklet about Medicines and Cases

– Best Case Presentation

  • Ahmed Abdelfatah has achieved 2 awards for:

– Volunteering in the design of the booklet about Clinical Nutrition

– Best second NICU Presentation

  • Merna Farahat, Hossam Naguib, Rawan Akram, Hadeer Adel, and Mohamed Ayman Abdelmongy have achieved awards for Best Flyers

Activity Awards
Title Compulsory training for Year 6 students at Imbaba General Hospital
Students Year 6 students (14)
Date November 2024
Details
  • As the journey at Imbaba General Hospital comes to an end, our Year 6 students from the School of Pharmacy have left an unforgettable mark of excellence. Over the past six weeks of training, they demonstrated remarkable dedication, creativity, and professionalism.
  • We are proud to announce their outstanding achievements:

– 8 Awards for Flyers Design & Presentation

– 3 Awards for Posters

– 1 Award for Journal Club

– 1 Award for Case Presentations

– 1 Award for Drug Formulary Book

And to top it off, 2 of our talented students delivered a compelling summary presentation, beautifully encapsulating the entire training experience.

Activity Scientific Research
Title Research Abroad
Date October – December 2025
Organizer PHAR501 module
Participants Students: 4 – Y5
Details
  • Ruba Ahmed, Y5 student, traveled to conduct the practical part of the research for (PHAR501) module at Edinburgh Napier University, Scotland, from October to November 2025.
  • Zeina Hatem, Y5 student, traveled to conduct the practical part of the research for (PHAR501) module in Dr. Gupta’s laboratory at St. John’s University, USA, from October to December 2025.
  • Also, Rana Hani and Rawan Ali, Y5 students, traveled to conduct the practical part of their researches for (PHAR501) module at Kingstone University, England, from October to December 2025.

  1. Research labs: 4 multi-disciplinary research labs.
  2. Instruments: 50 modern lab instruments like HPLC Apparatus, Spectrophotometer, Flow Cytometer, Lyovapor, Rotary evaporator, Cooling Centrifuge, Biological inverted microscope, CO2 incubator, Ultra-low temperature deep freezer, laminar flow, and others.
  3. NGU Research Center: includes General lab, Two cell cultures labs, Tissue microarray lab, and 25 modern lab instruments like Immunofluorescent microscope, Gel-electrophoresis System, Double-beam Spectrophotometer, Multimode Microplate reader, StepOne & Quantstudio ABI Real Time qPCR, HPLC-UV/FI, -80oC freezer, and others.
  4. Animal House.

 

Research Areas:

1.      Pharmacotherapy role in improvement of disease outcomes
2.      Therapeutic Drug Monitoring.
3.      Drug interactions.
4.      Pharmacogenomics.
5.      Nutrigenomics.
6.      Pharmacoeconomics.
7.      Herbal medicines and tissue culture.
8.      Standardization of drugs.
9.      Formulation and evaluation of nano-drug delivery systems.
10.  Biopharmaceuticals (Biosimilars, Bioinformatics, Gene therapy, and recombinant DNA).
11.  Water resources.
12.  Cancers.
13.  Hepatic diseases.
14.  Metabolic disorders (Obesity and Diabetes).
15.  Cardiovascular diseases (Hypertension).
16.  Central nervous system and neurodegenerative diseases.
17.  Infectious diseases.
18.  Development and fabrication of Advanced Drug Delivery.
19.  Targeted Drug Delivery systems.
20.  Biopharmaceutics and Pharmacokinetics optimization.
21.  Patient centric formulations.

 

 

                                     Project title

Grant entity

         Fund

      Year

                                                                     NGU hosted research projects

1.       Capacity building for studying immunological response for the treatment of Hepatitis C virus

Prof. Nourtan Abdeltawab (PI)

 

NIH

180.000 USD

July 2023

Running

2.       Assessment of biosimilarity and interchangeability of locally produced biopharmaceuticals using statistically guided orthogonal testing protocols at industrial scale

Prof. Medhat Al-Ghobashy (PI)

Prof. Ahmed Sherif Attia

A/Prof. Mohamed Abdullah

 

STDF

5,000,000 EP

May

2019

Running

                                                        Research projects with NGU staff participation

3.       Formulation and Evaluation of Intranasal Glucagon-Like Peptide-1 Receptor Agonist-Loaded Nanoparticle System for Enhanced Bioavailability and Cognitive Disorder Studies

Prof. Mohamed Hassan AbouGhaly

 

STDF

3,499,200 EP

December

2025

Running

4.       Repurposing antivirals as novel anti-cancer drugs targeting structural and functional similarities between viral proteins and cancer (funded by NRC).

A/Prof. Sally Atef Tadros

 

CNR

Running

5.       The production of nanobodies using the yeast display technology as a non-conventional tool for precision medicine in infective diseases & beyond”

Prof. Ahmed Sherif Attia (PI)

Prof. Medhat Al-Ghobashy

 

ASRT

1,600,000 EP

December

2020

Running

6.       Towards the Establishment of a Globally Compliant Egyptian Active Pharmaceutical Ingredient Facility for Critical Diseases

A/Prof. Ahmed ElKerdawy

 

ASRT

10,000,000 EP

April

2020

Closed

7.       Development of Novel EGF Receptor Inhibitors Targeting Non-Small Cell Lung Cancer (NSCLC)

A/Prof. Ahmed ElKerdawy

 

STDF

100,000 EP

October

2019

Closed

8.       To Determine the Capability of the Cardioprotective Cyclocreatine Phosphate to Reduce the Progression of Myocardial Infarction to Heart Failure in the Standard ISO Rat Model

Prof. Medhat Al-Ghobashy

 

ASRT

1,000,000 EP

November

2018

Closed

9.       Design, Synthesis, and Biological Evaluation of Novel Raf -1/VEGFR-2 Inhibitors as Antiangiogenic Agents

A/Prof. Ahmed ElKerdawy

 

STDF

100,000 EP

October

2019

Closed

10.   Synthesis and biological evaluation of novel fibrates as antihyperlipidemic agents

A/Prof. Ahmed ElKerdawy

 

STDF

100,000 EP

October

2019

Closed

11.   Design, Synthesis and Biological Evaluation of Novel Chalcone-based Fibrates as Novel PPAR-α Agonists

A/Prof. Ahmed ElKerdawy

 

CNR

250,000 EP

March

2018

Closed

12.   Development of Novel VEGF Tyrosine Kinase Receptor Antagonists Utilizing Molecular Modeling Techniques

A/Prof. Ahmed ElKerdawy

 

STDF

100,000 EP

March

2017

Closed

13.   Formulation and Evaluation of Surface Functionalized Nanoparticles Enclosing Myelin Basic Protein for Treatment of Multiple Sclerosis

Prof. Medhat Al-Ghobashy (PI)

Prof. Ahmed Sherif Attia

A/Prof. Mohamed Abdullah

A/Prof. Muhammad Al-Shorbagy

 

STDF

100,000 EP

April

2016

Closed

Total number of international publications 277 Total citations 4055
Serial Publications IF Citations
1.      R.M. Essam, Y.S. Mohamed, S.S. El-Sayed, N.M. Kamel, Linking KATP channel activation to p-AKT/mTORC1/eEF2/BDNF axis unravels Nicorandil’s promise in countering acetaminophen-induced hepatic encephalopathy in mice, Life Sci 366–367 (2025) 123477.

https://doi.org/10.1016/j.lfs.2025.123477.

5.1 2
2.      R.M. Abdelsalam, H.W. Hamam, N.M. Eissa, A.E. El-Sahar, R.M. Essam, Empagliflozin Dampens Doxorubicin-Induced Chemobrain in Rats: The Possible Involvement of Oxidative Stress and PI3K/Akt/mTOR/NF-κB/TNF-α Signaling Pathways, Mol Neurobiol 62 (2025) 3480–3492.

https://doi.org/10.1007/s12035-024-04499-5.

4.3 7
3.      N.S. Abdel Razek, N.N. Nassar, R.H. Sayed, A.E. El-Sahar, D.M. Abdallah, Liraglutide orchestrates ferroptosis defense against murine cisplatin acute kidney injury: NRF2 activation via both KEAP1-dependent and -independent mechanisms is essential for SLC7A11/GPX4 renoprotection, Journal of Trace Elements in Medicine and Biology 92 (2025) 127755.

https://doi.org/10.1016/j.jtemb.2025.127755.

3.3 0
4.      M.-A.M. Kamal, R.M. Essam, N.F. Abdelkader, H.F. Zaki, Modafinil Ameliorated Fibromyalgia Syndrome in Rats by Modulating Mast Cells and Microglia Activation Through Dopamine/Substance P/MRGPRX/Histamine and PI3K/p-Akt/NF-κB Signaling Pathways, Journal of Neuroimmune Pharmacology 20 (2025) 38.

https://doi.org/10.1007/s11481-025-10194-6.

3.5 2
5.      M.A.E. Saad, R.H. Sayed, A.E. El-Sahar, N.H. Sayed, M.A. Kortam, N. Fathy, Ameliorative effect of palonosetron against binge alcohol-induced neurodamage via targeting miR-155/AKT/mTOR/AMPK-mediated autophagic pathway, Arch Biochem Biophys 771 (2025) 110525. https://doi.org/10.1016/j.abb.2025.110525. 3 0
6.      M.A. Saad, A.A. Rastanawi, A.E. El-Sahar, A. A. Z. El-Bahy, Ascorbic acid Mitigates behavioural disturbances associated with letrozole-induced PCOS via switching-off JAK2/STAT5 and JAK2/ERK1/2 pathways in rat hippocampus, Steroids 213 (2025) 109528.

https://doi.org/10.1016/j.steroids.2024.109528.

2.3 1
7.      H. Shoukry, A.A. Elsherbiny, S.A. Fahim, Bioinformatics analysis to explore the potential prognostic utility of hsa-miR-103a-3p in head and neck squamous cell carcinoma, Sci Rep 15 (2025) 41159.

https://doi.org/10.1038/s41598-025-26188-6.

3.9 0
8.      S.A. Fahim, Y.M. Attia, A. Messiha, A.Y. Nabawy, F. Refaat, W.H. El-Maadawy, Comparative safety and side effects of semaglutide and tirzepatide: Implications for clinical decision-making in obesity management, Biomedicine & Pharmacotherapy 193 (2025) 118731.

https://doi.org/10.1016/j.biopha.2025.118731.

7.5 0
9.      S.A. Fahim, M.Y. Al-Shorbagy, R.H. Sayed, A. Messiha, M.A. Saad, Enhancing mood post-bariatric surgery: Associations of rosuvastatin with vitamin D, oxidative stress, and neurotransmitter-related outcomes in rats, Biomedicine & Pharmacotherapy 192 (2025) 118582. https://doi.org/10.1016/j.biopha.2025.118582. 7.5 0
10.   A. Mostafa, A. Abusree Ahmed, R.T.M. Hassanien, H. Mahfouz, M. Salah, H.M. Amr, S.A. Fahim, Emerging role of hsa_circ_0000652, hsa-miR-21, SMAD2, and Foxo1 in type 2 diabetes mellitus pathogenesis, Human Gene 43 (2025) 201386.

https://doi.org/10.1016/j.humgen.2025.201386.

0.7 2
11.   W.H. El-Maadawy, E. Hafiz, S.A. Tadros, S.A. Fahim, H.M. Ebrahim, M.A. Fouad, Y.M. Attia, Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies, Sci Rep 15 (2025) 20118. https://doi.org/10.1038/s41598-025-04267-y. 3.9 0
12.   Y.M. Attia, S.A. Tadros, S.A. Fahim, D.M. Badr, Role of noncoding RNA as a pacemaker in cancer stem cell regulation: a review article, J Egypt Natl Canc Inst 37 (2025) 9. https://doi.org/10.1186/s43046-025-00266-2. 1.8 0
13.   M. Hassan, W.H. El-Maadawy, S.A. Fahim, S.M. Youssef, O.M. Badran, M. Balata, Integrating CTLA-4 Genetics and Soluble Isoforms for the Stratification of HCV-Related Hepatocellular Carcinoma Risk and Aggressiveness, Int J Mol Sci 26 (2025) 11067. https://doi.org/10.3390/ijms262211067. 4.9 0
14.   M. Hassan, W.H. El-Maadawy, Y. Elhusseny, F.E. Agamy, S.A. Fahim, M. Balata, Genetic Variants and Soluble Isoforms of PD-1/PD-L1 as Novel Biomarkers for Pancreatic Ductal Adenocarcinoma (PDAC) Susceptibility and Prognosis, Biomedicines 13 (2025) 2246. https://doi.org/10.3390/biomedicines13092246. 3.9 2
15.   Y.K.A. Rabou, A.A. Zayed, S.A. Fahim, M. Abdelgwad, A. El Fiki, N.N. Fayed, Exploring New and Promising Genetic Biomarkers for Evaluating Traumatic Brain Injuries: A Case-Control Study, Neurochem Res 50 (2025) 48. https://doi.org/10.1007/s11064-024-04292-9. 3.8 2
16.   S. Farouk, M.M. Elbrashy, R.I. Moustafa, R.M. El-Shenawy, N.M. Helmy, A. Khairy, N.G. Bader El Din, Unique dysregulation of miR-7, miR-15, and miR-203 as novel biomarkers in Egyptian colorectal cancer, Biomark Med 19 (2025) 999–1008.

https://doi.org/10.1080/17520363.2025.2585779.

2.1 0
17.   L.J. Abdel-Hafez, M.S. Basiouny, I.Y. Mostafa, R. Moustafa, K. Abuelhaded, H.M. Abd-Elhalim, A.A.S. Shaker, H. Elsayed, O. Salem, A.M.M. Sarguos, A.H.I. Faraag, Investigation of the Antibacterial Effectiveness of Hybrid Recombinant Bacteriocins Circular Enterocin and Pyocin L1 Derived from Pseudomonas aeruginosa and Enterococcus faecalis, Biochem Genet (2025).

https://doi.org/10.1007/s10528-025-11149-5.

1.6 1
18.   R.M. Kamal, A.M. El-Halawany, M.S. Hifnawy, A.M. Otify, W.G. Fahmy, N.M. Elhosseiny, A.S. Attia, B.M. Eltanany, L. Pont, F. Benavente, I.Y. Younis, M.M. Sabry, Targeting Acinetobacter baumannii lipase by coniferous species through metabolomics supported approach, Sci Rep 15 (2025) 32649.

https://doi.org/10.1038/s41598-025-16654-6.

3.9 0
19.   M.A. ELBANNA, S.A. ELBANNA, F. ABDELSAYED, M. ABD-EL-GHAFOUR, WHICH ORAL HYGIENE PROTOCOL SHOULD BE FOLLOWED BY PATIENTS WITH FIXED ORTHODONTIC APPLIANCES? A RANDOMIZED CLINICAL TRIAL, Journal of Evidence-Based Dental Practice 25 (2025) 102192.

https://doi.org/10.1016/j.jebdp.2025.102192.

4 0
20.   A. Hussien, A. Musa, H.T. Nour El-Din, A.M. Helal, Y.I. Nagy, H.G. Ezzat, A.S. Attia, A.S. Mayhoub, K. Shalaby, D.G.T. Parambi, M.M. Elsebaie, Phenyltriazole-based sulfonamides: novel dual-target agents against MRSA biofilms and resistant pathogens, RSC Adv 15 (2025) 17186–17202.

https://doi.org/10.1039/D5RA02412A.

4.6 2
21.   A.A. Abuelkhir, Y.I. Nagy, T. Gamal, A.M. Abdelhalim, A.S. Attia, A.S. Mayhoub, M.M. Elsebaie, Small Molecule Alkynyl‐Phenylaminoguanidines: A New Weapon Against Multi‐Drug Resistant Bacteria, ChemistrySelect 10 (2025).

https://doi.org/10.1002/slct.202404320.

2 3
22.   M.A.-A. Mohammed, M.A. Fouad, A. Mohammed aboelyazed, A.M. Yehia, S.T. Mahmoud, A validated and environmentally sustainable high-performance thin-layer chromatography method for the concurrent analysis of axitinib, pazopanib, crizotinib, ruxolitinib, and ibrutinib in bulk drug substances and pharmaceutical formulations, JPC – Journal of Planar Chromatography – Modern TLC 38 (2025) 595–609. https://doi.org/10.1007/s00764-025-00372-w. 1.1 0
23.   Y.M. Abdelfattah, A.M. Mahmoud, N.I. Abdelaziz, D.A. El Mously, Point-of-care colorimetric biosensor for H2O2 and glucose detection utilizing the peroxidase-like activity of 2D bimetallic metal organic framework nanosheets, Anal Chim Acta 1356 (2025) 343993. https://doi.org/10.1016/j.aca.2025.343993. 6 7
24.   Hussein N. Ghanem‏, A.A. El- Zaher, E.T. Abdelhamed, S. Tarek Mahmoud, Eco-Friendly Non-Derivatized HPLC Approach for Simultaneous Determination of Pregabalin, Milnacipran, and Duloxetine Employed in Fibromyalgia Treatment, Bulletin of Pharmaceutical Sciences Assiut University (2025) 0–0.

https://doi.org/10.21608/bfsa.2025.360088.2444.

0.087 0
25.   O.G. Hussein, Y. Mohamed, N. Mostafa, A.M. Mahmoud, Catalytic activity study of a laccase-like copper–gallic acid MOF and its applications in the colorimetric determination of norepinephrine and degradation of environmental pollutants, RSC Adv 15 (2025) 11730–11738. https://doi.org/10.1039/D5RA00942A. 4.6 8
26.   H.A.-H. Mohamed, M.B. NourEldin, A.A. El-Zaher, S.T. Mahmoud, Development of an eco-friendly UPLC method for simultaneous quantification of six selected phosphodiesterase-5 inhibitors and serotonin reuptake inhibitors in pharmaceutical formulations and adulterated food using a quality by design approach, Futur J Pharm Sci 11 (2025) 69. https://doi.org/10.1186/s43094-025-00824-4. 3 1
27.   A.M. Moussa, H.A. Allam, A.A. Al-Karmalawy, A.K. Salem, R. Alnajjar, S.T. Mahmoud, M.A. Fouad, M.K. El-Ashrey, Design and development of potent roflumilast analogues targeting PDE-4B: selectivity and pharmacokinetic insights, Bioorg Chem 167 (2025) 109201.

https://doi.org/10.1016/j.bioorg.2025.109201.

4.7 0
28.   A.A. Mouhamed, K. Orensa, M.O. Mekhail, N.I. Abdelaziz, A.M. Mahmoud, D.A. El Mously, Synthesis and characterization of core-shell mussel inspired magnetic molecularly imprinted polymer nanoparticles for the solid phase extraction of levofloxacin in human plasma, BMC Chem 19 (2025) 280.

https://doi.org/10.1186/s13065-025-01641-9.

4.6 1
29.   A.A. Mouhamed, A. Elsayed, N. Mostafa, A.M. Mahmoud, A. Elshaer, A.T. Soudi, Rapid nanocatalytic approach for azo dye degradation using bi-ligand nickle based-metal organic frameworks, BMC Chem 19 (2025) 287. https://doi.org/10.1186/s13065-025-01650-8. 4.6 1
30.   E.A. Moustafa, N.N.E. El‐Sayed, M.A. Fouad, A.M. El Kerdawy, M.A.F. Ezzat, H.A. Allam, Quinolone as a Privileged Scaffold: A Brief Overview on Early Classical and Recent Advanced Synthetic Pathways, Innovative Neuroprotective Potential, and Structure‐Activity Relationships, Drug Dev Res 86 (2025).

https://doi.org/10.1002/ddr.70132.

4.2 0
31.   M. Abdel-Halim, R.A. Wagdy, M. Salah, Y.-H. Wang, T.-P. Cheng, Y.-R. Lee, Y.-C. Chen, Y.M. Mandour, A.H. Abadi, M. Engel, T.-L. Hwang, Targeting Neutrophil-Mediated Inflammation: Identification of Pyrazolidinone Carboxamide Derivatives as Potent Selective Inhibitors of Formyl Peptide Receptor 1 (FPR1)-Activated Neutrophils, ACS Pharmacol Transl Sci 8 (2025) 1591–1609.

https://doi.org/10.1021/acsptsci.4c00715.

3.7 0
32.   K.A. Elsayad, G.F. Elmasry, S.T. Mahmoud, F.M. Awadallah, S. Giovannuzzi, C.T. Supuran, Development of novel amino-benzenesulfonamide derivatives and their analogues as carbonic anhydrase inhibitors: Design, synthesis, anticancer activity assessment, and pharmacokinetic studies using UPLC-MS/MS, Bioorg Chem 159 (2025) 108335.

https://doi.org/10.1016/j.bioorg.2025.108335.

4.7 3
33.   R.M. Sayed, S.T. Mahmoud, E.A. Mostafa, M.K. El‐Ashrey, M.A. Moffid, Insights Into the Complexities of Antithrombotic Interactions: A Core–Shell Particle‐Based UHPLC–MS/MS Method to Investigate Dexamethasone’s Influence on Apixaban and Rivaroxaban Pharmacokinetics, Sep Sci Plus 8 (2025).

https://doi.org/10.1002/sscp.70009.

1.6 1
34.   M.R. Fouad, M.A. Rabie, H.F. Zaki, R.M. Salama, Ertugliflozin ameliorates experimentally-induced colitis in rats by regulating the interplay between M1/M2 macrophage polarization, tight junction proteins, and MicroRNA 155 expression, Int Immunopharmacol 165 (2025) 115505. https://doi.org/10.1016/j.intimp.2025.115505. 4.7 0
35.   N. Abdalkader, A.M. Zawrah, S. Lasheen, A.M.Y. Osman, Prevalence of fatigue among pediatric cancer patients in Egypt, Discover Public Health 22 (2025) 479. https://doi.org/10.1186/s12982-025-00881-3. NA 0
36.   L.A. Elbendary, G.A. Abdel‐Latif, M.A. Khattab, A.E. El‐Sahar, R.H. Sayed, The Role of the AMY1 Receptor Signaling Cascade in the Protective Effect of Sulforaphane Against Nitroglycerin‐Induced Migraine in Mice, Arch Pharm (Weinheim) 358 (2025).

https://doi.org/10.1002/ardp.70107.

3.6 0
37.   R. Abdelhady, H.H. Arab, R.R. Fakhr Eldeen, H.N. Shalaby, D.A. Nawwar, M.A. Elhemely, R.H. Sayed, Unveiling the Therapeutic Potential of Dulaglutide in Mitigating Tacrolimus‐Induced Nephrotoxicity Through Targeting the miR‐22/HMGB‐1/TLR4/MyD88/NF‐κB Trajectory, Arch Pharm (Weinheim) 358 (2025). https://doi.org/10.1002/ardp.202500023. 3.6 1
38.   N. Al Mazrouei, M.M. ElGharbawy, M. Gamal, S. Emad, A.A. Mohamed, O.M. Ibrahim, A.A. Elnour, M.J. Ahmed, S.A. Beshir, V. Menon, S.F. Abdalla, A.A. Saeed, H.A. ElRamly, Evaluating liver type fatty acid binding protein as a diagnostic and prognostic biomarker in metabolic dysfunction-associated steatotic liver disease in pediatric patients, PLoS One 20 (2025) e0333581.

https://doi.org/10.1371/journal.pone.0333581.

2.6 0
39.   R. Eldash, M. Talat, CO22 Association Between Nonvalvular Atrial Fibrillation Type and Therapeutic Failure in Hospitalized Patients With History of Atrial Fibrillation Admitted to a Stepdown Unit, Value in Health 28 (2025) S45. https://doi.org/10.1016/j.jval.2025.09.124. 6 0
40.   A.M. Shaheen, R.H. Sayed, G.K. Helal, M.F. El-Yamany, M.I. Fahmy, Dapagliflozin ameliorates cisplatin-induced cognitive impairments in rats: Cross-talk between miRNA-21/p-ERK/p-38 MAPK and wnt/β-catenin signaling pathways, Neurotoxicology 111 (2025) 103348.

https://doi.org/10.1016/j.neuro.2025.103348.

3.9 0
41.   E.M. Elbaz, R.H. Sayed, A.A. Abdelkader, A.T. Fahim, Neuroprotective role of morin hydrate on 3-nitropropionic acid-elicited huntington’s disease: in vivo investigation of RIPK1/RIPK3/MLKL necroptosis signaling pathway, Molecular Medicine 31 (2025) 135.

https://doi.org/10.1186/s10020-025-01172-y.

6.4 7
42.   A. Hamdy, R.H. Sayed, M.F. El-Yamany, G.K. Helal, M.I. Fahmy, Repurposing of rebamipide as a neuroprotective agent to alleviate letrozole-induced depressive-like behaviors in female rats: Targeting SIRT1/FoxO1/wnt/ β-catenin, and related ferroptosis pathways, Life Sci 380 (2025) 123941. https://doi.org/10.1016/j.lfs.2025.123941. 5.1 0
43.   M.A. Rabie, W.H. Marcus, M.A. Sadek, H.A. Ruby, K.A.F. Emam, B. Budzynska, K. Skalicka-Wożniak, R.H. Sayed, L.A. Ahmed, N.S. El Sayed, Repositioning of a nutraceutical, scoparone, in the management of MK-801-induced schizophrenia-like behavior in Mice: An insight into SIRT1/PGC-1α/TFAM pathway, Eur J Pharmacol 1004 (2025) 177981. https://doi.org/10.1016/j.ejphar.2025.177981. 4.7 0
44.   M.M. Ali, R.H. Sayed, W. Wadie, R.A. Mohammed, Cilostazol and SB203580 combination: Targeting ER stress and p38MAPK signaling in Alzheimer’s disease mouse model, Eur J Pharmacol 1003 (2025) 177897. https://doi.org/10.1016/j.ejphar.2025.177897. 4.7 2
45.   R. Abdelhady, R.H. Sayed, N.S. Younis, O. Ali, M.A. Elhemely, A.M. Ashour, S.E. Alsufyani, H.H. Arab, M.S. Abdel‐Hamid, Targeting JNK1/2 and P38 Mitogen‐Activated Protein Kinases With Pazopanib Mitigates Bleomycin‐Induced Lung Fibrosis, Arch Pharm (Weinheim) 358 (2025). https://doi.org/10.1002/ardp.70105. 3.6 0
46.   N.M. Kamel, S.S. El-Sayed, S.O. Ali, R.H. Sayed, M.H. Safwat, Linagliptin mitigates lipopolysaccharide-induced acute kidney injury in mice: Novel renal BDNF/TrkB/NRF2-dependent antioxidant, anti-inflammatory, and antiapoptotic mechanisms, Life Sci 371 (2025) 123602. https://doi.org/10.1016/j.lfs.2025.123602. 5.1 3
47.   A. Youssef, D.A. Al-Mahdy, R.H. Sayed, M.A. Choucry, H. El-Askary, Evaluation of Hair Growth Promoting Activity of Standardized Soybean Extract on Testosterone-Induced Alopecia, J Med Food 28 (2025) 75–86. https://doi.org/10.1089/jmf.2023.0117. 2 1
48.   H.E. Eitah, R.H. Sayed, Y.A. Maklad, A.A. Gamal el Din, K. Mahmoud, A.E. El-Sahar, A. Alhejely, A.A. Abdulbaqi, H. Naeim Attia, Dipeptidyl peptidase-4 enzyme inhibition and its impacts on hepatic preneoplasia: a new avenue for liver cancer management, Front Pharmacol 16 (2025). https://doi.org/10.3389/fphar.2025.1559303. 4.8 2
49.   Elbaz, Eman M., Rabab H. Sayed, Amany A. Abdelkader, and Atef Tadros Fahim. “Neuroprotective role of morin hydrate on 3-nitropropionic acid-elicited huntington’s disease: in vivo investigation of RIPK1/RIPK3/MLKL necroptosis signaling pathway.” Molecular Medicine 31, no. 1 (2025): 135.

https://doi.org/10.1186/s10020-025-01172-y

1.5 1
50.   C. Yousry, M.M. Saber, M.H. Habib, L.M. Ibrahim, S.M. Abouelatta, Integrated statistically optimized Linezolid spanlastics and hirudin PLGA-nanoparticles for the topical management of cellulitis in mice, J Drug Deliv Sci Technol 114 (2025) 107623.

https://doi.org/10.1016/j.jddst.2025.107623.

4.9 0
51.   M.T. Teama, N.S. Abdelmalak, M.J. Naguib, S. Ahmed, Polymeric Micelles for Pulmonary Drug Delivery: A Comprehensive Review, Bionanoscience 15 (2025) 504.

https://doi.org/10.1007/s12668-025-02105-z.

3.2 4
52.   R. Albash, C. Yousry, M.A. El Hassab, W.M. Eldehna, A.A. Alaa-Eldin, Investigation of Moxifloxacin-loaded terpenes enriched cationic cerosomes (TECs) as an adjunct pulmonary therapy for COVID-19: in-silico study; D-optimal optimization; aerodynamic simulation assessment and cytotoxic evaluation., J Drug Deliv Sci Technol (2025) 106683. https://doi.org/10.1016/j.jddst.2025.106683. 4.9 3
53.   K. Zarif Attalla, D.H. Hassan, M.H. Teaima, C. Yousry, M.A. El-Nabarawi, M.A. Said, S.F. Elhabal, Enhanced Intranasal Delivery of Atorvastatin via Superparamagnetic Iron-Oxide-Loaded Nanocarriers: Cytotoxicity and Inflammation Evaluation and In Vivo, In Silico, and Network Pharmacology Study for Targeting Glioblastoma Management, Pharmaceuticals 18 (2025) 421.

https://doi.org/10.3390/ph18030421.

4.8 13
54.   D. Elkhayat, N.S. Abdelmalak, R. Amer, H.H. Awad, Ezetimibe Loaded Nanostructured Lipid Carriers Tablets: Response Surface Methodology, In-vitro Characterization, and Pharmacokinetics Study in Rats, J Pharm Innov 20 (2025) 11.

https://doi.org/10.1007/s12247-024-09911-0.

2.7 2
55.   M. El Halawany, H.A. Saleh, M. Khashaba, M.H.H. AbouGhaly, R. Latif, The effect of tranexamic acid-loaded alginate scaffolds on bone formation: hemostatic and histomorphometric analysis in a rabbit model, Futur J Pharm Sci 11 (2025) 99.

https://doi.org/10.1186/s43094-025-00849-9.

3 0
56.   S.M. El-Hady, S.M. Abouelatta, M.H.H. AbouGhaly, A.S.M. Abu EL-Enin, O.N. El-Gazayerly, Development of rivaroxaban orally disintegrating freeze- dried tablets loaded nanomixed micelles for special populations, Futur J Pharm Sci 11 (2025) 148.

https://doi.org/10.1186/s43094-025-00897-1.

3 0
57.   Mahdally NH, ElShiekh RA, Thissera B, Eltaher A, Osama A, Mokhtar M, Elhosseiny NM, Kashef MT, Magdeldin S, El Halawany AM, Rateb ME, Attia AS. Dihydrophenazine: a multifunctional new weapon that kills multidrug-resistant Acinetobacter baumannii and restores carbapenem and oxidative stress susceptibilities. J Appl Microbiol. 2024 May 1;135(5):lxae100.

doi: 10.1093/jambio/lxae100.

3.2 5
58.   Ibrahim SM, Kamel AS, Ahmed KA, Mohammed RA, Essam RM. The preferential effect of Clemastine on F3/Contactin-1/Notch-1 compared to Jagged-1/Notch-1 justifies its remyelinating effect in an experimental model of multiple sclerosis in rats. Int Immunopharmacol. 2024 Feb 15;128:111481.

doi: 10.1016/j.intimp.2023.111481.

4.8 15
59.   Fahim, S.A., ElZohairy, Y.A. & Moustafa, R.I. Favipiravir, an antiviral drug, in combination with tamoxifen exerts synergistic effect in tamoxifen-resistant breast cancer cells via hTERT inhibition. Sci Rep 14, 1844 (2024).

doi: 10.1038/s41598-024-51977-w

3.8 8
60.   Gaballah AI, Elsherbiny AA, Sharaky M, Hamed NO, Raslan NA, Almilaibary A, Fayyad RMA, Ousman MS, Hamdan AME, Fahim SA. Dexamethasone-tamoxifen combination exerts synergistic therapeutic effects in tamoxifen-resistance breast cancer cells. Biosci Rep. 2024 Jul 31;44(7):BSR20240367.

doi: 10.1042/BSR20240367.

3.8 3
61.   Abdalhameid E, Abd El-Haleim EA, Abdelsalam RM, Georgy GS, Fawzy HM, Kenawy SA. Cinnamic acid mitigates methotrexate-induced lung fibrosis in rats: comparative study with pirfenidone. Naunyn Schmiedebergs Arch Pharmacol. 2024 Feb;397(2):1071-1079. doi: 10.1007/s00210-023-02652-w. 3.1 8
62.   Abo-Zalam, H B., El Denshary, EED, Abdalsalam, RM, Khalil, IA, Khattab, MM, Hamzawy, MA, Revolutionizing Hyperlipidemia Treatment: Nanoencapsulated CoQ10 and Selenium Combat Simvastatin-Induced Myopathy and Insulin Resistance in Rats. Adv Pharm Bull (2024); 14(2):364-377. doi: 10.34172/apb.2024.010 3.1 3
63.   Sabry MM, El-Halawany AM, Fahmy WG, Eltanany BM, Pont L, Benavente F, Attia AS, Sherbiny FF, Ibrahim RM. Evidence on the inhibitory effect of Brassica plants against Acinetobacter baumannii lipases: phytochemical analysis, in vitro, and molecular docking studies. BMC Complement Med Ther. 2024 Apr 19;24(1):164. doi: 10.1186/s12906-024-04460-y. 3.3 10
64.   Abuelkhir, A.A., Omara, M., Nagy, Y.I., Gouda AE, Attia A.S., Mayhoub A.S., Hagras M.. Position switch of phenylthiazoles: novel compounds with promising anti-MRSA USA300. Med Chem Res 33, 1178–1194 (2024).

doi: 10.1007/s00044-024-03243-x

2.6 2
65.   Elesawy WH, El-Sahar AE, Sayed RH, Ashour AM, Alsufyani SE, Arab HH, Kandil EA. Repurposing ezetimibe as a neuroprotective agent in a rotenone-induced Parkinson’s disease model in rats: Role of AMPK/SIRT-1/PGC-1α signaling and autophagy. Int Immunopharmacol. 2024 Sep 10;138:112640.

doi: 10.1016/j.intimp.2024.112640.

4.8 10
66.   Fathy N, Labib MA, Essam RM, El-Boghdady NA. The Interplay between MiR-134/BDNF and LKB1/AMPK/SIRT1 Accentuates the Antidepressant Efficacy of Empagliflozin in Ovariectomized Rats. ACS Chem Neurosci. 2024 Sep 30.

doi: 10.1021/acschemneuro.4c00313.

4.2 1
67.   Nermin M. Sheta, Shady M. Abd El-Halim, Sally A. Fahim, Marwa Sharaky, Alaadin E. El-Haddad, Mohamed A. Mamdouh, Sara M. Soliman, Xanthone-loaded niosomes as innovative potential delivery platform: Formulation, characterization, and cytotoxic effect on human cancer cell lines, Journal of Drug Delivery Science and Technology, Volume 102, Part B, 2024,106384, ISSN 1773-2247. doi: 10.1016/j.jddst.2024.106384. 4.9 2
68.   Abd-Elrasheed, E., Fahim, S.A., Nessim, C.K. et al. Innovative anti-proliferative effect of the antiviral favipiravir against MCF-7 breast cancer cells using green nanoemulsion and eco-friendly assessment tools. Sci Rep 14, 27939 (2024). doi: 10.1038/s41598-024-78422-2 3.8 3
69.   Azzam MA, Fahim SA, ElMonier AA, Maurice NW. Functional analysis of a panel of molecular markers for diagnosis of systemic lupus erythematosus in rats. Biosci Rep. 2024 Jul 31;44(7):BSR20240318.

doi: 10.1042/BSR20240318.

3.8 0
70.   El-Shenawy R, Moustafa RI, Helmy NM, El-Abd YS, Tabll AA, Elesnawy YK, Shawky H. Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals. Virol J. 2024 Nov 15;21(1):293.

doi: 10.1186/s12985-024-02551-3.

4 2
71.   Bader El Din, N. G., Moustafa, R. I., Ghaleb, E., El‑Shenawy, R., Agwa, M. M., Helmy, N. M., El‑Shiekh, M., Yousif, A. A., Mahfouz, M. S., Seif, A. S., Abdelghaffar, M. M., Elsayed, H.”Association of OAS1 gene polymorphism with the severity of COVID‑19 infection”. World Academy of Sciences Journal 6, no. 6 (2024): 72. https://doi.org/10.3892/wasj.2024.287 2
72.   Heggi MT, Nour El-Din HT, Morsy DI, Abdelaziz NI, Attia AS. Microbial evasion of the complement system: a continuous and evolving story. Front Immunol. 2024 Jan 4;14:1281096. doi: 10.3389/fimmu.2023.1281096. 5.7 14
73.   Eisa M, Gomez-Escobar E, Bédard N, Abdeltawab NF, Flores N, Mazouz S, Fieffé-Bédard A, Sakayan P, Gridley J, Abdel-Hakeem MS, Bruneau J, Grakoui A, Shoukry NH. Coordinated expansion of memory T follicular helper and B cells mediates spontaneous clearance of HCV reinfection. Front Immunol. 2024 Jun 10;15:1403769. doi: 10.3389/fimmu.2024.1403769. 5.7 5
74.   Eisa M, Flores N, Khedr O, Gomez-Escobar E, Bédard N, Abdeltawab NF, Bruneau J, Grakoui A, Shoukry NH. Activation-Induced Marker Assay to Identify and Isolate HCV-Specific T Cells for Single-Cell RNA-Seq Analysis. Viruses. 2024 Oct 17;16(10):1623. doi: 10.3390/v16101623. 3.8 2
75.   Fouad MA, Osman AA, Abdelhamid NM, Rashad MW, Nabawy AY, El Kerdawy AM. Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies. BMC Chemistry 18, 29 (2024). doi: 10.1186/s13065-024-01130-5 4.3 10
76.   Mostafa, N.; Chen, P.-J.; Darwish, S.S.; Su, Y.-C.; Shiao, M.-H.; Piazza, G.A.; Abadi, A.H.; Engel, M.; Abdel-Halim, M. N-Benzylated 5-Hydroxybenzothiophene-2-carboxamides as Multi-Targeted Clk/Dyrk Inhibitors and Potential Anticancer Agents. Cancers 202416, 2033.

doi: 10.3390/cancers16112033

4.5 3
77.   Zaky, Y.A., Rashad, M.W., Zaater, M.A., El Kerdawy A.M. Discovery of dual rho-associated protein kinase 1 (ROCK1)/apoptosis signal–regulating kinase 1 (ASK1) inhibitors as a novel approach for non-alcoholic steatohepatitis (NASH) treatment. BMC Chemistry 18, 2 (2024).

doi: doi.org/10.1186/s13065-023-01081-3

4.3 1
78.   Abdel-Mohsen, H.T., El Kerdawy, A.M. Design, Synthesis, Molecular Docking Studies and in Silico Prediction of ADME Properties of New 5-Nitrobenzimidazole/thiopyrimidine Hybrids as Anti-angiogenic Agents Targeting Hepatocellular Carcinoma (2024) Egyptian Journal of Chemistry, 67 (1), pp. 437-446. doi: 10.21608/EJCHEM.2023.212212.7998 1.1 10
79.   Gamal M.A., Fahim S.H., Giovannuzzi S., Fouad M.A., Bonardi A., Gratteri P., Supuran C.T., Hassan G.S., Probing benzenesulfonamide–thiazolidinone hybrids as multitarget directed ligands for efficient control of type 2 diabetes mellitus through targeting the enzymes: α-glucosidase and carbonic anhydrase II, European Journal of Medicinal Chemistry, 271,116434 (2024). doi: 10.1016/j.ejmech.2024.116434. 6 13
80.   El- Sayed N.F., El-Hussieny M., Mansour S.T., Fouad M.A., Saad M.A, Ewies E. F., Farnesyl pyrophosphate synthase inhibitors with antiosteoporosis efficacy in ovariectomized rats: A mixed binding approach beyond bisphosphonates, European Journal of Medicinal Chemistry, 276, 116679 (2024).

doi: 10.1016/j.ejmech.2024.116679.

6 0
81.   Abdo Moustafa E, Allam H, Fouad MA, El Kerdawy AM, Nasser Eid El-Sayed N, Wagner C, Abdel-Aziz HA, Abdel Fattah Ezzat M. Discovery of novel quinolin-2-one derivatives as potential GSK-3β inhibitors for treatment of Alzheimer’s disease: Pharmacophore-based design, preliminary SAR, in vitro and in vivo biological evaluation. Bioorg Chem. 2024 May;146:107324.

doi: 10.1016/j.bioorg.2024.107324.

4.5 16
82.   Mozayad, A.N., Fouad, M.A. & Elkady, E.F. Utilizing experimental design and desirability function in optimizing RP-HPLC method for simultaneous determination of some skeletal muscle relaxants and analgesics. Sci Rep 14, 10360 (2024). doi: 10.1038/s41598-024-58381-4 3.8 5
83.   Bekheit MS, Sabry E, Mohamed HA, Ewies EF, Kariuki BM, Fouad MA, Vullo D, Supuran CT. Novel sulfonamide-phosphonate conjugates as carbonic anhydrase isozymes inhibitors. Drug Dev Res. 2024 Feb;85(1):e22135.

doi: 10.1002/ddr.22135.

3.5 7
84.   Hassan, A.M.A., El-Hussieny, M., El-Sayed, N.F., Fouad, M.A., Ewies, E.F.,& Ezzat M.A.Synthesis and characterization of new tetrakisphosphonic acid derivatives as FPPS inhibitors and evaluation of their anti-osteoclastogenic potential for prevention of osteoporosis. Med Chem Res 33, 1167–1177 (2024). doi: 10.1007/s00044-024-03242-y 2.6 4
85.   Elkady E, Fouad M, Mozayad A. Application of Box-Behnken Design and Response Surface Methodology for Selecting the Optimum RP-HPLC Conditions for the Simultaneous Determination of Paracetamol and Diclofenac Sodium Along With Three Skeletal Muscle Relaxants in Three Different Pharmaceutical Dosage Forms. J Chromatogr Sci. 2024 Apr 23;62(4):328-338. doi: 10.1093/chromsci/bmad051. 1.5 8
86.   El Mously, D.A., Mahmoud, A.M., Khallaf, M.A. et al. Facile synthesis of copper nitroprusside chitosan nanocomposite and its catalytic reduction of environmentally hazardous azodyes. BMC Chemistry 18, 124(2024).

doi: 10.1186/s13065-024-01224-0

4.3 5
87.   Abo-Elmagd I.F., Mahmoud A.M., Al-Ghobashy M.A., Nebsen M., Rabie M.A., Mohamed A.F., Ahmed L.A., El Sayed N.S., Arafa R.K., Todd R., Elgebaly S.A. Development and validation of an LC‒MS/MS method for the determination of cyclocreatine phosphate and its related endogenous biomolecules in rat heart tissues (2024) BMC Chemistry, 18 (1), 214.

DOI: 10.1186/s13065-024-01304-1

4.3 1
88.   Moussa AM, Abdelrasheed Allam H, Al-Ashrey MK, Fouad MA,  Al-Karmalawy AM. Rationale design and synthesis of new roflumilast analogues as preferential selective and potent PDE-4B inhibitors. Bioorg Chem. 2024 December;153:107911.

doi: 10.1016/j.bioorg.2024.107911

4.5 4
89.   A. Faouzi, A. Arnaud, F. Hallé, J. Roussel, M. Aymard, V. Denavit, C.V. Do, A. Mularoni, M. Salah, A. ElHady, T.-N. Pham, A. Bancet, M. Le Borgne, R. Terreux, R. Barret, M. Engel, T. Lomberget, Design, synthesis, and structure–activity relationship studies of 6 H -benzo[ b ]indeno[1,2- d ]thiophen-6-one derivatives as DYRK1A/CLK1/CLK4/haspin inhibitors, RSC Med Chem (2024).

doi: 10.1039/D4MD00537F.

4.1 1
90.   Ibrahim OM, Al Mazrouei N, Elnour AA, Ibrahim R, H. Abdel-Qader D, Mohamed El Amin Ibrahim Hamid R, et al. (2024) Randomized controlled trial parallel-group on optimizing community pharmacist’s care for the elderly: The influence of WhatsApp-Email delivered clinical case scenarios. PLoS ONE 19(10): e0308448. doi: 10.1371/journal.pone.0308448 2.9 1
91.   Fahmy MI, Khalaf SS, Yassen NN, Sayed RH. Nicorandil attenuates cisplatin-induced acute kidney injury in rats via activation of PI3K/AKT/mTOR signaling cascade and inhibition of autophagy. Int Immunopharmacol. 2024 Jan 25;127:111457. doi: 10.1016/j.intimp.2023.111457. 4.8 17
92.   Rabie MA, Ghoneim AT, Fahmy MI, El-Yamany MF, Sayed RH. Activation of alpha-7 nicotinic acetylcholine receptor by tropisetron mitigates 3-nitropropionic acid-induced Huntington’s disease in rats: Role of PI3K/Akt and JAK2/NF-κB signaling pathways. Chem Biol Interact. 2024 Apr 25;393:110957.

doi: 10.1016/j.cbi.2024.110957.

4.7 7
93.   Haggagy MG, Ahmed LA, Sharaky M, Elhefnawi MM, Omran MM. SIRT1 as a potential key regulator for mediating apoptosis in oropharyngeal cancer using cyclophosphamide and all-trans retinoic acid. Sci Rep. 2024 Jan 2;14(1):41. doi: 10.1038/s41598-023-50478-6. 3.8 8
94.   Abdel-Qader DH, Albassam A, Taybeh E, Al Mazrouei N, Meer SMA, Al-Kubaisi KA, Ibrahim R, Elnour AA, Mohamed Ibrahim O, AbuRuz S. Lipid and Glucose Profile across Different Mental Disorders. Journal of Clinical Medicine. 2024; 13(9):2499. doi: 10.3390/jcm13092499 3.0 0
95.   Abdel-Qader DH, AbuRuz S, Sawan HM, Mazrouei NA, Ibrahim OM, Hamadi S, et al. Evaluation of the characteristics of iron metabolism markers in patients with CHF-related anemia in Jordan. J Adv Pharm Educ Res.2024;14(1):26-33. doi: 10.51847/9blTRBhr6V 1.0 1
96.   Fathy N, Farouk S, Sayed RH, Fahim AT. Ezetimibe ameliorates cisplatin-induced nephrotoxicity: A novel therapeutic approach via modulating AMPK/Nrf2/TXNIP signaling. FASEB J. 2024 Jan;38(1):e23382.

doi: 10.1096/fj.202302019R.

4.4 6
97.   Ruby HA, Sayed RH, Khattab MA, Sallam NA, Kenway SA. Fenofibrate ameliorates nitroglycerin-induced migraine in rats: Role of CGRP/p-CREB/P2X3 and NGF/PKC/ASIC3 signaling pathways. Eur J Pharmacol. 2024 Aug 5;976:176667. doi: 10.1016/j.ejphar.2024.176667. 4.2 6
98.   Hamouda HA, Sayed RH, Eid NI, El-Sayeh BM. Azilsartan Attenuates 3-Nitropropinoic Acid-Induced Neurotoxicity in Rats: The Role of IĸB/NF-ĸB and KEAP1/Nrf2 Signaling Pathways. Neurochem Res. 2024 Apr;49(4):1017-1033. doi: 10.1007/s11064-023-04083-8. 3.7 7
99.   Abdelrazek FN, Shalaby RA, Fahim SA, Essam RM, Anis SE, Attia YM, Abd El Malak NS. Novel fast dissolving freeze dried sublingual baicalin tablets for enhanced hepatoprotective effect: in-vitro characterization, cell viability, and in-vivo evaluation. Pharm Dev Technol. 2024 Apr;29(4):371-382.

doi: 10.1080/10837450.2024.2341243.

2.6 0
100.      Ali MM, Shoukri RA, Yousry C. Effect of particle size versus surface charge on the brain targeting behavior of elastic nanovesicles: In-vitro characterization, comparison between I-optimal and D-optimal statistical optimization and in-vivo pharmacokinetic evaluation. J Drug Deliv Sci Technol. 2024;96:105693.

doi:10.1016/j.jddst.2024.105693

4.5 8
101.      Yousry C, Goyal M, Gupta V. Excipients for Novel Inhaled Dosage Forms: An Overview. AAPS PharmSciTech. 2024 Feb 14;25(2):36.

doi: 10.1208/s12249-024-02741-w.

3.4 10
102.      Azrak ZAT, Taha MS, Jagal J, Elsherbeny A, Bayraktutan H, AbouGhaly MHH, Elshafeey AH, Greish K, Haider M. Optimized mucoadhesive niosomal carriers for intranasal delivery of carvedilol: A quality by design approach. Int J Pharm. 2024 Apr 10;654:123935. doi: 10.1016/j.ijpharm.2024.123935. 5.3 8
103.      El Halawany M, Khashaba M, AbouGhaly MHH, Latif R. Tranexamic acid loaded in a physically crosslinked trilaminate dressing for local hemorrhage control: Preparation, characterization, and in-vivo assessment using two different animal models. Int J Pharm. 2024 Jun 25;659:124219.

doi: 10.1016/j.ijpharm.2024.124219.

5.3 3
104.      Hammad RW, Sanad RA, Abdelmalak NS, Latif R. Cubosomal functionalized block copolymer platform for dual delivery of linagliptin and empagliflozin: Recent advances in synergistic strategies for maximizing control of high-risk type II diabetes. Drug Deliv Transl Res. 2024 Mar;14(3):678-695.

doi: 10.1007/s13346-023-01423-7.

5.7 6
105.      Elkhayat D, Abdelmalak NS, Amer R, and Awad HH. Ezetimibe-Loaded Nanostructured Lipid Carrier for Oral Delivery: Response Surface Methodology; In Vitro Characterization and Assessing the Antihyperlipidemic Effect in Rats. CS Omega 2024 9 (7), 8103-8116.

doi: 10.1021/acsomega.3c08428

3.7 7

 

  Publication IF Citations
1. Fahim SA, Ibrahim S, Tadros SA, Badary OA. Protective effects of butylated hydroxytoluene on the initiation of N-nitrosodiethylamine-induced hepatocellular carcinoma in albino rats. Hum Exp Toxicol. 2023 Jan-Dec;42:9603271231165664.

 

doi: 10.1177/09603271231165664.

2.8 1
2. Badr AM, Elkholy O, Said M, Fahim SA, El-Khatib M, Sabry D, Gaber RM. Diagnostic significance of hsa_circ_0000146 and hsa_circ_0000072 biomarkers for Diabetic Kidney Disease in patients with type 2 diabetes mellitus. J Med Biochem. 2023 Mar 15;42(2):239-248.

doi: 10.5937/jomb0-39361.

2.5 0
3. ElMonier AA, El-Boghdady NA, Fahim SA, Sabry D, Elsetohy KA, Shaheen AA. LncRNA NEAT1 and MALAT1 are involved in polycystic ovary syndrome pathogenesis by functioning as competing endogenous RNAs to control the expression of PCOS-related target genes. Noncoding RNA Res. 2023 Mar 3;8(2):263-271.

doi: 10.1016/j.ncrna.2023.02.008.

5 2
4. Shimaa Abdelsattar *, Sally A. Fahim, Hiba S Al-Amodi, Hala F.M. Kamel, Zeinab A. Kasemy, Fatma O. Khalil, Mahmoud S. Abdallah, Hanan M Bedair, Abd El-Naser Abd El-Ati Gad Alla, Alyaa Sabry, Mohamed A. Sakr, Mahmoud Selim, Eman M. Abd Elgayed. The Potential Role of Circulating Long miscellaneous RNAs in the Diagnosis and Prognosis of hepatitis C related Hepatocellular Carcinoma. Non-Coding RNA. 2023 4.5 0
5. Ewaisha, R., & Anderson, K. S. Immunogenicity of CRISPR therapeutics—Critical considerations for clinical translation. Frontiers in Bioengineering and Biotechnology. 2023, volume 11.

doi:10.3389/fbioe.2023.1138596

5.7 2
6. Mariam Omara, Mohamed Hagras, Mohamed M Elsebaie, Nader S Abutaleb, Hanzada T Nour El-Din, Maria O Mekhail, Ahmed S Attia, Mohamed N Seleem, Marwa T Sarg, Abdelrahman S Mayhoub.  Exploring novel aryl/heteroaryl-isosteres of phenylthiazole against multidrug-resistant bacteria. RSC Adv.  2023 Jul 6;13(29):19695-19709.

doi: 10.1039/d3ra02778c.

3.9 1
7. Essam, R.M., Saadawy, M.A., Gamal, M., Abdelsalam, R.M., El-Sahar, A.E. Lactoferrin averts neurological and behavioral impairments of thioacetamide-induced hepatic encephalopathy in rats via modulating HGMB1/TLR-4/MyD88/Nrf2 pathway. Neuropharmacology, 2023, 236, 109575.

 

doi: 10.1016/j.neuropharm.2023.109575

4.7 0
8. El-Sahar, A.E., Bekhit, N., Eissa, N.M., Abdelsalam, R.M., Essam, R.M. Targeting HMGB1/PI3K/Akt and NF-κB/Nrf-2 signaling pathways by vildagliptin mitigates testosterone-induced benign prostate hyperplasia in rats. Life Sciences, 2023, 322, 121645

doi: 10.1016/j.lfs.2023.121645.

6.1 2
9. Abdalhameid, E., Abd El-Haleim, E.A., Abdelsalam, R.M., Fawzy, H.M., Kenawy, S.A.  Cinnamic acid mitigates methotrexate-induced lung fibrosis in rats: comparative study with pirfenidone. Naunyn-Schmiedeberg’s Archives of Pharmacology, 2023.

doi: 10.1007/s00210-023-02652-w.

3.6 0
10. Mai A Abd-Elmawla, Reham M Essam, Kawkab A Ahmed, Maha Abdelmonem. Implication of Wnt/GSK-3β/β-Catenin Signaling in the Pathogenesis of Mood Disturbances Associated with Hyperthyroidism in Rats: Potential Therapeutic Effect of Naringin. ACS Chem Neurosci. 2023;14(11):2035-2048.

doi: 10.1021/acschemneuro.3c00013.

5 4
11. Eman M Elbaz, Reham M Essam, Kawkab A Ahmed, Maheera H Safwat. Donepezil halts acetic acid-induced experimental colitis in rats and its associated cognitive impairment through regulating inflammatory/oxidative/apoptotic cascades: An add-on to its anti-dementia activity. Int Immunopharmacol. 2023, 116:109841.

doi: 10.1016/j.intimp.2023.109841

5.6 4
12. Reham M Essam, Esraa A Kandil. p-CREB and p-DARPP-32 orchestrating the modulatory role of cAMP/PKA signaling pathway enhanced by Roflumilast in rotenone-induced Parkinson’s disease in rats. Chem Biol Interact. 2023 25:372:110366.

doi: 10.1016/j.cbi.2023.110366

5.1 1
13. Mona M Saber, Manal Moustafa Mahmoud, Hesham M Amin, Reham M Essam. Therapeutic effects of combining curcumin and swimming in osteoarthritis using a rat model. Biomed Pharmacother. 2023 166:115309.

doi: 10.1016/j.biopha.2023.115309.

7.5 0
14. Shohda A El-Maraghy, Aya Reda, Reham M Essam, Mona A Kortam. The citrus flavonoid “Nobiletin” impedes STZ-induced Alzheimer’s disease in a mouse model through regulating autophagy mastered by SIRT1/FoxO3a mechanism. Inflammopharmacology 2023;31(5):2701-2717.

doi: 10.1007/s10787-023-01292-z.

5.8 0
15. Hanan H. Ahmed, Reham M. Essam, Muhammed F. El-Yamany, Kawkab A. Ahmed and Ayman E. El-Sahar. Unleashing lactoferrin’s antidepressant potential through the PI3K/Akt/mTOR pathway in chronic restraint stress rats. Food Funct. 2023

doi: 10.1039/d3fo02222f.

6.1 0
16. Hebatollah E Eitah, Hanan Naeim Attia, Ahmed A F Soliman, Amina A Gamal El Din, Khaled Mahmoud, Rabab H Sayed, Yousreya A Maklad, Ayman E El-Sahar.  Vitamin D ameliorates diethylnitrosamine-induced liver preneoplasia: A pivotal role of CYP3A4/CYP2E1 via DPP-4 enzyme inhibition. Toxicol Appl Pharmacol. 2023  1:458:116324.

doi: 10.1016/j.taap.2022.116324.

3.8 0
17. El-Hussieny, M., Abd-El-Maksoud, M.A., Soliman, F.M., Fouad, M.A., El-Ashrey, M.K. Dual-target ligand discovery for Alzheimer’s disease: triphenylphosphoranylidene derivatives as inhibitors of acetylcholinesterase and β-amyloid aggregation. Journal of Enzyme Inhibition and Medicinal Chemistry, (2023) 38 (1), art. no. 2166040.

DOI: 10.1080/14756366.2023.2166040

5.6 1
18. Ola Ahmed Saleh, Amr Mohamed Badawey, Hassan Y. Aboul Enein and Marwa Ahmed Fouad. Enantioseparation, quantification, molecular docking and molecular dynamics study of five β adrenergic blockers on Lux Cellulose 2 column. BMC Chemistry, (2023) 17 (1), art. no. 22.

DOI: 10.1186/s13065-023-00925-2.

4.6 0
19. Salem, W.A., Elkady, E.F., Fouad, M.A., Mohammad, M.A.-A. DoE Screening and Optimization of Liquid Chromatographic Determination of Nicotinic Acid and Six Statins: Application to Pharmaceutical Preparations and Counterfeit Detection. Journal of chromatographic science, (2023) 61 (1), pp. 74-86.

DOI: 10.1093/chromsci/bmab131.

1.3 2
20. Abdel Rahman, D.E., Fouad, M.A., Mohammed, E.R., El-Zoheiry, H.H., Abdelrasheed Allam, H. Novel VEGFR-2 inhibitors as antiangiogenic and apoptotic agents via paracrine and autocrine cascades: Design, synthesis, and biological evaluation. Bioorganic Chemistry, (2023) 139, 106678.

doi: 10.1016/j.bioorg.2023.106678.

5.1 0
21. Ezzat, M.A.F., Abdelhamid, S.M., Fouad, M.A., Abdel-Aziz, H.A., Allam, H.A. Design, synthesis, in vitro, and in vivo evaluation of novel phthalazinone-based derivatives as promising acetylcholinesterase inhibitors for treatment of Alzheimer’s disease. Drug Development Research, (2023) 84(6), pp. 1231–1246.

doi: 10.1002/ddr.22082.

3.8 0
22. Ezzat, M.A.F., Elmasry, G.F., El-Mageed, M.M.A.A., Fouad, Marwa A., Abdel-Aziz, H.A., Elewa, S.I. Design, synthesis, and biological evaluation of furan-bearing pyrazolo[3,4-b]pyridines as novel inhibitors of CDK2 and P53–MDM2 protein–protein interaction. Drug Development Research, (2023) 84(6), pp. 1183–1203

doi: 10.1002/ddr.22079

3.8 0
23. Ahmed, R.F., Mahmoud, W.R., Abdelgawad, N.M., Fouad, M.A., Said, M.F. Exploring novel anticancer pyrazole benzenesulfonamides featuring tail approach strategy as carbonic anhydrase inhibitors. European Journal of Medicinal Chemistry, (2023) 261, 115805.

doi: 10.1016/j.ejmech.2023.115805.

6.7 0
24. Ehab Elkady, Marwa Fouad, Ayoub Mozayad. Application of Box–Behnken Design and Response Surface Methodology for Selecting the Optimum RP-HPLC Conditions for the Simultaneous Determination of Paracetamol and Diclofenac Sodium Along With Three Skeletal Muscle Relaxants in Three Different Pharmaceutical Dosage Forms. Journal of chromatographic science, (2023) In press.

DOI: doi.org/10.1093/chromsci/bmad051

1.3 2
25. Rania S M Ismail, Ahmed M El Kerdawy, Dalia H Soliman, Hanan H Georgey, Nagwa M Abdel Gawad, Andrea Angeli, Claudiu T Supuran. Discovery of a new potent oxindole multi-kinase inhibitor among a series of designed 3-alkenyl-oxindoles with ancillary carbonic anhydrase inhibitory activity as antiproliferative agents. BMC Chem 2023 Jul 18;17(1):81.

doi: 10.1186/s13065-023-00994-3.

4.6 2
26. Iman A Y Ghannam, Ahmed M El Kerdawy, Marwa M Mounier, Mahmoud T Abo-Elfadl, Islam H Ali. Novel 2-oxo-2-phenylethoxy and benzyloxy diaryl urea hybrids as VEGFR-2 inhibitors: Design, synthesis, and anticancer evaluation. Arch Pharm (Weinheim) 2023 Feb;356(2):e2200341.

doi: 10.1002/ardp.202200341.

5.1 1
27. Heba T Abdel-Mohsen, Ahmed M El Kerdawy, Andrea Petreni, Claudiu T Supuran. Novel benzenesulfonamide-thiouracil conjugates with a flexible N-ethyl acetamide linker as selective CA IX and CA XII inhibitors. Arch Pharm (Weinheim) 2023 Feb;356(2):e2200434.

doi: 10.1002/ardp.202200434.

5.1 1
28. Yomna I El-Gazzar, Heba R Ghaiad, Ahmed M El Kerdawy, Riham F George, Hanan H Georgey, Khairia M Youssef, Hussein I El-Subbagh. New quinazolinone-based derivatives as DHFR/EGFR-TK inhibitors: Synthesis, molecular modeling simulations, and anticancer activity. Arch Pharm (Weinheim) 2023 Jan;356(1):e2200417.

doi: 10.1002/ardp.202200417

5.1 3
29. Sandy N Aziz , Alia A Badawy , Demiana I Nessem , Nevine S Abd El Malak , Marianne J Naguib. Chitosan-coated alginate (CCA) nanoparticles for augmentation of topical antihistaminic activity of diphenhydramine: in-vitro optimization, skin histopathology and pharmacodynamic studies with in vitro/in vivo correlation. Drug development &industrial pharmacy. 2023 Apr;49(4):316-327.

doi: 10.1080/03639045.2023.2211672.

3.4 0
30. Reham Hammad, Rania Sanad, Nevine S. Abd El Malak, Randa Latif, Cubosomal-functionalized block copolymer platform for dual delivery of linagliptin and empagliflozin: Recent advances in synergistic strategies for maximizing control of high-risk type II diabetes Drug Delivery and Translational Research.2023 5.4 0
31. Salah, M.; Tahoun, M.; Rudzitis-Auth, J.; Stotz, L.; van Koppen, C. J.; Laschke, M. W.; Abdelsamie, A. S.; Frotscher, M. Potent Dual Inhibitors of Steroid Sulfatase and 17βHydroxysteroid Dehydrogenase Type 1 with a Suitable Pharmacokinetic Profile for In Vivo Proof-of-Principle Studies in an Endometriosis Mouse Model. J. Med. Chem. 2023, 66 (13), 8975–8992.

doi: 10.1021/acs.jmedchem.3c00571.

6.7 0
Serial Publications IF Citations
32.      Naglaa F. El-Sayed, Marwa El-Hussieny, Ewies F. Ewies, Mohamed F. El Shehry, Hanem M. Awad, Marwa A. Fouad. “Design, synthesis, biological evaluation, and molecular docking of new benzofuran and indole derivatives as tubulin polymerization inhibitors”, Drug Development Research, 83(2), 485-500, (2022).

DOI: 10.3390/molecules27175501.

5.004 0
33.      Asmaa Raafat, Samar Mowafy, Sahar M. Abouseri, Marwa A. Fouad, Nahla A. Farag. “Lead generation of cysteine based mesenchymal epithelial transition

(c-Met) kinase inhibitors: Using structure-based scaffold hopping, 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamics simulation”, Computers in Biology and Medicine, 146, 105526, (2022).

DOI: doi.org/10.1016/j.compbiomed.2022.105526

6.698 1
34.      Ewies, Ewies F.; Sabry, Eman; Bekheit, Mohamed S.; Fouad, Marwa A.; Vullo, Daniela; Supuran, Claudiu T. “Click chemistry-based synthesis of new benzenesulfonamide derivatives bearing triazole ring as selective carbonic anhydrase II inhibitors”, Drug Development Research, (2022) In press.

DOI: doi: 10.1002/ddr.21957

5.004 2
35.      El-Kersh, Dina M.; Abou El-Ezz, Rania F.; Fouad, Marwa; Farag, Mohamed A. “Unveiling Natural and Semisynthetic Acylated Flavonoids: Chemistry and Biological Actions in the Context of Molecular Docking”, Molecules, 27:5501, (2022)

DOI: 10.3390/molecules27175501

4.927 0
36.      Fouad, Marwa A.; Serag, Ahmed; Tolba, Enas H.; El-Shal, Manal A.; El Kerdawy, Ahmed M. “QSRR modeling of the chromatographic retention behavior of some quinolone and sulfonamide antibacterial agents using firefly algorithm coupled to support vector machine”, BMC Chemistry, 16, 85, 2022

DOI: 10.1186/s13065-022-00874-2

4.095 0
37.      Elkady, Ehab F.; Fouad, Marwa A.; Mozayad, Ayoub N. “Application of Box-Behnken experimental design and response surface methodology for selecting the optimum RP-HPLC conditions for the simultaneous determination of methocarbamol, indomethacin and betamethasone in their pharmaceutical dosage form”, BMC Chemistry 16, 114 (2022)

DOI: 10.1186/s13065-022-00908-9

4.095 0
38.      Wadhah Atef Salem, Ehab Farouk Elkady, Marwa Ahmed Fouad, Mohammad Abdul-Azim Mohammad. “DoE Screening and Optimization of Liquid Chromatographic Determination of Nicotinic Acid and Six Statins: Application to Pharmaceutical Preparations and Counterfeit Detection” J Chromatogr. Sci. 29;61(1):74-86 (2022)

DOI: 10.1093/chromsci/bmab131.

1.555 0
39.      El-Gazzar YI, Ghaiad HR, El Kerdawy AM, George RF, Georgey HH, Youssef KM, El-Subbagh HI.Arch Pharm (Weinheim). New quinazolinone-based derivatives as DHFR/EGFR-TK inhibitors: Synthesis, molecular modeling simulations, and anticancer activity. Arch Pharm (Weinheim). 18:e2200417. (2022)

DOI:  10.1002/ardp.202200417.

4.613 0
40.      Ali IH, Abdel-Mohsen HT, Mounier MM, Abo-Elfadl MT, El Kerdawy AM, Ghannam IAY. Design, synthesis and anticancer activity of novel 2-arylbenzimidazole/2-thiopyrimidines and 2-thioquinazolin-4(3H)-ones conjugates as targeted RAF and VEGFR-2 kinases inhibitors. Bioorg. Chem. 126:105883 (2022)

DOI: 10.1016/j.bioorg.2022.105883.

5.307          1
41.   Al-Warhi T, El Kerdawy AM, Said MA, Albohy A, Elsayed ZM, Aljaeed N, Elkaeed EB, Eldehna WM, Abdel-Aziz HA, Abdelmoaz MA Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights. Drug Des Devel Ther.  16;16:1457-1471 (2022)

DOI: 10.2147/DDDT.S356988.

4.319 1
42.   Hassan RM, Ali IH, Abdel-Maksoud MS, Abdallah HMI, El Kerdawy AM, Sciandra F, Ghannam IAY.  Design and synthesis of novel quinazolinone-based fibrates as PPARα agonists with antihyperlipidemic activity. Arch Pharm (Weinheim), 355(3):e2100399 (2022).

DOI: 10.1002/ardp.202100399

4.319 1
43.   Abdel-Mohsen HT, El Kerdawy AM, Omar MA, Petreni A, Allam RM, El Diwani HI, Supuran CT Application of the dual-tail approach for the design and synthesis of novel Thiopyrimidine-Benzenesulfonamide hybrids as selective carbonic anhydrase inhibitors. Eur J Med Chem. 15;228:114004 (2022).

DOI: 10.1016/j.ejmech.2021.114004.

7.088 7
44.   Iman A. Y. Ghannam, Ahmed M. El Kerdawy, Marwa M. Mounier, Mahmoud T. Abo‐elfadl, Islam H. Ali  Novel 2‐oxo‐2‐phenylethoxy and benzyloxy diaryl urea hybrids as VEGFR‐2 inhibitors: Design, synthesis, and anticancer evaluation Arch Pharm (Weinheim), e2200341 (2022)

DOI: 10.1002/ardp.202200341

4.613 0
45.   Heba T. Abdel‐Mohsen, Ahmed M. El Kerdawy, Andrea Petreni, Claudiu T. Supuran Novel benzenesulfonamide‐thiouracil conjugates with a flexible N‐ethyl acetamide linker as selective CA IX and CA XII inhibitors Arch Pharm (Weinheim). 2022, e2200434.

DOI: 10.1002/ardp.202200434

4.613 0
46.   Wagdy M. Eldehna, Raed M. Maklad, Hadia Almahli, Tarfah Al-Warhi, Eslam B. Elkaeed, Mohammed A. S. Abourehab, Hatem A. Abdel-Aziz and Ahmed M. El Kerdawy. Identification of 3-(piperazinylmethyl) benzofuran derivatives as novel type II CDK2 inhibitors: design, synthesis, biological evaluation, and in silico insights. J Enz. Inhib. Med. Chem.  37(1), 1227–1240 (2022).

DOI: 10.1080/14756366.2022.2062337.

5.756 5
47.   Eman A. Abd El-Meguid, Ahmed M. Naglah, Gaber O. Moustafa, Hanem M. Awad, Ahmed M. El Kerdawy Novel benzothiazole-based dual VEGFR-2/EGFR inhibitors targeting breast and liver cancers: Synthesis, cytotoxic activity, QSAR and molecular docking studies Bioorg. Med.l Chem. Lett. 58, 128529 (2022).

DOI: 10.1016/j.bmcl.2022.128529.

2.940 4
48.   El Gizawy HA, El-Haddad AE, Saadeldeen AM, Boshra SA. Tentatively Identified (UPLC/T-TOF-MS/MS) Compounds in the Extract of Saussurea costus Roots Exhibit In Vivo Hepatoprotection via Modulation of HNF-1α, Sirtuin-1, C/ebpα, miRNA-34a and miRNA-223. Molecules, 28;27(9):2802 (2022).

DOI: 10.3390/molecules27092802.

4.927 3
49.   El Gizawy HA, El-Haddad AE, Attia YM, Fahim SA, Zafer MM, Saadeldeen AM. In Vitro Cytotoxic Activity and Phytochemical Characterization (UPLC/T-TOF-MS/MS) of the Watermelon (Citrullus lanatus) Rind Extract. Molecules. 12;27(8):2480 (2022).

DOI: 10.3390/molecules27082480.

4.927 0
50.   Wadhah Atef Salem, Ehab Farouk Elkady, Marwa Ahmed Fouad, Mohammad Abdul-Azim Mohammad. “Analysis of Metformin and Five Gliptins in Counterfeit Herbal Products: Designs of Experiment Screening and Optimization”, Journal of AOAC International, 104(6), 1667–1680, (2021).

DOI: 10.1093/jaoacint/qsab106

1.913 1
51.   El-Hussieny, M., El-Sayed, N.F., Fouad, M.A., Ewies, E.F. “Synthesis, biological evaluation and molecular docking of new sulfonamide-based indolinone derivatives as multitargeted kinase inhibitors against leukemia”, Bioorganic Chemistry, 117, 105421, (2021).

DOI: 10.1016/j.bioorg.2021.105421

5.725 1
52.   Fouad, M.A., Zaki, M.Y., Lotfy, R.A., Mahmoud, W.R. “Design, synthesis, biological evaluation, and molecular docking of new benzofuran and indole derivatives as tubulin polymerization inhibitors”, Drug Development Research, 2021, 1-16, (2021).

DOI: 10.1002/ddr.21880

4.360 0
53.   Mohammad Abdul-Azim Mohammad, Ehab Farouk Elkady, Marwa Ahmed Fouad, Wadhah Atef Salem. “DoE Screening and Optimization of Liquid Chromatographic Determination of Nicotinic Acid and Six Statins: Application to Pharmaceutical Preparations and Counterfeit Detection”, Journal of Chromatographic Science, 1-13, (2021).

DOI: 10.1093/chromsci/bmab131

1.618 0
54.   Abd El-Aal, May A., Medhat A. Al-Ghobashy, and Yasser S. El-Saharty. “Preparation and characterization of 96-well microplates coated with molecularly imprinted polymer for determination and biosimilarity assessment of recombinant human erythropoietin.”, Journal of Chromatography A, 1641, 462012, (2021), ISSN 0021-9673.

DOI:  https://doi.org/10.1016/j.chroma.2021.462012.

4.759 5
55.   Nadim, Ahmed H., May A. Abd El-Aal, Medhat A. Al-Ghobashy, and Yasser S. El-Saharty. “Facile imprinted polymer for label-free highly selective potentiometric sensing of proteins: case of recombinant human erythropoietin.”, Analytical and Bioanalytical Chemistry, 413, 3611–3623, (2021).

DOI: https://doi.org/10.1007/s00216-021-03325-4.

4.157 5
56.   Nadim, Ahmed H., May A. Abd El-Aal, Medhat A. Al-Ghobashy, and Yasser S. El-Saharty. “Optimization of Polydopamine Imprinted Polymer for Label Free Sensitive Potentiometric determination of Proteins: Application to Recombinant Human Erythropoietin Sensing in Different Matrices.”, Microchemical Journal, 167, 106333, (2021).

DOI: https://doi.org/10.1016/j.microc.2021.106333.

4.821 4
57.   Gamal, Mohammed, Heba-Alla H. Abd-ElSalam, Ibrahim A. Naguib, Medhat A. Al-Ghobashy, Hala E. Zaazaa, and M. Abdelkawy. “Green and cost-effective extraction techniques of quercetin from mixture of nutraceuticals with yield analysis via spectrophotometry and high performance liquid chromatograph methods.”, Journal of AOAC International, 18:qsab071, (2021). DOI: 10.1093/jaoacint/qsab071. 1.913 3
58.   Mahdally, N. H., George, R. F., Kashef, M. T., Al-Ghobashy, M., Murad, F. E., & Attia, A. S. “Staquorsin: A Novel Staphylococcus aureus Agr-Mediated Quorum Sensing Inhibitor Impairing Virulence in vivo Without Notable Resistance Development”, Frontiers in microbiology12, 700494, (2021).

DOI: https://doi.org/10.3389/fmicb.2021.700494.   

5.640 14
59.   Abanoub Mosaad Abdallah, Nadia G. Zaki, Walaa H. Mahmoud, Ahmed M. El Kerdawy, Gehad G. Mohamed. “Synthesis, structural characterization, density functional theory calculations, and antimicrobial, anticancer, and antimetastatic properties of nanosized heteroleptic complexes of cocaine/TMEDA with d-block metal ions.” App. Organometallic. Chem.,35: e6441 (2021).

DOI:  https://doi.org/10.1002/aoc.6441

4.105 1
60.   Rasha M. Hassan, Islam H. Ali, Mohammed S. Abdel-Maksoud , Heba M. I. Abdallah, Ahmed M. El Kerdawy, Francesca Sciandra, Iman A. Y. Ghannam. “Design and synthesis of novel quinazolinone-based fibrates as PPARα agonists with antihyperlipidemic activity” Arch. Pharm. (2021); e2100399

DOI: https://doi.org/10.1002/ardp.202100399

3.751 0
61.   Abdalla R. Mohamed, Ahmed M. El Kerdawy, Riham F. George, Hanan H. Georgey, Nagwa M. Abdel Gawad. “Design, synthesis and in silico insights of new 7,8-disubstituted-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione derivatives with potent anticancer and multi-kinase inhibitory activities”, Bioorganic Chemistry, 107, 104569, (2021).

DOI: https://doi.org/10.1016/j.bioorg.2020.104569.

5.725 8
62.   Eldehna WM, Al-Rashood ST, Al-Warhi T, Eskandrani RO, Alharbi A, El Kerdawy AM. “Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and in silico studies”, J Enzyme Inhib Med Chem, 36(1), 270-285, (2021).

DOI:  10.1080/14756366.2020.1862101.

4.310 35
63.   Rasha M. Hassan, Mona E. Aboutabl, Manuela Bozzi, Mohammed F. El-Behairy, Ahmed M. El Kerdawy, Beatrice Sampaolese, Claudia Desiderio, Federica Vincenzoni, Francesca Sciandra, Iman A.Y. Ghannam. “Discovery of 4-benzyloxy and 4-(2-phenylethoxy) chalcone fibrate hybrids as novel PPARα agonists with anti-hyperlipidemic and antioxidant activities: Design, synthesis and in vitro/in vivo biological evaluation”, Bioorganic Chemistry,115, 105170, (2021). DOI: 10.1016/j.bioorg.2021.105170 5.725 2
64.   Heba Ibrahim, A. Abdo, Ahmed M. El Kerdawy, A. Sharaf Eldin. “Signal Detection in Pharmacovigilance: A Review of Informatics-driven Approaches for the Discovery of Drug-Drug Interaction Signals in Different Data Sources”, Artificial Intelligence in the Life Sciences1, 100005, (2021).

DOI: 10.1016/j.ailsci.2021.100005

——– 0
65.   Peter A. Halim, Hanan H. Georgey, Mina Y. George, Ahmed M. El Kerdawy, Mona F. Said. “Design and synthesis of novel 4-fluorobenzamide-based derivatives as promising anti-inflammatory and analgesic agents with an enhanced gastric tolerability and COX-inhibitory activity”, Bioorganic Chemistry,115, 105253, (2021).

DOI: 10.1016/j.bioorg.2021.105253

5.725 2
66.   Heba Ibrahim, Ahmed M. El Kerdawy, A. Abdo, A. Sharaf Eldin “Similarity-based machine learning framework for predicting safety signals of adverse Drug–Drug interactions”, Informatics in Medicine Unlocked, 100669, (2021).

DOI: 10.1016/j.imu.2021.100699.

2.110 5
67.   El-Haddad AE, El-Deeb EM, Amer AA, Saadeldeen AM, Ahmed FM, Salem MA, Taha HS. “Bioactive Phytoconstituents of Morus Plants exhibiting Numerous Therapeutic Activities”, Egyptian Journal of Chemistry, (2021).

DOI: 10.21608/EJCHEM.2021.76688.3788

——– 6
68.   El-Mancy, Shereen S., Alaadin E. El-Haddad, Walaa A. Alshareef, Amr M. Saadeldeen, Soad Z. El-Emam, and Osama S. Elnahas. “Enhancement of Antimicrobial and Antiproliferative Activities of Standardized Frankincense Extract Using Optimized Self-Nanoemulsifying Delivery System”, Scientia Pharmaceutica, 89(3), 36, (2021).

DOI: https://doi.org/10.3390/scipharm89030036.

——– 2
69.   Darwish, Amira Mohamed Galal, Hebatallah H. Abo Nahas, Yasmin H. Korra, Alaa A. Osman, Wedad M. El-Kholy, Maria Reyes-Córdova, Essa M. Saied, and Ahmed M. Abdel-Azeem. “Fungal Lipases: Insights into Molecular Structures and Biotechnological Applications in Medicine and Dairy Industry” Industrially Important Fungi for Sustainable Development, 461-514, Springer, Cham, (2021).

DOI: https://doi.org/10.1007/978-3-030-85603-8_13

——– 0
70.   Saied EM, El-Maradny YA, Osman AA, Darwish AMG, Abo Nahas HH, Niedbała G, Piekutowska M, Abdel-Rahman MA, Balbool BA, Abdel-Azeem AM. “A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19” Pharmaceutics, 13(11), 1759, (2021).

DOI: https://doi.org/10.3390/pharmaceutics13111759

6.321 28
71.   El Azab, Islam H., Essa M. Saied, Alaa A. Osman, Amir E. Mehana, Hosam A. Saad, and Nadia AA Elkanzi. “Novel N-bridged pyrazole-1-carbothioamides with potential antiproliferative activity: design, synthesis, in vitro and in silico studies” Future Medicinal Chemistry13(20), 1743-1766, (2021).

DOI: https://doi.org/10.4155/fmc-2021-0066

3.808 15
72.   Trabik, Yossra A., Eman M. Moenes, Medhat A. Al-Ghobashy, Marianne Nebsen, and Miriam F. Ayad. “Analytical comparability study of anti-CD20 monoclonal antibodies rituximab and obinutuzumab using a stability-indicating orthogonal testing protocol: Effect of structural optimization and glycoengineering.”, Journal of Chromatography B, 1159, 122359, (2020), ISSN 1570-0232.

DOI: https://doi.org/10.1016/j.jchromb.2020.122359.

1.911 2
73.   Mohamed, Hadeer G., Medhat A. Al‐Ghobashy, Mervat A. Fouad, and Hala S. Zaazaa. “Quality Assessment of Lactoferrin in some Marketed Nutraceuticals Derived from Milk using Validated Analytical Methods.”, ChemistrySelect, 5(46), 14816-14825, (2020).

DOI: https://doi.org/10.1002/slct.202003681.

2.109 1
74.   Nadia G. Zaki, Walaa H. Mahmoud, Ahmed M. El Kerdawy, Abanoub Abdullah, Gehad G. Mohamed. “Structural Characterization, Thermal Analyses, Antiproliferative and Antimicrobial Activity of Cocaine Complexes with Mn(II) and Cu(II)”, Egyptian Journal of Chemistry, 63(5), 1857-1868, (2020).

DOI: 10.21608/ejchem.2019.16748.2019.

0.966 5
75.   Nadia G. Zaki, Walaa H. Mahmoud, Ahmed M. El Kerdawy, Abanoub Mosaad Abdallah, Gehad G. Mohamed. “Heteroleptic complexes of cocaine/TMEDA with some f block metals: Synthesis, DFT studies, spectral, thermal, cytotoxicity and antimetastatic properties”, Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 229, 117938, (2020), ISSN 1386-1425.

DOI: https://doi.org/10.1016/j.saa.2019.117938.

3.232 11
76.   Ehab M. Gedawy, Asmaa E. Kassab, Ahmed M. El Kerdawy. “Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2/5-LOX inhibitors”, European Journal of Medicinal Chemistry, 189, 112066, (2020), ISSN 0223-5234.

DOI: https://doi.org/10.1016/j.ejmech.2020.112066.

5.573 43
77.   Heba T. Abdel-Mohsen, Ahmed M. El Kerdawy, Mohamed A. Omar, Emanuela Berrino, Ahmed S. Abdelsamie, Hoda I. El Diwani, Claudiu T. Supuran. “New thiopyrimidine-benzenesulfonamide conjugates as selective carbonic anhydrase II inhibitors: synthesis, in vitro biological evaluation, and molecular docking studies”, Bioorganic & Medicinal Chemistry, 28(5), 115329, (2020), ISSN 0968-0896.

DOI: https://doi.org/10.1016/j.bmc.2020.115329.

3.073 14
78.   Zaki, N.G., Mahmoud, W.H., El Kerdawy, A.M. et al. “Structural characterization, thermal, DFT, cytotoxicity, and antimetastatic properties of cocaine complexes with La(III), Er(III), and Yb(III)”, Res Chem Intermed, 46, 3193–3216, (2020).

DOI: https://doi.org/10.1007/s11164-020-04146-3.

2.262 7
79.   Abdel-Mohsen HT, Abd El-Meguid EA, El Kerdawy AM, Mahmoud AEE, Ali MM. “Design, synthesis, and molecular docking of novel 2-arylbenzothiazole multiangiokinase inhibitors targeting breast cancer”, Arch Pharm (Weinheim), 353(4), e1900340, (2020).

DOI:  10.1002/ardp.201900340.

2.590 15
80.   Heba Abdelrasheed Allam, Enayat E. Aly, Ahmed K.B.A.W. Farouk, Ahmed M. El Kerdawy, Essam Rashwan, Safinaz E.S. Abbass. “Design and Synthesis of some new 2,4,6-trisubstituted quinazoline EGFR inhibitors as targeted anticancer agents”, Bioorganic Chemistry, 98, 103726, (2020), ISSN 0045-2068.

DOI: https://doi.org/10.1016/j.bioorg.2020.103726.

4.831 29
81.   Riham F. George, Manal Kandeel, Dina Y. El-Ansary, Ahmed M. El Kerdawy. “Some 1,3,5-trisubstituted pyrazoline derivatives targeting breast cancer: Design, synthesis, cytotoxic activity, EGFR inhibition and molecular docking”, Bioorganic Chemistry99, 103780, (2020), ISSN 0045-2068.

DOI: https://doi.org/10.1016/j.bioorg.2020.103780.

4.831 13
82.   Abdel-Mohsen HT, Abdullaziz MA, El Kerdawy AM, Ragab FAF, Flanagan KJ, Mahmoud AEE, Ali MM, El Diwani HI, Senge MO. “Targeting Receptor Tyrosine Kinase VEGFR-2 in Hepatocellular Cancer: Rational Design, Synthesis and Biological Evaluation of 1,2-Disubstituted Benzimidazoles”, Molecules, 25(4), 770, (2020).

DOI: https://doi.org/10.3390/molecules25040770.

3.267 19
83.   Mohammad M. Al-Sanea, Ahmed Elkamhawy, Sora Paik, Kyeong Lee, Ahmed M. El Kerdawy, Bukhari Syed Nasir Abbas, Eun Joo Roh, Wagdy M. Eldehna, Heba A.H. Elshemy, Rania B Bakr, Ibrahim Ali Farahat, Abdulaziz I. Alzarea, Sami I. Alzarea, Khalid S. Alharbi, Mohamed A. Abdelgawad. “Sulfonamide-based 4-anilinoquinoline derivatives as novel dual Aurora kinase (AURKA/B) inhibitors: Synthesis, biological evaluation and in silico insights”, Bioorganic & Medicinal Chemistry, 28(13), 115525, (2020), ISSN 0968-0896.

DOI: https://doi.org/10.1016/j.bmc.2020.115525.

3.073 25
84.   Al-Warhi T, El Kerdawy AM, Aljaeed N, Ismael OE, Ayyad RR, Eldehna WM, Abdel-Aziz HA, Al-Ansary GH. “Synthesis, Biological Evaluation and In Silico Studies of Certain Oxindole–Indole Conjugates as Anticancer CDK Inhibitors”, Molecules, 25(9), 2031, (2020).

DOI: https://doi.org/10.3390/molecules25092031.

3.267 22
85.   Osman SM, Ayoub NA, Hafez SA, Ibrahim HA, El Raey MA, El-Emam SZ, Seada AA, Saadeldeen AM. “Aldose reductase inhibitor form Cassia glauca: A comparative study of cytotoxic activity with Ag nanoparticles (NPs) and molecular docking evaluation”, PLoS ONE, 15(10), e0240856, (2020).

DOI: https://doi.org/10.1371/journal.pone.0240856.

3.240 2
86.   Shendy, A.H., Eltanany, B.M., Al-Ghobashy, M.Aet al. “Coupling of GC-MS/MS to Principal Component Analysis for Assessment of Matrix Effect: Efficient Determination of Ultra-Low Levels of Pesticide Residues in Some Functional Foods”, Food Anal. Methods12, 2870–2885, (2019).

DOI: https://doi.org/10.1007/s12161-019-01643-z.

3.366 7
87.   El-Sayed, Ghada M., Medhat A. Al-Ghobashy, Ali K. Attia, and Samah M. Kamal. “Nanoparticle-Enhanced Potentiometric Ion-Selective Electrodes for Therapeutic Drug Monitoring of Linezolid.”, Journal of The Electrochemical Society, 166 (14), 1-9, (2019).

DOI:  10.1149/2.1221913jes.

4.316 6
88.   Hassan LA, Al-Ghobashy MA, Abbas SS. “Evaluation of the pattern and kinetics of degradation of adalimumab using a stability-indicating orthogonal testing protocol”, Biomed Chromatogr., 33(12), e4676, (2019).

DOI:  10.1002/bmc.4676.

1.902 3
89.   Al-Ghobashy MA, Nadim AH, El-Sayed GM, Nebsen M. “Label-Free Potentiometric Ion Flux Immunosensor for Determination of Recombinant Human Myelin Basic Protein: Application to Downstream Purification from Transgenic Milk”, ACS Sens., 4(2), 413-420, (2019).

DOI:  10.1021/acssensors.8b01315.

7.711 10
90.   Hassan, Lamiaa A., Sara M Shatat, Basma M Eltanany, Medhat A Al-Ghobashy, and Samah S Abbas. “Stability and biosimilarity assessment of infliximab using an orthogonal testing protocol and statistically-guided interpretation of peptide mapping”, Analytical methods, 11 (25), 3198-3211, (2019). DOI: 10.1039/c9ay00903e. 2.896 9
91.   Ibrahim, F.A., Al-Ghobashy, M.A. & Abo-Elmagd, I.F. “Energy-efficient carbon-doped titanium dioxide nanoparticles: synthesis, characterization, and catalytic properties under visible LED irradiation for degradation of Gemifloxacin”, SN Appl. Sci., 1, 631, (2019).

 DOI: 10.1007/s42452-019-0644-8

———- 2
92.   Iman A.Y. Ghannam, Eman A. Abd El-Meguid, Islam H. Ali, Donia H. Sheir, Ahmed M. El Kerdawy. “Novel 2-arylbenzothiazole DNA gyrase inhibitors: Synthesis, antimicrobial evaluation, QSAR and molecular docking studies”, Bioorganic Chemistry, 93, 103373, (2019).  DOI: 10.1016/j.bioorg.2019.103373. 3.926 14
93.   Heba T. Abdel-Mohsen, Mohamed A. Omar, Ahmed M. El Kerdawy, Abeer E.E. Mahmoud, Mamdouh M. Ali, Hoda I. El Diwani. “Novel potent substituted 4-amino-2-thiopyrimidines as dual VEGFR-2 and BRAF kinase inhibitors”, European Journal of Medicinal Chemistry, 179, 707-722, (2019), ISSN 0223-5234.

 DOI: 10.1016/j.ejmech.2019.06.063.

5.573 26
94.   Somaia S. Abd El-Karim, Yasmin M. Syam, Ahmed M. El Kerdawy, Tamer M. Abdelghany. “New thiazol-hydrazono-coumarin hybrids targeting human cervical cancer cells: Synthesis, CDK2 inhibition, QSAR and molecular docking studies”, Bioorganic Chemistry, 86, 80-96, (2019), ISSN 0045-2068.

 DOI: 10.1016/j.bioorg.2019.01.026.

3.926 40
95.   Wagdy M. Eldehna, Ahmed M. El Kerdawy, Ghada H. Al-Ansary, Sara T. Al-Rashood, Mamdouh M. Ali, Abeer E. Mahmoud. “Type IIA – Type IIB protein tyrosine kinase inhibitors hybridization as an efficient approach for potent multikinase inhibitor development: Design, synthesis, anti-proliferative activity, multikinase inhibitory activity and molecular modeling of novel indolinone-based ureides and amides”, European Journal of Medicinal Chemistry, 163, 37-53, (2019), ISSN 0223-5234.

 DOI: 10.1016/j.ejmech.2018.11.061.

5.573 41
96.   El Kerdawy, A.M., Osman, A.A. & Zaater, M.A. “Receptor-based pharmacophore modeling, virtual screening, and molecular docking studies for the discovery of novel GSK-3β inhibitors”, J Mol Model, 25(6), 171, (2019).

 DOI: 10.1007/s00894-019-4032-5.

1.346 18
97.   Attallah, O.A., Al-Ghobashy, M.A., Nebsen, M. et al. “Assessment of pectin-coated magnetite nanoparticles in low-energy water desalination applications”, Environ Sci Pollut Res25, 18476–18483 (2018).

DOI: 10.1007/s11356-018-2060-9.

4.223 7
98.   Medhat A. Al-Ghobashy, Samah M. Kamal, Ghada M. El-Sayed, Ali K. Attia, Mohamed Nagy, Ahmed ElZeiny, Marwa T. Elrakaiby, Mohammed M. Nooh, Maggie Abbassi, Ramy K. Aziz. “Determination of voriconazole and co-administered drugs in plasma of pediatric cancer patients using UPLC-MS/MS: A key step towards personalized therapeutics”, Journal of Chromatography B, 1092, 489-498, (2018), ISSN 1570-0232.

 DOI: 10.1016/j.jchromb.2018.06.043

1.911 5
99.   Olivia A. Attallah, Medhat A. Al-Ghobashy, Ahmed Taha Ayoub, Marianne Nebsen. “Magnetic molecularly imprinted polymer nanoparticles for simultaneous extraction and determination of 6-mercaptopurine and its active metabolite thioguanine in human plasma”, Journal of Chromatography A, 1561, 28-38, (2018), ISSN 0021-9673.

 DOI: 10.1016/j.chroma.2018.05.038

4.759 28
100.   Attallah OA, Al-Ghobashy MA, Ayoub AT, Tuszynski JA, Nebsen M. “Computer-aided design of magnetic molecularly imprinted polymer nanoparticles for solid-phase extraction and determination of levetiracetam in human plasma”, Rsc Advances, 8(26), 14280-92, (2018).  DOI: 10.1039/C8RA02379D. 3.361 11
101.   Ali K. Attia, Medhat A. Al-Ghobashy, Ghada M. El-Sayed, Samah M. Kamal. “Voltammetric monitoring of linezolid, meropenem and theophylline in plasma”, Analytical Biochemistry, 545, 54-64, (2018), ISSN 0003-2697.

DOI:  10.1016/j.ab.2018.01.009.

3.365 11
102.   Hoda E. Mohamed, Abeer A. Mohamed, Medhat A. Al-Ghobashy, Faten A. Fathalla, Samah S. Abbas. “Stability assessment of antibody-drug conjugate Trastuzumab emtansine in comparison to parent monoclonal antibody using orthogonal testing protocol”, Journal of Pharmaceutical and Biomedical Analysis, 150, 268-277, (2018), ISSN 0731-7085.

 DOI: 10.1016/j.jpba.2017.12.022.

3.935 23
103.   Sara M. Shatat, Basma M. Eltanany, Abeer A. Mohamed, Medhat A. Al-Ghobashy, Faten A. Fathalla, Samah S. Abbas. “Coupling of on-column trypsin digestion–peptide mapping and principal component analysis for stability and biosimilarity assessment of recombinant human growth hormone”, Journal of Chromatography B, 1072, 105-115, (2018), ISSN 1570-0232.

 DOI: 10.1016/j.jchromb.2017.11.007

1.911 11
104.   Marwa A. Fouad, Enas H. Tolba, Manal A. El-Shal, Ahmed M. El Kerdawy. “QSRR modeling for the chromatographic retention behavior of some β-lactam antibiotics using forward and firefly variable selection algorithms coupled with multiple linear regression”, Journal of Chromatography A, 1549, 51-62, (2018), ISSN 0021-9673.

 DOI: 10.1016/j.chroma.2018.03.042.

3.858 16
105.   Ibrahim, F.A., Al-Ghobashy, M.A., Abd El-Rahman, M.K. et al. “Optimization and in line potentiometric monitoring of enhanced photocatalytic degradation kinetics of Gemifloxacin using TiO2 nanoparticles/H2O2”. Environ Sci Pollut Res24, 23880–23892 (2017).

 DOI: 10.1007/s11356-017-0045-8.

4.223 10
106.   Heba S. Abed, Medhat A. Al-Ghobashy, Faten A. Fathalla, Maissa Y. Salem. “Evaluation of the combined effects of pegylation and glycosylation on the stability of erythropoietin using a stability-indicating SE-HPLC”, Biologicals, 50, 129-136, (2017), ISSN 1045-1056.

 DOI: 10.1016/j.biologicals.2017.08.012.

1.856 3
107.   Moenes, Eman M., Medhat A Al-Ghobashy, Abeer A Mohamed, and Maissa Y Salem. “Comparative Assessment of the Effect of Glyco-engineering on the Pattern and Kinetics of Aggregate Formation of Darbepoetin Alfa using a Stability-Indicating Orthogonal Testing Protocol”, Journal of Chromatography B1072, 405-414, (2017), ISSN 1570-0232. DOI: 10.1016/j.jchromb.2017.10.057. 1.911 6
108.   Khalifa M, Abdelsalam RM, Safar MM, Zaki HF. Phosphodiesterase (PDE) III inhibitor, Cilostazol, improved memory impairment in aluminum chloride-treated rats: modulation of cAMP/CREB pathway. Inflammopharmacology. (2022). Online ahead of print

DOI: 10.1007/s10787-022-01010-1.

5.093    0
109.   Saad MA, Eissa NM, Ahmed MA, ElMeshad AN, Laible G, Attia AS, Al-Ghobashy MA, Abdelsalam RM, Al-Shorbagy MY. Nanoformulated Recombinant Human Myelin Basic Protein and Rituximab Modulate Neuronal Perturbations in Experimental Autoimmune Encephalomyelitis in Mice. Int J Nanomedicine. 7;17:3967-3987.(2022) DOI:10.1016/j.biopha.2021.111494. 7.033 0
110.   Hussien YA, Mansour DF, Nada SA, Abd El-Rahman SS, Abdelsalam RM, Attia AS, El-Tanbouly DM. Linagliptin attenuates thioacetamide-induced hepatic encephalopathy in rats: Modulation of C/EBP-β and CX3CL1/Fractalkine, neuro-inflammation, oxidative stress and behavioral defects. Life Sci., 15;295:120378.(2022)

DOI: 10.1016/j.lfs.2022.120378

6.780            1
111.   El-Safty H, Ismail A, Abdelsalam RM, El-Sahar AE, Saad MA. Dapagliflozin diminishes memory and cognition impairment in Streptozotocin induced diabetes through its effect on Wnt/β-Catenin and CREB pathway. Brain Res Bull.,181:109-120 (2022)

DOI: 10.1016/j.brainresbull.2022.01.017.

3.715           2
112.   El-Shamarka ME, El-Sahar AE, Saad MA, Assaf N, Sayed RH. Inosine attenuates 3-nitropropionic acid-induced Huntington’s disease-like symptoms in rats via the activation of the A2AR/BDNF/TrKB/ERK/CREB signaling pathway. Life Sci. 2022, 1;300:120569.(2022)

DOI: 10.1016/j.lfs.2022.120569.

6.780            3
113.   El-Ghannam MS, Saad MA, Nassar NN, El-Yamany MF, El-Bahy AAZ. Linagliptin ameliorates acetic acid-induced colitis via modulating AMPK/SIRT1/PGC-1α and JAK2/STAT3 signaling pathway in rats. Toxicol Appl Pharmacol., 1;438:115906. (2022)

DOI: 10.1016/j.taap.2022.115906

4.460 3
114.   Saad MA, Al-Shorbagy MY, Arab HH. Targeting the TLR4/NF-κΒ Axis and NLRP1/3 Inflammasomes by Rosuvastatin: A Role in Impeding Ovariectomy-Induced Cognitive Decline Neuropathology in Rats. Mol Neurobiol., 59(7):4562-4577(2022).

DOI: 10.1007/s12035-022-02852-0.

5.686           1
115.   Al-Madhagy SA, Gad SS, Mostafa ES, Angeloni S, Saad MA, Sabry OM, Caprioli G, El-Hawary SS. A new arsenal of polyphenols to make Parkinson’s disease extinct: HPLC-MS/MS profiling, very interesting MAO-B inhibitory activity and antioxidant activity of Otostegia fruticosa. Nat Prod Res., 22:1-6.(2022)

DOI: 10.1080/14786419.2022.204481

2.488 1
116.   Amina A Gamal El Din , Khaled Mahmoud , Rabab H Sayed , Yousreya A Maklad, Ayman E El-Sahar. Vitamin D ameliorates diethylnitrosamine-induced liver preneoplasia: A pivotal role of CYP3A4/CYP2E1 via DPP-4 enzyme inhibition. Toxicol Appl Pharmacol. 1;458:116324. (2022)

DOI: 10.1016/j.taap.2022.116324

4.219              0
117.   Elsebaie MM, Nour El-Din HT, Abutaleb NS, Abuelkhir AA, Liang HW, Attia AS, Seleem MN, Mayhoub AS. Exploring the structure-activity relationships of diphenylurea as an antibacterial scaffold active against methicillin- and vancomycin-resistant Staphylococcus aureus. Eur J Med Chem., 15;234:114204 (2022).

DOI: 10.1016/j.ejmech.2022.114204.

7.088 3
118.   Nour El-Din HT, Elsebaie MMn   Abutaleb NS, Kotb AM, Attia AS,  Seleem MN, Mayhoub AS. Expanding the Structure-Activity Relationships of Alkynyl Diphenylurea Scaffold as Promising Antibacterial Agents. RSC Med. Chem., Online ahead of print (2022).  DOI:org/10.1039/D2MD00351A 3.470 0
119.   Ibrahim S, Fahim SA, Tadros SA, Badary OA. Suppressive effects of thymoquinone on the initiation stage of diethylnitrosamine hepatocarcinogenesis in rats. IJ Biochem Mol Toxicol. Aug;36(8):e23078. (2022)

DOI: 10.1002/jbt.23078

3.642 2
120.   Motawi TMK, Sadik NAH, Sabry D, Fahim SA, Shahin NN.rs62139665 olymorphism in the Promoter Region of EpCAM Is Associated With Hepatitis C Virus-Related Hepatocellular Carcinoma Risk in Egyptians. Front Oncol. 5;11:754104. (2022)

DOI: 10.3389/fonc.2021.754104.

6.24 0
121.   Amul M. Badr, Omayma Elkholy, Mona Said, Sally A. Fahim, Mohamed El-Khatib, Dina Sabry, Radwa M. Gaber. Diagnostic significance of hsa_circ_0000146 and hsa_circ_0000072 biomarkers for diabetic kidney disease in patients with type 2 diabetes mellitus. J Med Biochem. 42: 1–10, 2023.(2022)

DOI: 10.5937/jomb0-39361.

2.20 0
122.   Tadros SA, Attia YM, Maurice NW, Fahim SA, Abdelwahed FM, Ibrahim S, Badary OA. Thymoquinone Suppresses Angiogenesis in DEN-Induced Hepatocellular Carcinoma by Targeting miR-1-3p. Int J Mol Sci., Dec 14;23(24):15904. (2022)

DOI: 10.3390/ijms232415904.

6.20 0
123.   Showman, Maha M., Rania M. Abdelsalam, Mahmoud M. Tawfick, Sanaa A. Kenawy, and Mona M. El-Naa. “Antisense Tissue Factor Oligodeoxynucleotides Protected Diethyl Nitrosamine/Carbon Tetrachloride-Induced Liver Fibrosis Through Toll Like Receptor4-Tissue Factor-Protease Activated Receptor1 Pathway.”, Frontiers in Pharmacology, 12, 1140, (2021), ISSN 1663-9812.

https://doi.org/10.3389/fphar.2021.676608.

3.845 0
124.   Hagar B. Abo-Zalam , Ezzeldein S. El-Denshary, Rania M. Abdelsalam, Islam A. Khalil, Mahmoud M. Khattab, and Mohamed A. Hamzawy. “Therapeutic advancement of simvastatin-loaded solid lipid nanoparticles (SV-SLNs) in treatment of hyperlipidemia and attenuating hepatotoxicity, myopathy and apoptosis: Comprehensive study.”, Biomedicine & Pharmacotherapy, 139, 111494, (2021). https://doi.org/10.1016/j.biopha.2021.111494. 4.545 3
125.   Hagar B. Abo-Zalam , Rania M. Abdelsalam, Rehab F. Abdel-Rahman, Mohamed F. Abd-Ellah, Mahmoud M. Khattab “In Vivo Investigation of the Ameliorating Effect of Tempol against MIA-Induced Knee Osteoarthritis in Rats: Involvement of TGF-β1/SMAD3/NOX4 Cue.” Molecules. 19;26(22):6993 (2021), ISSN: 1420-3049. https://doi.org/10.3390/molecules26226993. 4.411 3
126.   Radwa N. MuhammadLamiaa A. AhmedRania M. AbdelSalamKawkab A. AhmedAmina S. Attia. “Crosstalk Among NLRP3 Inflammasome, ET B R Signaling, and miRNAs in Stress-Induced Depression-Like Behavior: a Modulatory Role for SGLT2 Inhibitors.” Neurotherapeutics. Online ahead of print (2021). ISSN: 1933-7213 (print); 1878-7479 (web).

https://doi.org/10.1007/s13311-021-01140-4.

7.620 11
127.   Amer MA, Wasfi R, Attia AS, Ramadan MA. “Indole Derivatives Obtained from Egyptian Enterobacter sp. Soil Isolates Exhibit Antivirulence Activities against Uropathogenic Proteus mirabilis”,  Antibiotics, 10(4), 363, (2021). https://doi.org/10.3390/antibiotics10040363 3.893 5
128.   Elhosseiny, Noha M., Tamer M. Samir, Aliaa A. Ali, Amani A. El-Kholy, and Ahmed S. Attia. “Development of an Immunochromatographic Strip Using Conjugated Gold Nanoparticles for the Rapid Detection of Klebsiella pneumoniae  Causing Neonatal Sepsis” Pharmaceutics, 13(8), 1141, (2021).

https://doi.org/10.3390/pharmaceutics13081141.

6.321 0
129.   Samar M. Shawki, Mohammed A. Saad, Rania M. Rahmo, Walaa Wadie and Hanan S. El-Abhar, “Liraglutide Improves Cognitive and Neuronal Function in 3-NP Rat Model of Huntington’s Disease”, Frontiers in pharmacology, Epub. Ahead of print, (2021).

https://doi.org/10.3389/fphar.2021.731483.

5.811 5
130.   Soha Ramadan, Manal M. Sabry, Muhammed A Saad, Simone Angeloni, Omar M. Sabry, Giovanni Caprioli & Soheir M. El Zalabani “Dismantling Parkinson’s disease with herbs: MAO-B inhibitory activity and quantification of chemical constituents using HPLC-MS/MS of Egyptian local market plants”, Natural Product Research, Epub. Ahead of print, (2021).

https://doi.org/10.1080/14786419.2021.2013836.

2.862 2
131.                Muhammed A.Saad, Maha A.E. Ahmed, Norhan N.Elbadawy, Noha F.Abdelkader “Nano-ivabradine averts behavioral anomalies in Huntington’s disease rat model via modulating Rhes/m-tor pathway”,Progress in Neuro-Psychopharmacology and Biological Psychiatry, 111, (2021), 110368.

https://doi.org/10.1016/j.pnpbp.2021.110368.

5.067 4
132.                Rofida A. Saleh, Tarek F. Eissa, Dalaal M. Abdallah, Muhammed A. Saad, Hanan S. El- Abhar. “Peganum harmala enhanced GLP-1 and restored insulin signaling to alleviate AlCl3-induced Alzheimer-like pathology model.” Scientific reports, 11, 12040, (2021).

https://doi.org/10.1038/s41598-021-90545-4.

4.380 6
133.                Doaa Fathi, Ahmed I.Abulsoud, Muhammed A.Saad, Noha N.Nassar, Mina M.Maksimose, Sherine M.Rizk, Mahmoud A.Senousy “Agomelatine attenuates alcohol craving and withdrawal symptoms by modulating the Notch1 signaling pathway in rats”, Life Sciences, 284, (2021), 119904.

https://doi.org/10.1016/j.lfs.2021.119904.

5.037 4
134.                Amr M. Emam, Muhammad A. Saad, Naglaa A. Ahmed, Hala F. Zaki. “Vortioxetine mitigates neuronal damage by restricting PERK/eIF2α/ATF4/CHOP signaling pathway in rats subjected to focal cerebral ischemia-reperfusion”, Life Sciences, 283, 119865, (2021), ISSN 0024-3205.

https://doi.org/10.1016/j.lfs.2021.119865.

5.037 4
135.                El-Yamany, Muhammed F., Eman S. Zaki, Sherif A. Shaltout, and Muhammed A. Saad. “Bone marrow mononuclear cells boosts anti-cytogentical aberration effect of N-Acetylcysteine and α-lipoic acid in rat’s liver and bone marrow: Implication of oxidative and inflammatory pathways”, Toxicology Mechanisms and Methods, 1-13, (2021).

https://doi.org/10.1080/15376516.2021.1906370.

2.987 2
136.                Hany H. Arab, Muhammad Y. Al-Shorbagy, Muhammed A. Saad. “Activation of autophagy and suppression of apoptosis by dapagliflozin attenuates experimental inflammatory bowel disease in rats: Targeting AMPK/mTOR, HMGB1/RAGE and Nrf2/HO-1 pathways”, Chemico-Biological Interactions, 335, 109368, (2021), ISSN 0009-2797.

https://doi.org/10.1016/j.cbi.2021.109368.

5.194 40
137.                Motawi, Tarek Mohamed Kamal, Nermin Abdel Hamid Sadik, Dina Sabry, Sally Atef Fahim, and Nancy Nabil Shahin. “rs62139665 polymorphism in the promoter region of EpCAM is associated with hepatitis C virus-related hepatocellular carcinoma risk in Egyptians.” Frontiers in Oncology: 5476. (2021).

DOI: 10.3389/fonc.2021.754104

6.230 0
138.                Muhammed A. Saad, Muhammad A. Eltarzy, Rania M. Abdel Salam, Maha A.E. Ahmed. “Liraglutide mends cognitive impairment by averting Notch signaling pathway overexpression in a rat model of polycystic ovary syndrome”, Life Sciences, 265, 118731, (2021), ISSN 0024-3205.

htts://doi.org/10.1016/j.lfs.2020.118731.

5.037 6
139.                Saad, Muhammad AE, Mohamed IM Fahmy, Rabab H. Sayed, Muhammad F. El‐Yamany, Reham El‐Naggar , Ahmed AE Hegazy, and Muhammad Al‐Shorbagy. “Eprosartan: A closer insight into its neuroprotective activity in rats with focal cerebral ischemia–reperfusion injury.”, Journal of Biochemical and Molecular Toxicology, (2021). https://doi.org/10.1002/jbt.22796. 3.652 2
140.                Nour El-Din HT, Elhosseiny NM, El-Gendy MA, Mahmoud AA, Hussein MMM, Attia AS. “A Rapid Lysostaphin Production Approach and a Convenient Novel Lysostaphin Loaded Nano-emulgel; As a Sustainable Low-Cost Methicillin-Resistant Staphylococcus aureus Combating Platform”, Biomolecules. 10(3), 435, (2020). https://doi.org/10.3390/biom10030435 4.879 8
141.                Rasha R. Yossef, Mohamed F. Al-Yamany, Muhammed A. Saad, Ayman E. El-Sahar. “Neuroprotective effects of vildagliptin on drug induced Alzheimer’s disease in rats with metabolic syndrome: Role of hippocampal klotho and AKT signaling pathways”, European Journal of Pharmacology, 889, 173612, (2020), ISSN 0014-2999.

https://doi.org/10.1016/j.ejphar.2020.173612.

3.263 10
142.                Hadir Farouk, Muhammed A. Saad, Sawsan S. Mahmoud, Mohammed F. El-Yamany, Ola A. Sharaf, Rania F. Ahmed, Ezz E. El-Denshary. “Effect of (+) and (-) hydroxycitric acid sterio-isomers present in natural products in counteracting insulin resistance”, Egyptian Journal of Chemistry, 63(11), 4341-4354, (2020).

DOI: 10.21608/ejchem.2020.25054.2493.

0.966 0
143.                Ayman E. El-Sahar, Alyasaa A. Rastanawi, Muhammed F. El-Yamany, Muhammed A. Saad. “Dapagliflozin improves behavioral dysfunction of Huntington’s disease in rats via inhibiting apoptosis-related glycolysis”, Life Sciences, 257, 118076, (2020), ISSN 0024-3205. https://doi.org/10.1016/j.lfs.2020.118076. 3.647 18
144.                Hebatullah S. Helmy, Mahmoud A. Senousy, Ayman E. El-Sahar, Rabab H. Sayed, Muhammed A. Saad, Eman M. Elbaz. “Aberrations of miR-126-3p, miR-181a and sirtuin1 network mediate Di-(2-ethylhexyl) phthalate-induced testicular damage in rats: The protective role of hesperidin”, Toxicology, 433–434, 152406, (2020). https://doi.org/10.1016/j.tox.2020.152406. 4.099 19
145.                Hany H. Arab, Muhammed A. Saad, Ayman E. El-Sahar, Muhammad Y. Al-Shorbagy. “Mechanistic perspective of morin protection against ketoprofen-induced gastric mucosal injury: Targeting HMGB1/RAGE/NF-κB, DJ-1/Nrf2/HO-1 and PI3K/mTOR pathways”, Archives of Biochemistry and Biophysics, 693, 108552, (2020), ISSN 0003-9861. https://doi.org/10.1016/j.abb.2020.108552. 3.391 13
146.                Saad MAE, Fahmy MIM, Al-Shorbagy M, Assaf N, Hegazy AAE, El-Yamany MF. “Nateglinide Exerts Neuroprotective Effects via Downregulation of HIF-1α/TIM-3 Inflammatory Pathway and Promotion of Caveolin-1 Expression in the Rat’s Hippocampus Subjected to Focal Cerebral Ischemia/Reperfusion Injury”, Inflammation, 43(2), 401-416, (2020).

Doi: 10.1007/s10753-019-01154-3.

3.212 5
147.                Muhammed A. Saad, Ayman E. El-Sahhar, Hany H. Arab, Muhammad Y. Al-Shorbagy. “Nicorandil abates arthritic perturbations induced by complete Freund’s adjuvant in rats via conquering TLR4-MyD88-TRAF6 signaling pathway”, Life Sciences, 218, 284-291, (2019), ISSN 0024-3205.

https://doi.org/10.1016/j.lfs.2019.01.002

5.037 11
148.                Radwan, A., El-Lakkany, N. M., William, S., El-Feky, G. S., Al-Shorbagy, M. Y., Saleh, S., & Botros, S. A. “Novel praziquantel solid lipid nanoparticle formulation shows enhanced bioavailability and antischistosomal efficacy against murine S. mansoni infection”, Parasites Vectors12(1), 304, (2019).

https://doi.org/10.1186/s13071-019-3563-z.

3.876 10
149.                Choucry, A.M., Al-Shorbagy, M.Y., Attia, A.S. et al. “Pharmacological Manipulation of Trk, p75NTR, and NGF Balance Restores Memory Deficit in Global Ischemia/Reperfusion Model in Rats”, J Mol Neurosci, 68(1), 78–90, (2019).

https://doi.org/10.1007/s12031-019-01284-1.

3.444 7
150.                Hassan NF, Nada SA, Hassan A, El-Ansary MR, Al-Shorbagy MY, Abdelsalam RM. “Saroglitazar Deactivates the Hepatic LPS/TLR4 Signaling Pathway and Ameliorates Adipocyte Dysfunction in Rats with High-Fat Emulsion/LPS Model-Induced Non-alcoholic Steatohepatitis”, Inflammation, 42(3), 1056-1070, (2019).

Doi: 10.1007/s10753-019-00967-6.

4.092 16
151.                Eman M. Elbaz, Hebatullah S. Helmy, Ayman E. El-Sahar, Muhammed A. Saad, Rabab H. Sayed. “Lercanidipine boosts the efficacy of mesenchymal stem cell therapy in 3-NP-induced Huntington’s disease model rats via modulation of the calcium/calcineurin/NFATc4 and Wnt/β-catenin signalling pathways”, Neurochemistry International, 131, 104548, (2019), ISSN 0197-0186. https://doi.org/10.1016/j.neuint.2019.104548. 3.881 8
152.                Noha Abdel-Rahman, Maha H. Sharawy, Nirmeen Megahed, Mohammed S. El-Awady. “Vitamin D3 abates BDL-induced cholestasis and fibrosis in rats via regulating Hedgehog pathway”, Toxicology and Applied Pharmacology, 380, 114697, (2019), ISSN 0041-008X. https://doi.org/10.1016/j.taap.2019.114697. 4.219 2
153.                Ibrahim, S.M., Al-Shorbagy, M.Y., Abdallah, D.M. et al. “Activation of α7 Nicotinic Acetylcholine Receptor Ameliorates Zymosan-Induced Acute Kidney Injury in BALB/c Mice”, Sci Rep8(1), 16814, (2018). https://doi.org/10.1038/s41598-018-35254-1. 4.380 15
154.                Rabab M. Ali, Muhammad Y. Al-Shorbagy, Maged W. Helmy, Hanan S. El-Abhar. “Role of Wnt4/β-catenin, Ang II/TGFβ, ACE2, NF-κB, and IL-18 in attenuating renal ischemia/reperfusion-induced injury in rats treated with Vit D and pioglitazone”, European Journal of Pharmacology, 15(831), 68-76, (2018), ISSN 0014-2999.

https://doi.org/10.1016/j.ejphar.2018.04.032.

4.432 24
155.                Mohammed K. AbdElhameid, Madlen B. Labib, Ahmed T. Negmeldin, Muhammad Al-Shorbagy & Manal R. Mohammed, “Design, synthesis, and screening of ortho-amino thiophene carboxamide derivatives on hepatocellular carcinomaas VEGFR-2Inhibitors”, Journal of Enzyme Inhibition and Medicinal Chemistry33(1), 1472-1493, (2018).

DOI: 10.1080/14756366.2018.1503654.

5.051 11
156.                Abd Elhameid MK, Ryad N, Al-Shorbagy MY, Mohammed MR, Ismail MM, El Meligie S. “Design, Synthesis and Screening of 4,6-Diaryl Pyridine and Pyrimidine Derivatives as Potential Cytotoxic Molecules”, Chem Pharm Bull, 66(10), 939-952. (2018).

Doi: 10.1248/cpb.c18-00269.

1.645 5
157.                Mai El Halawany, Randa Latif and Mohamed H. H. AbouGhaly. Hemostatic Alginate/Nano‐Hydroxyapatite Composite Aerogel Loaded with Tranexamic Acid or the Potential Protection against Alveolar Osteitis. Pharmaceutics,14(10), 2255 (2022)

DOI: 10.3390/pharmaceutics14102255

6.525 0
158.                Hammad RW, Sanad RA, Abdelmalak NS, Latif R. Architecting novel multilayer nanosponges for co-administration of two drugs managing high-risk type II diabetes mellitus patients suffering from cardiovascular diseases. Int J Biol Macromol. 1;220:1429-1443 (2022)

DOI: 10.1016/j.ijbiomac.2022.09.099

8.025               0
159.                Farag MM, Louis MM, Badawy AA, NessemDI, Abdelmalak NS. Drotaverine Hydrochloride Superporous Hydrogel Hybrid System: a Gastroretentive Approach for Sustained Drug Delivery and Enhanced Viscoelasticity. AAPS PharmSciTech, 23:124 (2022)

DOI: org/10.1208/s12249-022-02280-2

3.45 0
160.                Rodayna Atef Shalaby, Omaima El-Gazayerly, Mohammed Abdallah.  Cubosomal Betamethasone-Salicylic Acid Nano Drug Delivery System for Enhanced Management of Scalp Psoriasis. Int J Nanomedicine. 13;17:1659-1677 (2022).

DOI: 10.2147/IJN.S345430.

7.033 2
161.                Abdelmonem R, Elhabal SF, Abdelmalak NS, El-Nabarawi MA, Teaima MH. “Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study.”, Pharmaceutics, 13(2), 221, (2021).

https://doi.org/10.3390/pharmaceutics13020221.

6.321 5
162.                Nageeb El-Helaly, S.; Abd-Elrasheed, E.; Salim, S.A.; Fahmy, R.H.; Salah, S.; EL-Ashmoony, M.M. “Green Nanotechnology in the Formulation of a Novel Solid Dispersed Multilayered Core-Sheath Raloxifene-Loaded Nanofibrous Buccal Film; In Vitro and In Vivo Characterization”, Pharmaceutics, 13, 474, (2021).

https://doi.org/10.3390/pharmaceutics13040474.

6.321 3
163.                Tawfik, M.A., Mohamed, M.I., Tadros, M.I., El-Helaly S.N. “Low-Frequency Sonophoresis as an Active Approach to Potentiate the Transdermal Delivery of Agomelatine-Loaded Novasomes: Design, Optimization, and Pharmacokinetic Profiling in Rabbits.” AAPS PharmSciTech 22, 261 (2021).

https://doi.org/10.1208/s12249-021-02147-y

3.246 1
164.                Marwa Eid Sayyed, Mohamed AbdEl-Motaleb, Ismail Taha Ibrahim, Hassan Medhat Rashed, Mohamed Ahmed El-Nabarawi, Mohamed Abdallah Ahmed. “Preparation, characterization, and in vivo biodistribution study of intranasal 131I-clonazepam-loaded phospholipid magnesome as a promising brain delivery system: Biodistribution and pharmacokinetic behavior of intranasal 131I-Clonazepam loaded phospholipid magnesome as a potential brain targeting system”, European Journal of Pharmaceutical Sciences, 169, 106089, (2021).

https://doi.org/10.1016/j.ejps.2021.106089

4.384 1
165.                Mohamed Abdallah Ahmed, Wedian Younis Abdelgawad, Mary Kamal Gad, Magdy Ibrahim Mohamed. “A novel approach for the treatment of oral ulcerative lesion using mucoadhesive proniosome gel”, Journal of Drug Delivery Science and Technology, 102460, (2021), ISSN 1773-2247.

https://doi.org/10.1016/j.jddst.2021.102460.

2.734 1
166.                A. Ramadan, E.B. Basalious and M. Abdallah. “Industrial application of QbD and NIR chemometric models in quality improvement of immediate release tablets”, Saudi Pharmaceutical Journal, (2021), ISSN 1319-0164. https://doi.org/10.1016/j.jsps.2021.04.012. 2.879 2
167.                Farag MM, Abd El Malak NS, Yehia SA, Ahmed MA. “Hyaluronic Acid Conjugated Metformin-Phospholipid Sonocomplex: A Biphasic Complexation Approach to Correct Hypoxic Tumour Microenvironment.”, Int J Nanomedicine., 16, 1005-1019, (2021).

Doi:10.2147/IJN.S297634

6.400 6
168.                Sandy N. Aziz, Alia A. Badawy, Demiana I. Nessem, Nevine S. Abd El Malak. “Promising nanoparticulate system for topical delivery of diphenhydramine hydrochloride: In-vitro and in-vivo evaluation”, Journal of Drug Delivery Science and Technology, 55, 101454, (2020). https://doi.org/10.1016/j.jddst.2019.101454 3.981 2
169.                Reham Waheed Hammad, Rania Abdel-Basset Sanad, Nevine Shawky Abdelmalak, Faisal A. Torad, Randa Latif. “New intranasal cross-linked mosapride xyloglucan pluronics micelles (MOS-XPMs) for reflux esophagitis disease: In-vitro optimization and improved therapeutic efficacy”, Journal of Advanced Research, 23, 83-94, (2020). https://doi.org/10.1016/j.jare.2020.01.013. 10.479 5
170.                Farag, Michael M., Nevine S. Abd El Malak, Soad A. Yehia, and Mohammed A. Ahmed. “Sonocomplexation as an effective tool to enhance the antitumorigenic effect of metformin: Preparation, in vitro characterization, molecular dynamic simulation & MiaPaCa-2 cell line hypoxia evaluation.”, Journal of Drug Delivery Science and Technology59, 101968, (2020), ISSN 1773-2247.

https://doi.org/10.1016/j.jddst.2020.101968.

3.981 3
171.                Louis, Mina M., Alia A. Badawy, Demiana I. Nessem, and Nevine S. Abd Elmalak. “Drotaverine hydrochloride gastroretentive floating mini-tablets: Formulation, in-vitro and in-vivo evaluation.”, Journal of Drug Delivery Science and Technology, 57, 101733, (2020), ISSN 1773-2247. https://doi.org/10.1016/j.jddst.2020.101733 3.981 7
172.                Omar NE, El-Fass KA, Abushouk AI, Elbaghdady N, Barakat AEM, Noreldin AE, Johar D, Yassin M, Hamad A, Elazzazy S, Dermime S. “Diagnosis and Management of Hematological Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic Review”, Front Immunol., 11, 1354, (2020). Doi: 10.3389/fimmu.2020.01354. 5.085 2
Activity Scientific Research
Title Students’ International Publications
Details Ahmed Elsayed, SOP student, has published an international article from PHAR501 module, titled “Rapid Nanocatalytic Approach for Azo Dye Degradation Using Bi-Ligand Nickel-Based Metal–Organic Frameworks” in the esteemed journal BMC Chemistry with an impressive impact factor of 4.6, under mentorship and guidance from Prof. Amr Mohamed Bakheet (Analytical Chemistry Department) and AL. Noha Mostafa Abdelhameed (Pharmaceutical Chemistry Department).

Activity Scientific Research
Title Students’ International Publications
Details Hanin Shoukry, SOP student, has published an international article from PHAR501 module, titled “R Bioinformatics Analysis to Explore the Potential Prognostic Utility of hsa-miR-103a-3p in Head and Neck Squamous Cell Carcinoma” in the esteemed journal Scientific Reports with an impressive impact factor of 3.9, under mentorship and guidance from A/Prof. Sally Atef and TA. Aliaa El-Sherbiny (Biochemistry Department).

Activity Scientific Research
Title Students’ International Publications
Details Fady Refaat, SOP student, has published an international review article, titled “Comparative Safety and Side Effects of Semaglutide and Tirzepatide: Implications for Clinical Decision-Making in Obesity Management” in the esteemed journal Biomedicine and Pharmacotherapy with an impressive impact factor of 7.5, under mentorship and guidance from A/Prof. Sally Atef (Biochemistry Department) and TA. Ashrakat Yousry (Microbiology and Immunology Department).

Activity Scientific Research
Title Students’ International Publications
Details Abdelrahman K. Salem, SOP student, has published an international article from PHAR501 module, titled “Design and Development of Potent Roflumilast Analogues Targeting PDE-4B: Selectivity and Pharmacokinetic Insights” in the esteemed journal Bioorganic Chemistry with an impressive impact factor of 4.7, under mentorship and guidance from Prof. Marwa Fouad and A/Prof. Sally Tarek (Pharmaceutical Chemistry Department).

Activity Scientific Research
Title Students’ International Publications
Details Mostafa Mohsen Elgharabawy, SOP former student and SOP TA (Clinical Pharmacy Department), has published an international article from PHAR501 module, titled “Evaluating Liver-Type Fatty Acid Binding Protein as a Diagnostic and Prognostic Biomarker in Metabolic Dysfunction-Associated Steatotic Liver Disease in Pediatric Patients” in the esteemed journal PLOS ONE with an impact factor of 2.6,  under mentorship and guidance from Prof. Osama Hussien and Dr. Heba Elramly (Clinical Pharmacy Department).

Activity Scientific Research
Title Students’ International Publications
Details Jana Elhelw, SOP student, has published a book chapter titled “The Impact of Micronutrients on Cognitive Functions” in the book titled “Feeding the Mind: The Connection Between Diet, Drugs, and Mental Health” published by “Springer Nature”.

Additionally, Jana Elhelw has published an international article titled “Genetic Predispositions and Nutritional Strategies: A Review of Nutrigenomics in Parkinson’s Disease” in the esteemed journal Neuroscience with an impact factor of 2.8.

Activity Scientific Research
Title Students’ International Publications
Details Mariam Soliman, SOP student, has published an international article from PHAR501 module, titled “Pharmacokinetic assessment and metabolic stability of a novel multi-targeted Clk/Dyrk inhibitor using a validated LC-MS/MS method: In vitro and in vivo insights” in the esteemed journal of Chromatography B with an impact factor of 1.9, under mentorship and guidance from Prof. Marwa Fouad, A/Prof. Sally Tarek, and AL. Noha Mostafa Abdelhameed (Pharmaceutical Chemistry Department).

Activity Scientific Research
Title Students’ International Publications
Details Kholoud Lasheen, Nouran Ahmed, and Zeinab Mohamed, SOP students, have published an international article from PHAR501 module, titled “The Protective Effect of Febuxostat in a Rotenone Mouse Model of Parkinson’s Disease: The Interplay Between PI3K/Akt/mTOR, GSK-3β, and Nrf2/HO-1 Signaling Pathways” in the esteemed Journal of Pharmacy and Pharmacology with an impact factor of 3.2, under mentorship and guidance from Prof. Rabab Hamed (Clinical Pharmacy Department).

Activity Scientific Research
Title Students’ International Publications
Details Zeinab Hassan, SOP student, has published an international article from PHAR501 module, titled “Galactosylated Bilosomes for Liver-Targeted Delivery of Ledipasvir: Optimization, Conjugate Synthesis, and Cellular Evaluation” in the esteemed Pharmaceutical Development and Technology journal with an impact factor of 2.5, under mentorship and guidance from Dr. Ahmed Magdy (Pharmaceutics and Industrial Pharmacy Department).

Activity Scientific Research
Title Students’ International Publications
Details Hatem Wael Hamam, has published an international article from PHAR501 module, titled “Empagliflozin Dampens Doxorubicin-Induced Chemobrain in Rats: The Possible Involvement of Oxidative Stress and PI3K/Akt/mTOR/NF-κB/TNF-α Signaling Pathways” in the esteemed Molecular Neurobiology journal

with an impact factor of 4.6, under mentorship and guidance from Prof. Rania Mohsen, A/Prof. Ayman El-Sahhar, A/Prof. Reham Essam, and Assistant lecturer Noha Eissa (Department of Pharmacology and Toxicology)

Activity Scientific Research
Title Students’ International Publications
Details Enaya Ghaleb, has published an international article from PHAR501 module, titled “Association of OAS1 gene polymorphism with the severity of COVID‑19 infection” in the esteemed World Academy of Sciences journal with an impact factor of 2.1, under mentorship and guidance from A/Prof. Rehab Ibrahim (Department of Microbiology and Immunology)

Activity Scientific Research
Title Students’ International Publications
Details Yara Mohammed, has published an international article from PHAR501 module, titled “Catalytic activity study of a laccase-like copper–gallic acid MOF and its applications in the colorimetric determination of norepinephrine and degradation of environmental pollutants” in the esteemed RSC Advances journal with an impact factor of 3.9, under mentorship and guidance from A/Prof. Amr Bekheet (Department of Analytical Chemistry) and A.L. Noha Mostafa (Department of Pharmaceutical Chemistry)

Activity Scientific Research
Title Students’ International Publications
Details Yasmine Abdelfattah, has published an international article from PHAR501 module, titled “Point-of-care colorimetric biosensor for H₂O₂ and glucose detection utilizing the peroxidase-like activity of 2D bimetallic metal-organic framework nanosheets” in the esteemed Analytica Chimica Acta journal with an impact factor of 5.3, under mentorship and guidance from A/Prof. Amr Bekheet and TA. Noha Abdelaziz (Department of Analytical Chemistry)

 

SOP AWARDS

Shortlisted for Times Higher Education (THE) Awards in the category of “Teaching and Learning Strategy of the Year”

 

The School of Pharmacy was accredited by National Authority for Quality Assurance & Accreditation of Education (NAQAAE) on the 24th of April 2024

 

STUDENTS AWARDS

The team of SOP awareness campaign titled “Antibiotics With or Against You: The Decision is in Your Hand” had won the 2nd position in the Future Fighters against Antimicrobial Resistance (AMR) Program Competition among 23 Egyptian universities in December 2025. The competition was organized by Egyptian Drug Authority (EDA), in collaboration with World Health Organization Egypt (WHO) and ReAct Africa.

Our talented NGU Basketball students’ team have brought home the *2nd place* trophy in the Basketball Ramadan Tournament for the 6th of October sector, with the participation of 4 SOP students.

Our SOP Y3 student Nour Ghaleb secured first-runner-up place in the L’Oréal BrandStorm 2025 Egypt National Finals competition.

Our Y4 student, Rewan Yassin, nominated as a top performer at EGYouth4climate organized by the National Advisory on Youth and Climate, Egypt on May 15, 2025.

The NGU SOP Kidguard team achieved a great success in solving one of the challenges of the Bio iChallenge competition in cooperation with their industrial partner “Eva Limitless”, as the team was able to invent a new formula for a highly effective nutritional supplement. The NGU SOP Kidguard is a student research team includes Adel Mohamed Adel, Laila Adel Ali, Noreen Mohamed Tayal (Year 6 Students), and Ola Marzouk Sayed (Year 5 Student), under the supervision of Prof. Osama Hussein Kamel (Clinical Pharmacy), Prof. Nevine Shawqi Abdelmalak (Pharmaceutics and Industrial Pharmacy).

Top 100 of the GEN Z competition by the Ministry of Higher Education and Scientific Research Innovators Support Fund, out of 7053 teams!

BIO-ICHALLENGE Competition -Securing fund to propel their innovative project forward

 

STAFF AWARDS

Prof. Ahmed Sherif Attia, Professor of Microbiology & Immunology at NGU School of Pharmacy, has received the prestigious Bioscience Microbiological Sciences Award 2024. The Bioscience Scientists Awards are among the largest and most prestigious recognitions in the Middle East, celebrating groundbreaking contributions to the advancement of science and innovation. Prof. Attia’s exceptional work has earned him this honor, highlighting his significant impact on the field of microbiology and immunology.

 

Prof. Marwa Ahmed Fouad has been awarded by ACDIMA for her outstanding research published in the international journal Bioorganic chemistry entitled “New phosphazine and phosphazide derivatives as multifunctional ligands targeting acetylcholinesterase and β-Amyloid aggregation for treatment of Alzheimer’s disease”

 

Dr. Rabab Hamed received the State Encouragement Award in Medical Sciences

 

A.Prof/ Ahmed El Kerdawy won the first place for the Scientific Challenge Spring 2021 of BioSolveIT – Finest Software for Drug Discovery – a software for drug discovery

Event Name: SOP Academic Achievers for Semester 1 AY2025-2026

     Date: 18 February 2026

     Read the full story here.

 

Event Name: Graduation Ceremony for NGU SOP (Classes of 2024 and 2025)

     Date: 14 February 2026

     Read the full story here.

 

Event Name: SOP International Publication Ceremony 2025

     Date: 26 January 2026

     Read the full story here.

 

Event Name: PHAR501: Scientific Posters and Articles

     Date: 5, 20, 22 January 2026

     Read the full story here.

 

Event Name: World Antimicrobial Awareness Week (WAAW)

     Date: 12 December 2025

     Read the full story here.

 

Event Name: WHO and EDA Visit for the completion of the AMR Curriculum Assessment Tool for Pharmacy Education

     Date: 07 December 2025

     Read the full story here.

 

Event Name: UCL QA Review Visit

     Date: 18-20 November 2025

     Read the full story here.

 

Event Name: Recent Advances And Challenges In Antimicrobial Resistance: Threat From The Pink Corner

     Date: 10 – 12 November 2025

     Read the full story here.

 

Event Name: Powering Value and Access Through Patient-Centered Collaboration

     Date: 09 – 12 November 2025

     Read the full story here.

 

Event Name: Workshop “Prescribing Skills Assessment (PSA)”

     Date: 06 October 2025

     Read the full story here.

 

Event Name: Workshop “Art of Originality: Mastering Turnitin”

     Date: 01 October 2025

     Read the full story here.

 

Event Name: NGU Administrative Staff Appreciation Ceremony 2025

     Date: 28 September 2025

     Read the full story here.

 

Event Name: World Pharmacists Day

     Date: 24 September 2025

     Read the full story here.

 

Event Name: Workshop “AI Literacy”

     Date: 22 September 2025

     Read the full story here.

 

Event Name: Annual Student Conference 2025-2026 “The Pharmacy Student WALKTHROUGH EXPERIENCE: The Road to Greatness”

     Date: 17 September 2025

     Read the full story here.

 

Event Name: New Student Orientation 2025-2026

     Date: 16 September 2025

     Read the full story here.

 

Event Name: Workshop “Hands-on Structural Biology, Crystallography, and Cryo-EM Data Analysis”

     Date: 10-16 September 2025

     Read the full story here.

 

Event Name: Workshop “Classification of Healthcare Data as an Entry Point for Data Governance in the Healthcare Sector”

     Date: 02 September 2025

     Read the full story here.

 

Event Name: MOU with Hospice Egypt

     Date: 30 June 2025

     Read the full story here.

 

Event Name: Cosmetics Master Class: From Basics to Brilliance

     Date: 24, 25, and 29 June 2025

     Read the full story here.

 

Event Name: MOU with Gulf Medical University

     Date: 10 April 2025

     Read the full story here.

 

Event Name: SOP Employment Fair

     Date: 9 – 10 April 2025

     Read the full story here.

 

Event Name: 3rd International Conference of NGU SOP titled: Innovative Pharmaceutical Horizons: Bridging Science, Education, and Green Practices

     Date: 9 & 10 April 2025

     Read the full story here.

 

Event Name: SOP Ramadan Iftar

     Date: 12 March 2025

     Read the full story here.

 

Event Name: International Publication Ceremony 2024

     Date: 22 Jan 2025

     Read the full story here.

 

Event Name: MOU with EVA Pharma

     Date: 17 Dec 2024

     Read the full story here.

 

Event Name: Cosmetics Master Class: From Basics to Brilliance

     Date: 9, 16, and 23 Nov 2024

     Read the full story here.

 

Event Name: CBD in Pharmacy and the Egyptian Health Council taught

     Date: 18 Nov 2024

     Read the full story here.

 

Event Name: Unlock the Power of Network Pharmacology: The Intersection of Biology and Pharmacology

     Date: 19 and 26 Oct 2024

     Read the full story here.

 

Event Name: World Pharmacist Day, Pharmacy Profession: Socio-environmental impact

     Date: 24 Sep 2024

     Read the full story here.

 

Event Name: Annual Student Conference 2024-2025

     Date: 17 Sep 2024

     Read the full story here.

 

Event Name: New Student Orientation 2024-2025

     Date: 16 Sep 2024

     Read the full story here.

 

Event Name: Molecular Dynamic Simulation: A Transformative tool in Drug Discovery

     Date: 7-8 Sep 2024

     Read the full story here.


Event Name: SOP Students’ Poster Presentation at FIP World Congress

     Date: 1-4 September 2024

     Read the full story here.

 

Event Name: UCL Visit

     Date: 28-30 May 2024

     Check out the photos here.

 

– Session Name: Entrepreneurship

     Presented by: Dr. Lamia El Ayouby

     Session Date: 13 May 2024

     Read the full story here.

 

– Session Name: Medical Affairs Overview

     Presented by: Mr. Peter Effat

     Session Date: 13 May 2024

     Read the full story here.

 

– Session Name: Sales Management Overview

     Presented by: Mr. Ahmed Azouz

     Session Date: 29 April 2024

     Read the full story here.

 

– Session Name: Art of Communication and Persuasion

     Presented by: Dr. Merna Masoud

     Session Date: 22 April 2024

     Read the full story here.

 

– Session Name: Marketing Research at a Glance-Course

     Presented by: Dr. Mary Faisal

     Session Date: 20 April 2024

     Read the full story here.

 

Event Name: Care for Every Breath Conference by Haleon

     Date: April 2024

     Read the full story here.

 

Event Name: AIPC 2024 – International Healthcare Collaboration

     Date: April 2024

     Read the full story here.

 

– Session Name: Selling Skills

     Presented by: Dr. Merna Masoud

     Session Date: 4 March 2024

     Read the full story here.

 

– Session Name: Pharmaceutical Pharmacogenomics

     Presented by: Prof. Ahmed Wahid

     Session Date: 4 March 2024

     Read the full story here.

 

Event Name: Poster Presentation at DUPHAT International Conference

     Date: 9-11 January 2024

     Read the full story here.

 

Event Name: NAQAAE Visit to SOP

     Date: December 2023

     Read the full story here.

 

– Session Name: Future of Pharma Industry

     Presented by: Dr Sameh EL Bagoury

     Session Date: 18 Dec 2023

     Read the full story here.

 

– Session Name: How to create a productive & effective daily Habit

     Presented by: Dr. Mirna Masoud

     Session Date: 11 Dec 2023

     Read the full story here.

 

– Session Name: Fundamentals of Pharma Marketing

     Presented by: Dr. Mostafa Mahmoud

     Session Date: 4 Dec 2023

     Read the full story here.

 

– Session Name: Inspiring insights shaping the future of pharmacy education and research

     Presented by: Prof. Manal Maher

     Session Date: 30 November 2023

     Read the full story here.

 

– Session Name: How to manage your career journey Successfully

     Presented by: Dr. Rania Hassan

     Session Date: 22 November 2023

     Read the full story here.

 

– Session Name: How to Know Your Personality Strength and Use it Properly in the Workplace

     Presented by: Mirna Masoud

     Session Date: 20 November 2023

     Read the full story here.

 

– Session Name: Preventing Antimicrobial Resistance Together

       Presented by: Dr. Abeer El Behairy

       Session Date: 27 November 2023

       Read the full story here.

 

– Session Name: The Evolution of Green Pharmacy

    Presented by: Prof. Osama Ibrahim

    Session Date: 23 October 2023

    Read the full story here.

 

– Session Name: Antibiotics use; Myths & Facts

      Presented by: Dr. Nouran Hisham

      Session Date: 3 of October 2023

      Read the full story here.

 

– Session Name: Climate Change and Global Health-Preparedness and Response

     Presented by: Dr. Radwa Ewaisha

     Session Date: 2 of October 2023

     Read the full story here.

 

– Top Achievers Ceremony

      Date: 21 Sep 2023

      Read the full story here.



Roche Interview

     Date: 25 June 2023

     Read the full story here.

 

– SOP Conference

    Date: 21-22 June 2023

    Read the full story here.

 

– PHAR501 Final Presentation

     Date: 25 of May 2023

     Read the full story here.

 

Accsight – MOU

    MOU Date: 29 March 2023

    Read the full story here.

 

– Session Name:  Accelerate your Science Research and Education with Journal of Visualized Experiment

   Presented by: Dr. Passant Emad who is a Curriculum specialist, JoVE

   Session Date: 1 February 2023

   Read the full story here.

 

– Session Name: World’s water day

      Presented by: Dr.Radwa Ewaisha

      Session Date: 13 of March 2023

      Read the full story here.

 

– International Publication in 2022

      Date: 25 of Jan 2023

      Read the full story here.

 

– PHAR501 Final Presentation

      Date: 22 of January 2023

      Read the full story here.

 

– Session Name:  Sustainability in universities ranking Session.

      Presented by: Mai Rashad

      Session Date: 4 of January 2023

      Read the full story here.

 

– New year Ceremony

      Date: 27 of December 2022

      Read the full story here.

 

– Session Name: Is the Pandemic Over? – Covid19 Update

      Presented by: Dr. Radwa Ewaisha

      Session Date: 22 of December 2022

      Read the full story here.

 

Session Name:  Multiple Sclerosis session in collaboration with Pantomath

      Presented by: Dr. Rehab Shammah

      Session Date: 12 of December 2022

      Read the full story here.

 

– RAY-MOU

      MOU date: 7 December 2022

      Read the full story here.

 

– Liptis-MOU

      MOU date: 14 of November 2022

      Read the full story here.

 

– Session Name:  Digital Health Session

      Presented by: Dr. Heba Ali

      Session Date: 26 of October 2022

      Read the full story here.

 

– Pharmacotherapy Course

      Date: 25 of October 2022

      Read the full story here.

 

– SOP Top Achievers

       Date: 9 of October 2022

       Read the full story here.

 

Session Name:  Climate Change

      Presented by: Dr.Radwa Ewaisha

      Session Date: 21 of September 2022

      Read the full story here.

 

– L’Oréal Egypt-MOU

       MOU date: 24 July 2022

       Read the full story here.

 

  • Annual Winter Fair

  • Visit to 57357 Hospital


  • Outstanding performance of the non-academic staff for the Academic Year 2022-2023

  • The Future of Healthcare IT
  • Breast Cancer Awareness

  • Workshop: Accelerate your science research and education with Journal of visualized experiment

  • Awareness talk: Rationing Water Use

  • Awareness campaign: Role of vitamins in nutrition

  • Awareness campaign: Maternal health

  • Awareness campaign: Endemics in Egypt

  • Awareness campaign: Adolescence Mental Health


 

  • Awareness talk: How to use the Excel?

  • Training course: First Aids

  • International Publications Awards Ceremony

  • Staff Farewell celebration for the academic year 2022-2023

  • Annual Ramadan Night and Iftar

  • 57357 Hospital Visit

  • International Day for the Elimination of Violence Against Women – Hospice Egypt

 

  • Convoy to Beni-Suef

 

  • International Women’s Day- Hospice Egypt

  • Taaer Al Ganna Orphanage for disabled children

  • Campaign: RAMADAN Boxes
  • Charity exhibition: Charitable clothing exhibition for college employees

At SOP-NGU, we are committed to promoting sustainability in all aspects of education and research. As part of our dedication to a greener future, we recognize the importance of incorporating sustainability principles into the field of pharmacy. Our innovative approach to green pharmacy focuses on minimizing environmental impact while optimizing patient care. By integrating sustainable practices into pharmaceutical research, production, and distribution, we aim to reduce waste, conserve energy, and mitigate the ecological footprint of the healthcare industry. Through collaborative efforts with students, faculty, and community partners, we strive to shape the next generation of pharmacists who are not only knowledgeable in their field but also equipped with the tools to contribute to a healthier planet.

Sustainable Development Goals  

The United Nations Sustainable Development Goals (SDGs) are a set of 17 global goals aimed at addressing various social, economic, and environmental challenges to achieve a more sustainable and equitable world by 2030. These goals include eradicating poverty and hunger, ensuring quality education and healthcare, promoting gender equality, fostering sustainable cities and communities, and addressing climate change, among others. The SDGs serve as a blueprint for international cooperation and guide organizations and institutions in their efforts to contribute to sustainable development.

The School of Pharmacy at Newgiza University is deeply committed to the UN Sustainable Development Goals. As a leading institution in pharmaceutical education and research, the NGU SOP recognizes its role in promoting the well-being of individuals and communities. The SOP aligns its curriculum, research activities, and community engagement initiatives with the SDGs. It emphasizes the importance of providing quality pharmaceutical education that equips future pharmacists with the knowledge and skills to contribute to the achievement of several goals, such as ensuring access to affordable and quality healthcare, promoting responsible consumption and production, and enhancing partnerships for sustainable development. Additionally, the SOP actively engages in research projects that tackle pressing health challenges, supports community outreach programs to improve public health, and promotes sustainable practices within its facilities. By integrating the SDGs into its mission and activities, the School of Pharmacy at New Giza University demonstrates its dedication to advancing sustainable development and making a positive impact on society.

Learn more about the SDGs in this video:

https://www.youtube.com/watch?v=0XTBYMfZyrM

 

Why Sustainability in Pharmacy Matters

Pharmacies are at the heart of healthcare delivery, and they have a unique opportunity to lead the way in sustainable practices. By adopting green initiatives, pharmacies can:

  • Reduce Environmental Impact: By minimizing waste, conserving resources, and using eco-friendly materials, pharmacies can significantly decrease their environmental footprint.
  • Promote Public Health: Sustainable practices can positively impact public health by reducing exposure to harmful chemicals and pollutants.
  • Engage the Community: Implementing sustainable practices can create a positive image for your pharmacy and foster community engagement.
  • Stay Ahead of Regulatory Changes: Governments and regulatory bodies are increasingly focusing on sustainability. Adapting early can keep your pharmacy ahead of compliance requirements. Resources

    – United Nations Sustainable development goals Click here– Sustainability practices at WHO Click here– Environmentally sustainable health systems: a strategic document Click here– Sustainability in Pharmacy (FIP development goals) Click here–  Sustainability in Health care: The role of pharmacist and pharmacy practice Click hereResearchThe research conducted at the School of Pharmacy at New Giza University demonstrates a remarkable alignment with multiple UN Sustainable Development Goals (SDGs), including good health and well-being, clean water and sanitation, and life on land. The SOP’s research initiatives are aimed at developing sustainable health solutions that address pressing global challenges. Researchers focus on discovering innovative pharmaceuticals and drug delivery systems that promote good health and well-being while minimizing environmental impact. Additionally, the SOP’s research efforts extend to studying the development of eco-friendly and sustainable chemical processes in the field of green chemistry, contributing to the SDG of clean water and sanitation. By actively engaging in research that merges health and environmental considerations, the School of Pharmacy at NGU exemplifies its commitment to protecting life on land and promoting sustainable solutions that benefit both human health and the planet.

    SDG   
    Number of publications 193 2 2 2

    Learn more about our research here.

     

    Awareness and Education

    The School of Pharmacy at New Giza University (NGU SOP) is deeply committed to raising awareness and promoting education about sustainable development and climate among both its students and the wider public. Recognizing the urgent need for collective action to address environmental challenges, the NGU SOP integrates sustainability and climate topics into its curriculum, ensuring that students receive comprehensive education on these vital subjects. The school organizes workshops, seminars, and guest lectures focused on sustainable development and climate-related issues, fostering a sense of responsibility and equipping students with the knowledge and skills to become agents of change. Furthermore, the NGU SOP actively engages with the public through awareness campaigns and community outreach programs, aiming to educate and inspire individuals to adopt sustainable practices in their daily lives. By prioritizing awareness and education, the NGU SOP demonstrates its commitment to nurturing a generation of pharmacists who are well-informed and actively contribute to a sustainable future.

     

    – Climate Action Club Session
    Read Full story here 

    – Help Solve the Water Crisis
    Read Full story here

    – Climate Change and Global Health-Preparedness and Response
    Read Full story here

    – Eco-friendly Pharmacy Practice
    Read Full story here 

    – Care for every breath
    Read Full story here

    Some of our public awareness videos created by Dr. Radwa Ewaisha:

    • How is Climate Change Affecting our Health?

    https://youtu.be/zQSgZjhdHA8

     

    • What does a world that is 3˚C warmer look like?

    https://youtube.com/shorts/AN9gSe_eTCY?feature=share

     

    • How can you help with climate change?

    https://youtube.com/shorts/OrH3vgXjwOg?feature=share

     

    • 70% Decline in Animal Populations since 1970

    https://youtube.com/shorts/kGHLY-QvRV4?feature=share

     

    Student Activities

    The students at the School of Pharmacy at New Giza University (NGU SOP) are actively engaged in various activities that promote sustainable development. Recognizing the importance of their role as future healthcare professionals and responsible global citizens, the students organize and participate in initiatives that raise awareness and drive positive change. They collaborate on projects focused on sustainable healthcare practices, such as reducing waste in pharmaceutical settings, promoting responsible medication use, and advocating for access to affordable and environmentally friendly healthcare solutions. The students also organize awareness campaigns, workshops, and seminars to educate their peers and the wider community about sustainable development, climate change, and the impact of their actions on the environment. Through their active involvement, the students at NGU SOP demonstrate their dedication to fostering a sustainable future and making a meaningful impact in their field and beyond.

    Some of our student activities include:

    • Winter Clothes Recycling Fair

    Read full story here 

     

    • NGU SOP Student participates in COP27.

    Read full story here

     

    • NGU SOP Student attends COP28

    Read full story here

     

    • Our Youth Ambassador at the Barbados Connecting Climate Minds Meeting

    Read full story here

    Climate Action Club

    The Climate Action Club at the School of Pharmacy at New Giza University (NGU SOP) plays a pivotal role in promoting awareness and fostering engagement among students and the wider public. Committed to addressing the urgent challenges of climate change, this student-led club organizes a range of activities and initiatives. They host workshops, seminars, and panel discussions to educate students and the public about the impacts of climate change and the importance of sustainable practices. The club also collaborates with other organizations and institutions to organize awareness campaigns, tree-planting initiatives, and clean-up drives to actively contribute to environmental conservation efforts. By creating a platform for dialogue, raising awareness, and driving action, the Climate Action Club at NGU SOP empowers students and the public to be active participants in combating climate change and building a more sustainable future.

    Some of our activities:

    – Climate Change – The Greatest Threat to Human Health: by Dr. Radwa Ewaisha

    Read Full story here 

    – Plant for the planet: Contribution of Freshmen students on their orientation day in promoting awareness of the global climate change issue through planting basil and fenugreek.
    Read full story here

    – Christmas carnival event: Students built a Christmas tree out of recycled plastic bottles proving the importance of sorting recyclable materials.
    Read full story here 

    The program included gaining skills such as: communication and leadership skills, entrepreneurship and innovation skills and multiple advocacy skills. In addition to these skills participants had the chance to gain knowledge on how climate change affects every single one of us and how to implement the gained knowledge on climate change to our careers.

    -Climate Change Session: by Prof. Fagr AbdelGawad

    Read full story here 


    Ecofriendly Team

    Our Ecofriendly Team is a group of passionate individuals dedicated to making a positive impact on the environment through sustainable practices. Comprised of students and staff members, we come together with a shared vision of creating a greener and more sustainable campus community. Through our collaborative efforts, we strive to implement eco-friendly initiatives and raise awareness about the importance of environmental conservation. From organizing recycling drives to promoting energy conservation, our team actively seeks innovative solutions to reduce our ecological footprint. Together, we inspire and empower others to adopt sustainable habits and make a difference in their daily lives.

    We encourage all members of the New Giza School of Pharmacy community to actively participate in our sustainability efforts and be part of the movement towards a more environmentally conscious future. Together, we can create a greener, more sustainable future for pharmacy practice.

     

    For inquiries or suggestions, please contact Yara Zaky at Yara.Zaky@ngu.edu.eg

     

 

  • Heart Failure Awareness Campaign
  • SOP Talent Competition
  • Sandoz Internship
  • Year 1 Internship at Baheya
  • Cairo university (forensic medicine internship)
  • PHAR502 module Presentations

 

  • Nawah Scientific Day
  • Year 3 poster presentation

  • L’Oreal Brand storming competition
  • Championships (Basketball)
  • PHAR501
  • Hikma Clothes startup brand

  • Ramadan Iftar

  • Roche Conference
  • The National Museum of Egyptian Civilization
  • EVA Cosmetics
  • Football tournament for girls
  • Charitable Padel tournament
  • Scientific trip: Vitabiotics UK and UCL visit
  • Informative talk: Data collection and monitoring
  • Informative talk: Introduction to Marketing Research
  • Informative talk: Medical Quires Handle Process
  • Informative talk: Sandoz Biosimilars
  • Workshop: Digital Health
  • Informative talk: Patient Journey Partner
  • Scientific event: Launching NGU Pharmaceutical Society


  • Workshop: CV writing and Interviewing skills
  • Campaign: Blood donation
  • Campaign: Fight the Fakes
  • Campaign: Multiple Sclerosis
  • Campaigns: CNS disorders

  • PHAR501: Experiential Research Module
  • Global Napi
  • Eva Cosmetics
  •  Marcyrl
  • Awareness talk: Is the pandemic over?
  • Cultural trip: Forever is Now exhibition


  • Freshmen Student’s Welcome Orientation
  • Top achievers’ ceremony for the AY2021/2022

  • Entertainment trip: Saint Catherine Mountain
  • International day of “Hospice”

  • International day for the “Elimination of violence against women” and Hospice Egypt
    Fundraising event

  • 57357 Voluntary Day

  • Third Convoy to Beni Suef

  • Year-2 visit to EL-Ezaby Pharmacy

 

  • NGU pharmaceutical society club (EPSF scientific annual conference)

 

  • Sandoz session- Soft skills

 

  • How to Pass an Interview? -Dr. Tarek Morsi

 

  • Radio Pharmacy Session-Dr Sherif Kamal

 

  • Year-3 CNS illness Leaflet Campaign

 

  • Year-3 visit to Liptis Pharmaceuticals

 

  • Global Napi Pharmaceutical visit-Year-3

 

  • Medical Queries handling process- Dr. Mirette Romany, Johnson & Johnson

 

  • Career discovery Session, Mariam Fouad-Sandoz

 

  • SOP top achievers Ceremony

 

  • EVA Talented Interns Graduation

 

 

 

 

                                                               Placement Visits Plan Report

                                                                           S1 AY2025/2026

Placement Year Number of Students Expecting Date
EVA Cosmetics Year 2

students

           54 students

11 November 2025

09 December 2025

Amoun pharmaceuticals Apologized due to unavailability of the sterile area
EVA Pharmaceuticals Year 3

students

            49 students

23, 26 November 2025
MARC Year 4

students

            35 students

06 November 2025
Viatris 10 December 2025
MinaPharm 16 December 2025

 

                                                              Placement Visits Plan Report

                                                                          S2 AY2024/2025

Placement Year Number of Students Date
El-Ezaby community pharmacy Year 1

PHAR101

             58 students 13, 15/04/2025
Year 2

PHAR203

             54 students 22/02/2025

12/04/2025

Year 5

PHAR503

             70 students 23, 30/04/2025

6, 7, 14/05/2025

Nile Badraway Hospital Year 2

PHAR203

             54 students 7, 14/04/2025
Year 3

PHAR304

             34 students 12, 13/04/2025
Year 4

PHAR404

            21 students

    Infectious diseases

16, 18/02/2025

2, 3/03/2025

           21 students

           Cardiology

23, 25/02/2025

9, 11/03/2025

Year 5

PHAR503

            70 students 19, 26/02/2025

12, 19, 26/03/2025

8, 16, 23, 30/04/2025

3, 6, 7, 14/05/2025

Maadi Military Hospital Year 4

PHAR404

            21 students

         Critical Care

16, 18, 23, 25/02/2025

2, 3, 9, 11/03/2025

Year 5

PHAR503

            70 students 19, 26/03/2025

8, 16/04/2025

 

Placement Year Number of Students Date
El-Salam El-Dawley Hospital Year 4

PHAR404

              21 students

            Respiratory

16, 18, 23, 25/03/2025
              21 students

       Transplantation

26/03/2025
              21 students

       Clinical Nutrition

19/03/2025
Al-Shorouk Hospital Year 4

PHAR404

             21 students

            Nephrology

16, 18, 23, 25/03/2025
National Cancer Institute Year 4

PHAR404

             21 students

             Oncology

16, 22, 23, 30/04/2025

4, 7, 15/05/2025

             21 students

            IV Mixing

16, 22, 30/04/2025

4/05/2025

             21 students

                  DIC

23/04/2025

7, 15/05/2025

 

                                                               Placement Visits Plan Report

                                                                            S1 AY2024/2025

Placement Year Number of Students Expecting Date
EVA Cosmetics Year 2

students

50 divided on 2 batches 12, 19 November 2024
Amoun pharmaceuticals 13, 14 November 2024
Marcyrl 13, 14 November 2024
Liptis Year 3

students

             35 students 27 November 2024
EVA Pharmaceuticals 12, 19 December 2024
Viatris Year 4

students

             21 students 2 December 2024
MARC 3 December 2024
MinaPharm 11 December 2024

 

About the Center

The School of Pharmacy Entrepreneurship and Career Center (SOPECC) strives to enhance the professional, and entrepreneurial skills among students and graduates. Our ultimate objective is to assist them in making crucial decisions that result in exceptional academic and professional accomplishments, ultimately benefiting the community in the field of primary healthcare and fostering communication with diverse sectors of society. To accomplish this, we offer a wide range of high-quality courses, organized visits, informative workshops, specialized programs, and facilitate communication with the pharmaceutical market. Moreover, we conduct seminars to raise awareness about the requirements of the profession and its impact on the community. Recognizing that pharmacists play a pivotal role in providing services to the community, we emphasize their significance as the forefront and gateway to delivering professional and awareness-related services. Overall, SOPCC is dedicated to equipping individuals with the necessary skills, knowledge, and awareness to excel in their careers and contribute meaningfully to the community, both at a professional and societal level.

Vision

Our goal is to establish ourselves as a leading international career center that equips students and graduates with the necessary professional and entrepreneurial skills to excel in both local and international markets

Mission

Our mission is to foster the development of professional, and entrepreneurial skills among students and graduates, providing them with the necessary support to pave the way for exceptional academic and professional achievements. This will be achieved through the delivery of high-quality courses, organized visits, engaging workshops, specialized programs, and facilitating connections with pharmaceutical employers.

Goals

  • Establish collaborations with companies and hospitals interested in providing training opportunities for students.
  • Create cooperation protocols with associations and institutions dedicated to enhancing the skills of students and graduates.
  • Invite experienced professionals from Egypt and abroad who have excelled in the field of pharmacy to conduct workshops or online webinars.
  • Organize events to bring together students, experts, and successful recent graduates from various pharmacy fields for open discussions, idea exchange, and the transfer of professional experiences.

Through these initiatives and programs, we strive to bridge the gap between academia and the labor market, empowering our students and graduates with the necessary skills and experiences to succeed in their pharmacy careers.

Organogram

Services

Professional Guidance

  • Personal and career development
  • Business ethics and management
  • C.V. Writing
  • Job interviewing skills

Personal development

  • Career orientation
  • Soft skills
  • Team development
  • Time management

Recruitment and placement

  • C.Vs’ revision and collection
  • Organizing job interveiws
  • Creating and implementing placements and internships

 

SOP Placement Plan

 

AY2024-2025/Semester-1

Placement Year Number of Students Expecting Date
EVA Cosmetics Year 2

students

50 divided on 2 batches November 2024
L’Oréal Egypt Year 2

students

50 divided on 2 batches November 2024
Global Napi Year 3

students

35 students November/December 2024
EVA Pharmaceuticals Year 3

students

35 students December 2024
MARC Year 4

students

21 students November 2024
L’Oréal Egypt Year 4

students

21 students November/December 2024
MinaPharm Year 4

students

21 students November/December 2024

 

AY2023-2024/Semester-1

Year Placement Expecting Date
Year 2

 

EVA Cosmetics November 2023
L’Oréal Egypt November 2023
Year 3 Global Napi November/December 2023
EVA Pharmaceuticals November/December 2023
Year 4 MARC November/December 2023
L’Oréal Egypt November/December 2023

 

AY2023-2024/Semester-2

 

Year Placement Expecting Date
Year 1 Community pharmacy

El Ezzaby

April 2024
Year 2 Community pharmacy

El Ezzaby

April 2024
Nassaem Hospital
Year 3 El Nile Badrawy Hospital March 2024
Year 4 El Nile Badrawy

El Salam international hospital

March/ April 2024
Year 5 Nassaem Hospital

57357 Hospital

April 2024
Community pharmacy

El Ezzaby

May 2024

 

Activities

– Workshop “How to get through the Canadian License Exam”

  • Date: 11 February 2026
    • The SOP Entrepreneurship and Career Center organized a capacity building workshop titled “How to get through the Canadian License Exam”, on Wednesday, February 11, 2026.
    • The workshop was delivered by Dr. Belal Zoweil (Associate at Shoppers Drug Mart and pursuing a PhD in Health Economics at the University of Lancaster, UK), who has transitioned from staff pharmacist to managing a successful franchise at Shoppers Drug Mart with an impressive annual turnover of over $10 million.
    • Belal Zoweil guided students with essential tips to get through the Canadian License Exam.

 

– Workshop “L’Oreal BrandStorm Competition”

  • Date:07 December 2025
    • The SOP Entrepreneurship and Career Center organized a second capacity building workshop titled “L’Oreal BrandStorm Competition” on Sunday, December 07, 2025.
    • The workshop was delivered by Nour Ghaleb (Year 4 Student and L’Oréal BrandStorm Ambassador).
    • Nour shared her insights and tips for excelling in the L’Oréal BrandStorm competition.
    • A total of 48 SOP students from different years attended the workshop.

 

– Workshop “L’Oreal BrandStorm Competition”

  • Date: 30 November 2025
    • The SOP Entrepreneurship and Career Center organized a capacity building workshop titled “L’Oreal BrandStorm Competition” on Sunday, November 30, 2025.
    • The workshop was delivered by Dr. Karim Magdy (Talent Lead at L’Oréal).
    • The workshop was an engaging introductory session on the L’Oréal BrandStorm competition. Dr. Karim shared valuable insights into the competition’s innovative challenges and the exciting world of beauty and marketing.
    • A total of 85 SOP students from different years attended the workshop and were inspired to unleash their creativity and tackle real-world business scenarios.

 

– Workshop “Your Future Career: From Confusion to Clarity”

  • Date:24 November 2025
    • The SOP Entrepreneurship and Career Center organized a capacity building workshop titled “Your Future Career: From Confusion to Clarity” on Monday, November 24, 2025.
    • The workshop was delivered by Dr. Sarah Saber (Regional Regulatory Affairs Head at Boehringer Ingelheim).
    • The workshop was powerful, filled with clarity, confidence, and real-world insight, where Dr. Sara guided students through building direction, overcoming uncertainty, and making informed, value-driven career decisions.
    • A total of 77 SOP students from different years attended the workshop.

 

– Workshop “Healthcare in EMEA: Reimbursement & Challenges”

  • Date: 23 November 2025
    • The SOP Entrepreneurship and Career Center organized a capacity building workshop titled “Healthcare in EMEA: Reimbursement & Challenges” on Sunday, November 23, 2025.
    • The workshop was delivered by Dr. Sherif El-Baz (Early Products HEMAR Manager UK at Johnson & Johnson).
    • The workshop offered valuable insights into the evolving landscape of healthcare, Diverse Healthcare Systems, Health Economic Systems, Drug Registration at the MENA region versus European systems, and Investment Strategies.
    • A total of 31 SOP students from Year 4 attended the workshop.

 

– Workshop “Rx for Success: Navigating Your Career as Pharmacists”

  • Date: 26 October 2025
    • The SOP Entrepreneurship and Career Center organized a capacity building workshop titled “Rx for Success: Navigating Your Career as Pharmacists” on Sunday, October 26, 2025.
    • The workshop was delivered by Dr. Mounir Masoud (HR Senior Manager at Eva Cosmetics).
    • The workshop provided students with valuable insights on career development and growth within the pharmaceutical industry.
    • A total of 86 SOP students from different years attended the workshop.

 

– Workshop “Medical Queries Handling Process”

  • Date: 16 October 2025
    • As part of involving relevant labor market stakeholders in teaching and student capacity building, the PHAR402 module organized a workshop titled “Medical Queries Handling Process” on Thursday, October 16, 2025.
    • The workshop was delivered by Dr. Miret Romany (Johnosn and Johnson).
    • The workshop focused on effective strategies for managing and responding to medical inquiries with accuracy and professionalism through identifying reliable information sources, communicating clearly with healthcare professionals, and ensuring patient safety through evidence-based responses.
    • A total of 22 SOP Year 4 students attended the workshop.

 

– Workshop “Research Data Collection”

  • Date: 14 October 2025
    • As part of involving relevant labor market stakeholders in teaching and student capacity building, the PHAR402 module organized a workshop titled “Research Data Collection” on Tuesday, October 14, 2025.
    • The workshop was delivered by Dr. Islam Anan (CEO of Accsight).
    • The workshop offered invaluable insights into the methodologies and best practices for gathering research data, empowering students with the tools they need for their upcoming projects. The interactive discussion fostered engagement and curiosity, highlighting the importance of rigorous data collection in the field of pharmacy.
    • A total of 15 SOP Year 4 students attended the workshop.

 

– Workshop “An Introduction to Year 6 and How to Benefit from it”

  • Date: 13 October 2025
    • The SOP Entrepreneurship and Career Center organized a capacity building workshop titled “An Introduction to Year 6 and How to Benefit from it” on Monday, October 13, 2025.
    • The workshop was delivered by Dr. Emad George (Quality Assurance Director at Global Napi Pharmaceuticals).
    • The workshop provided the privilege of learning about maximizing final year in pharmacy.
    • A total of 67 SOP students from different years attended the workshop.

 

– Workshop “Good Data Management and Research”

  • Date: 07 October 2025
    • As part of involving relevant labor market stakeholders in teaching and student capacity building, the PHAR402 module organized a workshop titled “Good Data Management and Research” on Tuesday, October 07, 2025.
    • The workshop was delivered by Dr. Islam Anan (CEO of Accsight).
    • The workshop offered valuable insights into research data collection methods, where the students engaged in interactive discussions, learning about the importance of accurate data gathering and its impact on research outcomes.
    • A total of 20 SOP Year 4 students attended the workshop.

 

– Workshop “Data Collection and Monitoring”

  • Date: 06 October 2025
    • As part of involving relevant labor market stakeholders in teaching and student capacity building, the PHAR402 module organized a workshop titled “Data Collection and Monitoring” on Monday, October 06, 2025.
    • The workshop was delivered by Dr. Ahmed Hamouda (Clinical Research Director at Ray CRO).
    • The workshop offered valuable insights that are essential for the module and sparked students’ interest in the field of clinical research. Dr. Hamouda shared his expertise and real-world experiences, engaging students in discussions about the importance of accurate data collection in clinical trials.
    • A total of 30 SOP Year 4 students attended the workshop.

 

– Workshop “How To Develop Your Career In Bioinformatics”

  • Date: 29 September 2025
    • The SOP Entrepreneurship and Career Center organized a capacity building workshop titled “How to Develop Your Career in Bioinformatics” on Monday, September 29, 2025.
    • The workshop was delivered by Dr. Arwa Mo’men (Operations manager at Colours Educational Hub and a leading expert in bioinformatics).
    • The workshop provided an excellent opportunity to explore the intersection between pharmacy and bioinformatics, learn about potential career paths, and receive valuable advice on how students can enhance their skills in this innovative and evolving field.
    • A total of 26 SOP students attended the workshop.

 

– Workshop “Introduction To Marketing Research”

  • Date: 29 September 2025
    • As part of the involvement of relevant labor market stakeholders in teaching and student capacity building, the PHAR402 module organized a workshop titled “Introduction to Marketing Research” on Monday, September 29, 2025.
    • The workshop was conducted by Dr. Mary Faisal (market research expert and certified life coach).
    • The workshop was highly insightful, covering key topics such as gathering information about target markets and understanding customer behavior within the pharmaceutical industry.
    • A total of 27 SOP Year 4 students attended the workshop.

 

– How To Shape Your Career

  • Date: 29 April 2025
    • The SOP Career Guidance and Entrepreneurship Center organized the fourth training and awareness workshop for S2 of the AY 2024/2025 titled “How to shape your career”, on Tuesday, April 29, 2025, where the training was conducted by Dr. Nadia El-Shafei (R&S Management Consultancy).
    • The workshop was attended by 82 SOP students from different study years.

 

– Signature Impact: Your Personal Brand as a Competitive Edge

  • Date: 28 April 2025
    • The SOP Career Guidance and Entrepreneurship Center organized the third training and awareness workshop for S2 of the AY 2024/2025 titled “Signature Impact: Your Personal Brand as a Competitive Edge”, on Monday, April 28, 2025, where the training was conducted by Dr. Ragaa Magdy (Ruja Cosmetics Founder).
    • The workshop was attended by 66 SOP students from different years.

 

– Diabetes education and care for diabetes patients according to Canadian guidelines

  • Date: 24 Feb 2025
    • The SOP Career Guidance and Entrepreneurship Center organized the sixth training and awareness workshop for the AY 2024/2025 titled “Diabetes education and care for diabetes patients according to Canadian guidelines”, on Monday, February 24, 2025, where the training was conducted by A/Prof. Amr Bekheet (NGU School of Pharmacy).
    • The workshop was attended by 70 SOP students from year 5 of study.

 

– Sales and marketing fundamentals for Pharma

  • Date: 20 Feb 2025
    • The SOP Career Guidance and Entrepreneurship Center organized the fifth training and awareness workshop for the AY 2024/2025 titled “Sales and marketing fundamentals for Pharma”, on Thursday February 20, 2025, where the training was conducted by Dr. Mohamed AbouZaid (Senior Sales Manager at Astra Zeneca).
    • The workshop was attended by 70 SOP students from Year 5.

 

– Building a career in Pharmacy

  • Date: 10 Dec 2024
    • The SOP Career Guidance and Entrepreneurship Center organized the fourth training and awareness workshop for the AY 2024/2025 titled “Building a career in Pharmacy”, on Tuesday, December 10, 2024, where the training was conducted by Dr. Faisal Fouad (Global Napi).
    • He talked about different careers in Pharmacy profession and how to develop your career path.
    • The workshop was attended by 134 SOP students from different years.

 

– How to make a professional LinkedIn profile

  • Date: 3 Dec 2024
    • The SOP Career Guidance and Entrepreneurship Center organized the third training and awareness workshop for the AY 2024/2025 titled “How to make a professional LinkedIn profile”, on Tuesday December 03, 2024, where the training was conducted by Dr. Mary Faisal (Brain Health USA).
    • She talked about the importance of LinkedIn in career development and provided the pathway to make a professional LinkedIn profile.
    • The workshop was attended by 14 SOP students from Year 4.

 

– Entrepreneurship: The Hair Addict

  • Date: 25 Nov 2024
    • The SOP Career Guidance and Entrepreneurship Center organized the second training and awareness workshop for the AY 2024/2025 titled “Entrepreneurship: The Hair Addict”, on Monday, November 25, 2024, where the training was conducted by Eng. Doaa Gawish (Founder and CO of Hair Addict).
    • She provided a detailed explanation of the importance of entrepreneurship and gave a talk on her journey of success in founding Hair Addict Company.
    • The workshop was attended by 69 SOP students from different years of study.

 

– Digital and Media Consumer Buzz

  • Date: 25 Nov 2024
    • The SOP Career Guidance and Entrepreneurship Center organized the first training and awareness workshop for the AY 2024/2025 titled “Digital and Media Consumer Buzz” on Monday, November 25, 2024, where the training was conducted by Dr. Peter Effat (Sandoz Egypt).
    • He provided a detailed explanation of the importance of digital and media advertising in marketing and entrepreneurship.
    • The workshop was attended by 69 SOP students from different years of study.

 

– Entrepreneurship

  • Presented by: Dr. Lamia El Ayouby- Assistant Professor of Entrepreneurship at NGU’s School of Business and Finance

– Marketing Research at a Glance-Course

– Medical Affairs overview

  • Presented by: Mr. Peter Effat-Head of Medical Affairs at Sandoz

– Sales management overview

  • Presented by: Dr Ahmed Azouz

– Art of Communication and Persuasion

  • Presented by: Dr Mirna Masoud, Sandoz

– Selling skills

  • Presented by: Dr Mirna Masoud, Sandoz

– Future of Pharma Industry

  • Presented by: Dr Sameh El Bagoury, General Manager at Sandoz Egypt & Libya

– Fundamentals of Pharma Marketing

  • Presented by: Dr Mostafa Mahmoud, Sandoz

– Sandoz Internship

– Year 1 Internship at Baheya

– Cairo University (forensic medicine internship)

– Hikma Clothes startup brand

– Healthcare IT

  • Presented by: Sandra EL Zeni- Implementation manager, Dedalus Healthcare LLC
  • Session Date: 26 October 2023.



– How to know your personality strength

  • Presented by: Mirna Masoud- Trainer at Sandoz
  • Session Date: 20 Nov 2023



Digital Transformation in Pharma Industry

  • Presented by: Tarek Mattar-Commercial Excellence & Operation head, Sandoz
  • Session Date: 22 Nov 2023

– How to create a productive & effective daily habit

  • Presented by: Mirna Masoud-Trainer at Sandoz
  • Session Date: 11 Dec 2023

– How to manage your career Journey Successfully 

  • Presented by: Rania Hassan – HR head
  • Session Date: 22 Nov 2023


– Marketing Research 

  • Presented by: Dr. Mary Faisal
  • Session Date: 3 Oct 2023

– Medical Queries handling process

  • Presented by: Mirette Romany-Medical information lead at Johnson and Johnson
  • Session Date: 19 Oct 2023


– Research data collection & Management
. 

  • Presented by: Dr. Islam Anan, CEO at Accsight
  • Session Date: 11 Dec 2023



– Sandoz Soft Skills Session

  • Presented by: Dr Ahmed Abdelaziz
  • Session Date: 13 Feb 2023

 

– Selling skills

  • presented by: Merna Masoud
  • Session Date: 4 March 2024


– Roche interviews for Year 5 student



L’Oréal Brand storming Competition


SOP is unique in providing distinguished field training to all the students in all levels during the semester, in addition to summer training. SOP has prepared a specification for field training compatible with the educational programs’ competencies and learning outcomes of the modules.

The program aims to provide student interns with an overview of the current healthcare environment, expose them to current standards of care and policy driven pharmacy practice unique to hospitals and health-systems.

The school has concluded various memoranda of understanding, collaboration protocols and agreements with pharmaceutical companies, medical centers, and hospitals to provide student training in industrial pharmacy and clinical pharmacy. Example of these are the Armed Forces Medical Center in Maadi, Nassaem Hospital, Baheya Center for Early Detection and Treatment of Breast Cancer, International Medical Center, El-Moalmeen Hospital, Dar Al-Fouad Development Academy, Sandoz Egypt Co., L’Oréal Egypt Co., Magic Pharma/Vitabiotics Co., and Liptis Pharmaceuticals Co.

Upon successful completion of the requirements, the intern will receive a certificate of competence of the training.

Summer Internships:

 

  • Sandoz Egypt
  • Cairo University (Forensic Medicine Internship)

 

  • Year 1 Internship at Baheya

 

  • Sandoz Internship

 

  • Eva Internship

 

  • Global Napi Internship



 

  • Magic Pharma Internship


 

  • Roche Conference Internship

 

This committee offers continuous interaction with students to permit maximum academic assistance to each student throughout his/her academic study. An academic advisor and a tutor are assigned to each group of students (5-10 students each) to observe their academic progress and offer support to each student. The goal of the advisory team in coordination with module leads and year leads is to remove any barriers that students may experience during their scholastic years. Moreover, struggling students receive more comprehensive assistance and close follow up to improve their educational performance.

The Quality Assurance Unit (QAU) of NGU School of Pharmacy was established at the beginning of the AY2019/2020. QAU seeks to inculcate the culture of quality among all faculty members, including staff members, teaching assistants, admins, technicians, and students. QAU works to ensure the quality of the educational process, scientific research, and community participation, and to achieve the requirements of the labor market and align to the standards of the National Authority for Quality Assurance and Accreditation of Education (NAQAAE). QAU participated in achieving the institutional accreditation from NAQAAE in April 2024 immediately after the graduation of the first batch of students. QAU operates through an approved and announced internal bylaw that includes all the competencies of the unit’s employees and its executive committees, and a guide to ensure the quality of achieving the standards of the National Authority for Quality Assurance and Accreditation of Education (NAQAAE).

  • QAU Organogram:

The School of Pharmacy academic calendar 2024-2025

Academic Calendar for Health Sciences Schools 2024-2025

 

Tuition Fees:

The School of Pharmacy tuition fees for the academic year (2025-2026): EGP 172,600 + 500 USD for Egyptian students. For more information, please click here.

 

Deadlines:

The deadline for the academic year 2025/2026 will be announced soon.

Fill out the online application form.

For more information about the application process and how to apply to the School of Pharmacy, please visit the Admissions section.

Postgraduate Program Overview

The School of Pharmacy at Newgiza University offers a comprehensive postgraduate program comprising four specialised master’s degrees, designed to advance professional expertise and research capabilities in key areas of pharmaceutical sciences. The program is structured to align with international academic standards and address the evolving needs of the healthcare and pharmaceutical industries.

Master of Clinical Pharmacy

The Master of Clinical Pharmacy at the School of Pharmacy, Newgiza University is a forward-thinking, patient-centred postgraduate program designed to prepare pharmacists for advanced clinical roles across diverse healthcare settings. Rooted in evidence-based practice and guided by the latest developments in pharmacotherapy, precision medicine, and clinical decision-making, this program equips pharmacists with the clinical expertise, critical thinking skills, and research capabilities necessary to optimise medication therapy and lead interdisciplinary healthcare teams.

Delivered by a distinguished faculty of clinicians, researchers, and healthcare leaders, the program integrates cutting-edge clinical knowledge through case-based learning and individualised mentoring. Graduates will be well-positioned to make meaningful contributions to patient care, engage in impactful clinical research, and assume leadership roles in healthcare systems, academia, and policy-making arenas, both regionally and globally.

 Master of Pharmaceutical Chemistry

The master’s Program of Pharmaceutical Chemistry at Newgiza University is designed to prepare students for impactful careers in the pharmaceutical industry and research sectors. This program offers a robust curriculum covering key areas in medicinal chemistry, including organic synthesis, pharmaceutical analysis, drug metabolism, spectroscopy, computational chemistry, and AI-driven drug design, as well as quality control. Students will gain a solid foundation in both theoretical knowledge and practical applications. Students in this program will learn from leading researchers in pharmaceutical chemistry, combining theoretical foundations with hands-on laboratory experience. The key research directions within the program will include the Design and synthesis of novel therapeutic agents, Analytical method development and validation for pharmaceutical compounds, Drug metabolism, pharmacokinetic profiling, and stability studies, as well as computational drug design and molecular modelling.

Master of Pharmacology and Toxicology

The Master’s Program in Pharmacology and Toxicology at the School of Pharmacy, Newgiza University, is designed to foster expertise in translational research, with a strong emphasis on experimental models that bridge innovative lab discoveries to real-world clinical solutions. The program prepares students to tackle pressing global health challenges—from drug development to environmental safety—by integrating advanced in vivo techniques and molecular pharmacology.

This master’s program emphasises interdisciplinary research across several high-impact domains. Core areas of investigation include neuropharmacology and central nervous system (CNS) disorders, oncology with a focus on chemotherapy-induced toxicity, as well as cardiovascular and metabolic pharmacology. The program also addresses a wide range of toxicological challenges, including organ-specific and developmental toxicity, as well as the effects of environmental pollutants and heavy metals. Additionally, neuroscience research extends to the field of addiction science. These integrated research themes support the development of innovative therapeutics and enhance our mechanistic understanding of drug action and toxicity.

Master of Pharmaceutics and Industrial Pharmacy

This Master’s program provides advanced training in the design, development, and manufacturing of pharmaceutical dosage forms.

It begins with a comprehensive pre-master phase covering essential topics such as Nanomedicines, Polymers in Drug Delivery, Formulation of Natural Products and Cosmeceuticals, Kinetics of Stability and Stability Testing, Advanced Pharmacokinetics, Quality by Design (QbD) and Good Manufacturing Practice (GMP), Pharmaceutical Manufacturing, Instrumental Analysis, and Personalized Medicine.

Students must complete a practical component to gain hands-on experience in formulation, analysis, and industrial techniques. The program culminates in the submission of a research thesis supervised by distinguished professors in novel areas of drug delivery, such as nanoformulations, drug targeting, solubilisation of active ingredients, solid dispersions, solid dosage form development, cosmeceuticals, among others.

This program prepares graduates for careers in the pharmaceutical industry, regulatory affairs, or further academic research.

Program structure:

Postgraduate programs at the Faculty follow the European Credit Transfer System (ECTS). The total number of credits required for the master’s degree is 80 ECTS credits, equivalent to 40 credit hours.

To be awarded the master’s degree in Pharmaceutical Sciences in any of the offered programs, a student must fulfil the following requirements:

  • Completion of general courses totalling 8 ECTS credits (equivalent to 4 credit hours).
  • Completion of specialised courses, as determined by the relevant department, totalling 32 ECTS credits (equivalent to 16 credit hours).
  • Preparation and submission of a master’s thesis, which is evaluated as 40 ECTS credits (equivalent to 20 credit hours).

Eligibility and Terms of Acceptance:

To be eligible for admission to the master’s programs at NGU, applicants must meet the following criteria:

  • Hold a Bachelor of Pharmacy/ PharmD / PharmD clinical degree from a recognised university.
  • A minimum cumulative grade of “Good”

Admission

The application online will be available twice every year:

  • Fall Semester:
    – online application: from the 1st of July
    – Study starts in October (for 15 weeks)
  • Spring Semester:
    – online application from 1st of January
    – Study starts in March (for 15 weeks)

Admission Process:

  1. Filling the online application form
  2. Pre-screening of applicants by the School of Pharmacy Admission Office
  3. Personal interview with the academic committee.
  4. Successful applicants will receive a provisional acceptance email.
  5. Admission will be confirmed only upon submission of all hard copies of the required documents and payment within the specified deadline.

Required documents for the application:

Academic Required Documents:

  • Bachelor’s degree in pharmacy from one of the faculties of pharmacy at Egyptian universities with a minimum overall grade of “Good”, or an equivalent degree recognised by the Supreme Council of Egyptian Universities.
  • Academic transcript covering all courses completed over the five-year study period leading to the bachelor’s degree.

Non-Academic Required Documents:

  • Approval from the employer to pursue further studies, or a letter from the Central Administration of Pharmaceutical Affairs (for freelance pharmacists or pharmacists under governmental assignment).
  • An official letter from the employer confirming that the applicant will be available two days per week during the study period.
  • Original birth certificates (Computerised)
  • Copy of Egyptian national ID (For Egyptians Only)
  • Copy of passport (required for International applicants)
  • 4 personal photos (size: 4×6)
  • For Egyptian Males Only: a document clarifying their military service status.

Tuition Fees for Academic Year 2025/2026

The program consists of two academic years, comprising two semesters of pre-master courses, followed by a master’s thesis year, with the possibility of extension if needed.

Master’s Tuition Fees for Academic Year 2025/2026 for Postgraduate Students:

Fees in EGP
First Year

(Pre-master courses)

100,000 LE over two semesters

+ 10,000 LE “Bench Fees”

Second Year

(Thesis)

 150,000 LE
Third Year(If needed to complete the master’s thesis)  15,000 LE Per Semester
  • Exclusive 10% discount on tuition fees for the master’s program for NGU graduates.

Prof. Manal Mohamed Maher

Dean of the School of Pharmacy
Load Profile

Prof. Osama Hussein Kamel

Professor of Clinical Pharmacy and Pharmacy Practice & Vice Dean for Postgraduate studies and research
Load Profile

Prof. Marwa Fouad

Professor of Pharmaceutical Chemistry & Vice Dean for Education and Student Affairs
Load Profile

Prof. Rania Mohsen Abdulsalam

Professor of Pharmacology and Toxicology & Vice Dean of Enviromental Affairs and Community Services
Load Profile

Prof. Nevine Shawky

Professor of Pharmaceutics and Industrial Pharmacy
Load Profile

Prof. Ahmed Sherif Attia

Professor of Microbiology & Immunology
Load Profile

Prof. Mohamed AbouGhaly

Professor of Pharmaceutics and Industrial Pharmacy
Load Profile

A/Prof. Rabab Hamad Sayed

Associate Professor of Clinical Pharmacy and Pharmacy Practice
Load Profile

A/Prof. Rania Salama

Associate Professor of Clinical Pharmacy and Pharmacy Practice
Load Profile

A/Prof. Amr M. Saadeldeen

Associate Professor of Pharmacognosy and Natural Products
Load Profile

A/Prof. Carol Yousry Ghattas

Associate Professor of Pharmaceutics and Industrial Pharmacy
Load Profile

A/Prof. Sally Tarek

Associate Professor of Pharmaceutical Chemistry
Load Profile

A/Prof. Reham Mohamed Essam El-Wasly

Associate Professor of Pharmacology and Toxicology
Load Profile

A/Prof. Sally A. Fahim

Associate Professor of Biochemistry and Molecular Biology
Load Profile

A/Prof. Mohamed Salah

Associate Professor of Pharmaceutical chemistry
Load Profile

A/Prof. Amr M. Mahmoud Bekhet

Associate Professor of Analytical Chemistry
Load Profile

A/Prof. Rehab Moustafa

Associate Professor of Microbiology and Immunology
Load Profile

Dr. Heba Ali

Lecturer of Clinical Pharmacy
Load Profile

Dr. Ahmed Magdy

Lecturer of Pharmaceutics and Industrial Pharmacy
Load Profile

Dr. Shahira AbdelSalam ElBanna

Lecturer of Microbiology and Immunology
Load Profile